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Abstract
Data has emerged which indicates that antimicrobial use in animals has created a
reservoir of resistant bacteria and resistance genes that have spread to humans.
The aim of this study was to examine the influence of animal antimicrobial use on
human strains of S. aureus. Phenotypic and genotypic methods assessed the genetic
population structure, potential for host adaptation, frequency of antimicrobial resistance,
presence and frequency of genes encoding tetracycline and macrolide resistance and
structural variation in lelK genes in S. aureus from animals compared with human
clinical strains. In addition, the transferability of letK resistance plasmids from animal
strains to S. aureus 8325-4 was investigated.
DNA based typing exhibited 100% typeability, high levels of discrimination and a high
degree of concordance between methods. Multi-locus sequence typing (MLST)
identified six sequence types (CC5, CC15, CC22, CC25, CC30 and CC45) common to
both isolate collections that represented four of the five major human methicillin
resistant Staphylococcus aureus (MRSA) clonal lineages. The relatedness of these
clones was further supported by the analysis of 20 different virulence determinants.
Isolates of CC5 exhibited resistance to ciprofloxacin, clindamycin, erythromycin,
penicillin, streptomycin, tobramycin and tylosin, CC 15 to penicillin and tetracycline,
CC22 to penicillin and rifampicin and CC30 to penicillin. Isolates of CC45 were fully
susceptible. Low level biocide resistance was detected but the significance of this was
unclear.
3
The tetK and ermC genes were the predominant tetracycline and macrolide resistance
genes. tetK was harboured by animal isolates of CC5 and CC 15 and ermC by animal
isolates of CC5. Restriction fragment length polymorphism (RFLP) of tetK amplicons
produced indistinguishable restriction patterns. High frequency transfer of a tetK
plasmid from a chicken S. aureus (CC5) to S. aureus 8325-4 was observed.
These data support the hypothesis that animals represent an important reservoir of
antibiotic resistant S. aureus with the ability for strain and antibiotic resistance gene
transfer to humans.
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Chapter 1 Introduction
1.1 General Introduction
"Antibiotic resistance as a phenomenon is, in itself not surprising nor is it new. It is
however, newly worrying because it is accumulating and accelerating, while the world's
tools for combating it decreases in power and number" (Joshua Lederberg: Nobel prize
winner, 1958)
Almost 50 years later the levels of antimicrobial resistance has reached an alarming
level with the real potential to enter a post antibiotic era259. Worldwide there is serious
concern over the soaring levels of antibiotic resistance detected in a wide variety of
clinical and environmental organisms61,125. When a growing portion of bacteria
develops resistance, effectiveness of our current treatments and our ability to control
many infectious diseases will be jeopardized. It is generally accepted that the main risk
factor for the increased resistance seen in pathogenic bacteria is the increased use of
antibiotics which has led to the emergence and dissemination of resistant bacteria and
resistance genes 449.
Some reports have suggested that most of the antibiotic resistance problems in humans
stem from overuse or from inadequate controls in human medicine. While the
consumption and the rates of antibiotic resistance in humans has definitely increased
within Europe, especially the southern and eastern states there is an increasing interest
in the range of antibacterial compounds being used for clinical and nonclinical purposes
especially in the fields of animal husbandry, horticulture and fish farming and the risk
oft " f ibi . fr . al t h 291,161ransmission 0 anti iotic resistance om amm s 0 umans .
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1.2 Antibiotic use in agriculture
One of the central issues in this area is the fact that some antibiotics commonly used in
animals both for therapy and growth enhancement are either identical to or are related to
agents used in humans (Table 1.1) with relatively few animal specific agents such as
streptothricin and coccidiostats 126,335,352,376,222,475, 147,232,45,46,363,462,326,338,482,162,385.
Table 1.1 Antibiotics commonly used in agriculture
Antibiotic class Animal Human
Aminoglycosides Avilmycin, Apramycin, Gentamicin,
Kanamycin,
Spiramycin, Gentamicin Tobramycin, Amikacin
Amphenicols Ch loram ph en icol Chloramphenicol
Cephalosporins Cephadroxil, Cefuroxime,
Ceftriaxone, Cefotaxime,
Cephalexin Cefuroxime
Glycopeptides Avoparcin Vancomycin, Teicoplanin
Lincosamides Lincomycin Clindamycin
Macrolides Tylosin Erythromycin
Nitrofurans Nitrofurantoin Nitrofu ran toi n
Penicillins Penicillin Penicillin
Fluroquinolones Enrofoxacin Ciprofloxacin
Pleuromutilins Tiamulin, Valnemulin Valnemulin
Polyenes Amphotericin B Amphotericin B
Polypeptides Bacitracin Bacitracin
Streptogramins Virginiamycin Synercid
Tetracycline, Tetracycline,
Tetracyclines o xytetracycli n e, Oxytetracycline,
Doxycycline, Doxycycline,
Ch lortetracycli n e Ch lortetracycl ine
Sulphonam ides Sulfadoxine, Sulfatroxazole, Sulphamethoxazole
Sulfadiamine
Framycetin, Fusidic acid, Isoniazid, Rifampicin,
Others Polymixin B, Tiamulin, Ethambutol,
T ilmicosin, Polymyxin B, Fusidic
Nourseothricin acid
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Antibiotics have been used in clinical medicine for over 60 years and were introduced
into veterinary practice soon after490•
There are four ways in which substances exhibiting antimicrobial activity are used in
animals; therapy=", metaphylaxis'F', prophylaxis'r" and growth promotion+".
1.2.1 Therapeutic use of antibiotics
Therapeutic use of antibiotics is intended to treat and control existing bacterial infection
and involves using curative doses of antibiotic agents for a relatively short period of
time391• The modes of application of antibiotic agents for therapeutic purposes differ
with respect to the size of the group of animals. In principle, individual animal
treatment has to be differentiated from group treatment. Individual animal treatment is
usually offered for domestic petsl68, as well as horses used for sport and leisure. Among
food-producing animals, individual antibiotic therapy is most commonly used in the
treatment of mastitis in dairy cattle and respiratory infection in calves". Individual
antibiotic therapy is comparable to the use of antibiotics in human medicine where
every diseased animal is examined which may include laboratory analysis, such as
identification of the pathogen and antibiotic susceptibility testing, and antibiotics only
given to animals showing signs of clinical disease, either orally or perenterally, and the
dose given being appropriate to the animal and particular pathogen=".
The nature of modem animal production systems, particularly pig and poultry, make
individual treatment impractical and for fish production mass medication is the only
feasible means of treatment2,164,373. Many antibiotics are administered in water or feed
to animals raised in large numbers under industrial conditions e.g. 10,000-30,000
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chickens/turkeys in a flock, 100 weaner pigs in one pen385 or >30,000 beef cattle in a
single herd289.
1.2.2 Prophylactic use of antibiotics
Prophylactic or strategic use of antibiotics, at therapeutic levels, are used when the
spread of clinical disease cannot be contained by vaccination, changes in animal
management, or improvements in hygiene and when the development of disease in
animals in contact with an infected source is virtually inevitable without antibiotic
intervention 208,290. Numerous modem animal production systems rely on the
prophylactic use of antibiotics at particular periods in the production process. For
instance, in dairy cattle, the intramammary administration of antibiotics at the end of the
lactation period has been shown to prevent mastitis". In addition, the production of
pork and beef both rely on the prophylactic use of antibiotics during weaning or mixing
of animals from different herds. It has been shown that without this intervention an
increase in respiratory and enteric infection can occur severely compromising animal
welfare385•
1.2.3 Metaphylactic use of antibiotics
Metaphylaxis is a specific form of disease prevention in which all animals in a herd or
flock are treated when a set proportion of animals become diseased during a defined
period, and the probability of most or all of them getting infected are high208• Early
medication of the entire animal group has been shown to improve morbidity and
mortality rates while reducing the amount of antibiotics required in the treatment of a
large clinically ill population.
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1.2.4 Antibiotics used for growth promotion
Antibiotic growth promoters (AGP) are antimicrobial drugs added to animal feed at
subtherapeutic levels to enhance growth, improve feed efficiency45,127,221,426 and reduce
waste production in food animals449. In the past, it was recognised that subtherapeutic
levels of antibiotics had a positive effect on growth performance and herd health.
Feeding antibiotics to animals has been shown to significantly increase weight gain226
and to improve feed utilization by up to 7%453. Antibiotics used for this purpose have
also been called performance enhancers, feed savers and antimicrobial feed additives482•
The mechanisms of growth promotion are still not exactly knowrr'". Experiments with
germ-free chickens have indicated that the action of the AGP is mediated by their
antibacterial effect!". Four hypotheses have been proposed to explain their action: (i)
nutrients may be protected against bacterial destruction; (ii) improved digestion,
metabolism and absorption of essential nutrients such as carbohydrates, proteins, amino
acids, minerals and vitamins may improve because of thinning of the small intestinal
barrier; (iii) the antibiotics may decrease the production of toxins by intestinal bacteria;
and (iv) there may be a reduction in the incidence of subclinical intestinal
infections+!". It has also been reported that the use of AGP may have additional
benefits for the environment, with reductions in the excretion of methane, nitrogen and
phosphorous and reduced fly survival. And for the animal due to better heat tolerance
and improved immune status247• The use of antibiotics as AGP has been a hallmark of
modem intensive farming practice, but as detailed below their use is not without
criticism 162,447,470.
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While the distinction between the four uses of antibiotics in animals seems clear the
terminologies are not uniform. The American Veterinary Medical Association (AVMA)
defines "therapeutic" as including treatment, control and prevention of bacterial disease.
Also the distinction between prophylaxis and growth promotion is less clearly defined
than between prophylaxis and therapy. In the United States of America (USA) some
antibiotics may be approved for both purposes, and some growth promoters may help to
prevent disease, even at nontherapeutic doses. This is an important point as the
administration of antibiotics for limited periods can almost always be justified on the
grounds of disease prevention and animal welfare289•
1.3 Antibiotic consumption in agriculture
There is significant concern over the amounts of antibiotic used in agriculture. Accurate
figures on the global antibiotic use/consumption in animals are hard to obtain447.
However, it has been estimated that approximately 1x 106 t of antibiotics have been used
in the last 50 years with 5xl05 t used in the treatment of disease in animals, soft fruits
and vegetables'?", fishl64,334,373,for plant propagation in horticulture'P and also as
AGp54,64,75,127.Most data on antibiotic use in animals are based on the monetary value
of sales of antibiotics, which distorts the data, with published figures estimating that the
use of antibiotics in humans can be up to 20 times higher than in animals". Antibiotics
used in human medicine are more expensive per gram of active compound than those
used in veterinary medicine and are significantly more expensive than those used as
AGP74. It has been reported that this method of estimating the consumption of
antibiotics in animals can be very misleadingt'".
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1.3.1 Agricultural antibiotic consumption in Europe
The availability of data on the consumption of antibiotics in agriculture in Europe is
limited. A report published in 1995 estimated the world animal antibiotic market to be
worth 11 billion Euros and that the European Union (EU) accounted for 30% of this
market with 48% therapeutic use and 37% used as feed additive248.
Across Europe there are large differences in the use of antibiotics in animal production
between different countries. Prior to the 1999 EU restriction on the use of AGP the
consumption of antibiotics in Belgium, France, Ireland, and the Netherlands, countries
with large intensive animal production systems, for both growth promotion and therapy
were thought to be equal. In contrast, the use of AGP in Austria has been reported to be
three times higher than the therapeutic use of antibiotics'i". However, in Sweden and
Finland, countries that have historically been more restrictive in the use of AGP, <1%
of all antibiotics used in animals were given for this purpose242. Conversely, the use of
antibiotics for growth promotion in Germany, Greece, Italy, Portugal, Spain, and the
UK are estimated to be 15%-50% lower than those used therapeuticallyl".
Limited information is available regarding the consumption of different antimicrobial
agents in different countries or for different animal species. Studies have reported the
approximate consumption of antibiotics, in animals, across Europe for specific years",
Helmuth et al report that in 1984 1,520 t of antimicrobials were used in animals both
therapeutically and as growth promoters within Europel8o. Data from 1997 determined
that antibiotic use in animals had increased by 335% to 5,093 t, of which 3,494 t
(68.6%) were being used therapeutically, with tetracyclines accounting for 2284 t
(65%)426 and 1210 t of antibiotics frequently used in human clinical medicine including
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macrolides, penicillins, aminoglycosides, co-trimoxazole, fluoroquinolones,
cephalosporins, amphenicols, lincosamides, polypeptides, nitrofurans, steroid
antibiotics, polyenes and pleuromutilins (Table 1.1). The remaining 1,599 t (31.4%) of
antibiotics were given to livestock for growth improvemenr'P,
Based on body mass the mean therapeutic antibiotic dose has been estimated to be 241
mg/kg for humans and 54 mg/kg for animals/'". However, there are large differences in
the doses of antibiotics given to animals in countries across Europe. This is thought to
be related to the intensity of farm production. In Austria, Ireland, Denmark, Finland and
Sweden the therapeutic. antibiotic dose given to animals are well below the mean at
6mg/kg, 12 mg/kg and 24 mg/kg respectively. In contrast, within countries such as
Spain, Greece and the United Kingdom the therapeutic dose given is 103 mg/kg, 134
mg/kg and 148 mg/kg, respectively. These levels far exceed the mean therapeutic dose
and suggests the imprudent use of antibiotics in these EU states426•
Data on the overall use of antibiotic formulations have been published sporadically
from countries within Europe and Scandinavia but generally do not include specific
figures on antibiotic use in different animal species or groups of animals nor are there
an fi . bacteri c. • I 168289Y igures on rates of resistance among actena rrom aruma s ' .
Denmark is different and since 1994 has monitored and published trends in, (i) the
consumption of antimicrobial agents (Figure 1.1) (ii) the association between
consumption and the occurrence of resistance, (iii) the resistance among bacteria from
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animals, food and humans, and (iv) models transmission of resistance from animals to
humans 3,26,336
Figure 1.1 Antibiotic consumption in animals in Denmark (t)
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During the period 1996-1999 Denmark terminated the use of AGP which lead to a 50%
1994 1996 1998 1999 2000 2001 2002 2003
Year
reduction in their total consumption of antimicrobials. This also resulted in a 76% .,
increase in the therapeutic use of antimicrobials from 1998 to 2003. Even taking into
account the significant increase in the therapeutic use of antibiotics the overall
consumption of antimicrobials in 2003 is less that half the 1994 figure.'.
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Data from 2003 indicate that tetracyclines were the predominant antibiotic group used
in food animals accounting for 26.6% of all antibiotic use. This was significantly lower
than tetracycline use in Europe. In contrast, other antibiotics (~-lactamase susceptible
penicillins, aminoglycosides, cephalosporins, sulphonamide/trimethoprim,
sulphonamides, macrolides, lincosamides and tiamulin) were used at a higher level in
Denmark (Table 1.2). Approximately 80% of the Danish veterinary antibiotic
consumption is used in the production of pigs. It is interesting to note that while the use
of AGP is banned in Denmark 0.4 t of antibiotics were used for this purpose in 2003.
These antibiotics were used in the production of pigs for export to Poland where there
were no restrictions in the use of AGP at that time",
Table 1.2 Therapeutic consumption of antibiotics (%) in Denmark (2003)3 and Europe
(excluding Denmark) (1997)
Antibiotic groups Denmark Europe
Tetracyclines 26.6 65
Penicillins 18.5 9.5
Aminoglycosides 11.4 4.4
Cephalosporins 10.8 N/A
Trimethopriml
Sulphamethoxazole 10.3 2.1
Sulphonamides 0.8 N/A
MacrolideslLincosamides
ITiamulin 20.1 12.1
Other undifferentiated agents 1.4 6.6
N/A, data not available
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1.3.2 Antimicrobial sales figures for food and non-food animals in the UK for the
period 1993-2004
1.3.2.1 Total consumption
The Veterinary Medicines Directorate (VDM) is responsible for the authorisation of
veterinary medicines in UK and in February 2001 and 2005 published sales figures for
antibiotics used as veterinary medicine products and growth promoters for the period
1993-2004 (Figure 1.2)428.
Figure 1.2 Sales of antimicrobial therapeutic products and growth promoters (t) for the
period 1993-2004 in food and non-food animals in the UK428.
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Between 1993 and 1996 the total sales of antimicrobial therapeutic products and growth
promoters used in animals increased by 33% (495 t to 659 t) then declined steadily to
their lowest level in 1999 when legislation was passed by the EU restricting the use of
bacitracin, spiramycin, tylosin and virginiamycin as AGP430. There was a 5% increase
in overall sales in 2000 due to the higher therapeutic use of tetracyclines, trimethoprim-
sulphonamide and macrolides in pigs, poultry and multi-species products. This
increased therapeutic use of antibiotics was thought to be due to the EU restrictions on
the uses of antibiotics as AGP and the increased presence of diseases such as Porcine
Dermatitis and Nephritis Syndrome and Post-Weaning Multi-System Wasting
Syndrome (PDNSIPMWS) in pig production'r", However, the total sales figures for
antimicrobial therapeutic products and growth promoters over the period 1999-2004
remained broadly stable with sales in 2004 only 2.6% higher than those for 1993.
Nevertheless, the average overall sales of therapeutic antimicrobials and AGP over this
12 year period (1993-2004) was 545 t per annum428.
1.3.2.2 UK sales of therapeutic antibiotics used in food and non-food animals by
antibiotic group
In 2004 tetracyclines, trimethoprim+sulphonamide and p-Iactams (including penicillin)
accounted for most of the therapeutic antibiotic agents sold for use in food and non-food
animals (including companion, working and wild animals). Combined these antibiotics
accounted for 89% of total sales (tetracycline 63%, trimethoprim+sulphonamide 20%
and penicillins 16%) (Figure 1.3). Over the seven year period 1998-2004 the average
consumption of tetracyclines, trimethoprim + sulphonamide, p-Iactams,
aminoglycosides and macrolides was 216 t, 88 t, 58 t, 18 t and 46 t, respectively. There
has been a decreasing trend in the sales of trimethoprim + sulphonamide and an
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increasing trend in the sales of macrolides whilst sales have remained relatively stable
for the classes ~- lactams, aminoglycosides, fluoroquinolones and other antimicrobial
agents (Figure 1.3)428.
Figure 1.3 Sales of antimicrobial therapeutic agents (%) in food and non-food animals
for the period 1998-2004428.
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• Figures for sales of antimicrobial therapeutic agents in food animals only.
" These include Lincomycin, tiamulin, valnemulin, florfenicol, Novobiocin, decoquinate and diclazuril.
1.3.2.3 Antibiotic formulations and routes of administration.
Prior to the restrictions on the use of AGP 90% of all antibiotics used in food animal
production were administered via medicated feed or by a water/oral route, which is an
indicator of AGP use. In 2000, one year after the EU ban on AGP, this figure was 92%
and remained constant at 90-91% through 2001-2004 (Figure 1.4)428.
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Therefore, unlike Denmark, the restriction on the use of antibiotics as growth promoters
across the ED did nothing to reduce the overall sales of antibiotics, the antibiotic groups
used or the methods used to administer these agents.
Figure 1.4 Sales of antimicrobial therapeutic agents (t active agent) by route of
administration in food animals for the period 1998-2004
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1.3.2.4 Sales of therapeutic antimicrobial agents by food animal species in the UK
While the VMD has attempted to give clear and accurate data on antibiotic consumption
among a range of food animals they have found it impossible to determine the exact
usage in different species.
It is clear from the data that approximately 70% of antibiotic products are approved for
use in more than one animal species428 (Figure 1.5).
Over the 12 year period (1993-2004) aquaculture has made a significant reduction in
their use of therapeutic antibiotics while significantly increasing the production of both
salmon and trout. In 1993 aquaculture consumed lOt of antibiotics and produced
55,000 t of fish and by 2004 the consumption of antibiotics had reduced by 60% with a
290% increase in fish production. It is suggested that this reduction in antibiotic use is
due mainly to improvements in fish husbandry and a more effective use of vaccines to
prevent bacterial infections 164,373. Other than fish production the overall sales of
therapeutic antimicrobials over the period 1993-2004 has remained stable428•
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Figure 1.5 Sales of therapeutic antimicrobial agents (%) by food animal species 1993-
2004.
100
cMulti-
80 species*
• Fish
~ 60 o Poultry--'I)~
~ 40 OPigs
rz:J
20 • Sheep
0 .Cattle
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Year
* A combination of two or more of the following - cattle, pigs, sheep and poultry
1.3.3 Agricultural consumption of antibiotics in the USA
Many of the antibiotics commonly used in animals both for therapy and growth
enhancement within the USA are either identical to or are related to agents used in
humans including penicillins, tetracyclines, cephalosporins, fluoroquinolones,
glycopeptides, aminoglycosides and streptogramins (Table 1.3)134,226.
Reliable data on the use of antibiotics in animal production are not publicly available,
making it difficult to determine which drugs are used in what quantities and for what
purposes289. Within the USA no single government agency is able to supply accurate
data on the amounts of antibiotic used in animals. Estimates of antibiotic consumption
have been produced based on figures compiled from a variety of agencies including the
Food and Drug Administration (FDA), Centre for Disease Control (CDC) and United
States Department of Agriculture (USDA). Figures published by these agencies in 2001
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indicate that 16,000 t of antibiotics are used in agriculture each year and that 70%
(11,200 t) are used as AGP in the production of pigs, cattle and poultry142. Prescotr'F,
while not giving any specific figures, considered that 40% of the total antibiotic
production in the USA was for animal production and that 55-60% of the production of
benzylpenicillin and tetracycline was used in animal feed. Levr61 agreed with the
Prescott figure of 40% of total production, which he estimated to be 23,000 t, 7,000 t
(44%) higher than the figures produced by the FDA, CDC and the USDA. Levy
estimated a higher figure than Prescott's (80%) for tetracycline and benzylpenicillin use
at subtherapeutic doses mixed in animal rations as AGP259. The Union of Concerned
Scientists (UCS), an environmental advocacy group in the USA, has published figures
on the estimated annual use of antibiotics in animal production. They estimate that
12,100 t of antibiotics are used each year with 11,200 t (92.6%) given to animals for
non-therapeutic purposes while only 900 t were given in treatment of disease162. In
contrast, a survey by the Animal Health Institute, a lobby group for the meat and
livestock industry, reported in 2001 that only 8,100 t of antibiotics were used in animals
with 6,700 t (83%) used therapeutically, either treatment or prophylaxis, with the
remaining 1,400 t (17%) used as AGP142.
Groups supporting the use of AGP indicate that their use protect animals from a variety
of infectious diseases": While animal welfare groups disagree with these claims and
suggest that the long term use of antibiotic prophylaxis is unnecessary''".
The overuse of antibiotics, whether in human medicine or agriculture, is a serious
problem26o. The UCS suggests that the agricultural use of antibiotics is likely to be a
larger part of the overall antibiotic resistance problem than is currently thought and
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conclude that it is a general misconception that human medicine is the major abuser of
antibiotics and that it is the production of food animals where the abuse is occurring'Y.
Table 1.3 Examples of antimicrobials approved for use in the United States of America
in food animals.
Purpose Cattle Pigs Poultry Fish
Amoxicillin* Amoxicillin* Erythromycin" Onnetoprim
Cephapirin" Amoicillin* Fluoroquinolone" Sulohonamide*
Erythromycin" Chlortetracvcline" Gentamicin* Oxvtetracycline*
J
Fluoroauinolone* Gentamicin* Neomvcin"
Gentamicin* Lincomvcin" Penicillin*
Novobiocin Sulfamethazine Spectinomycin"
Penicillin* Tiamulin Tetracycline*
Sulohonamides* Tylosin Tylosin
Tilmicosin VirginiamYcin
Tylosin
] Bacitracin= Asanilic acid BambermvcinChlortetracycline- Bacitracin+ Bacitracin+
U Lasalocid Bambermvcin Chlortetracvcline"Monensin Chlortetracycline= Penicillin-Oxytetracvcl ine- Ervthromvcin= Tylosin] ] Penicillins VirginiamycinTiamulin
Tylosin
Virziniamvcin
• Antimicrobial agents used in human medicine
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1.4 EU ban on AGP
The era of antibiotics as growth promoters (AGP) began in 1946 with the recognition of
a substantial growth response to the inclusion of streptomycin in the feed of chickensi",
By 1949 it was shown that both pigs and chickens fed a diet supplemented with the
dried biomass recovered from the fermentation of Sterptomyces aureofaciens, used in
the production of chlortetracycline, had a significantly improved daily weight gain
ranging from 3 to 19%54,116,226.Antibiotics were approved for use as AGP in the USA in
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1949 and by 1953 UK approval was also given49o. At a time when livestock
management was changing rapidly from low-performance, high mortality, free range
farming to a more controlled and intensive husbandry, and when post war demands on
increased food production were high, the discovery of an unexpected method to
accelerate animal growth was received with interest and enthusiasm by scientists,
agriculture and the general public. In April 1950 the discovery of AGP was front-page
news in both New York and London'<'. However, the down side of this was that by the
mid-1960's transferable antibiotic resistance was detected in Salmonella sp from farm
animals+". Such was the concern that the UK government instructed a select
committee, chaired by Michael Swann, to investigate the possible human clinical
consequences of the use of antibiotics as AGP.
The Swann report was published in 1969 and concluded that molecules that are used for
therapy in man and/or animals may not be used as an agricultural growth promoter420.
Legislation restricting the use of antibiotics of therapeutic value in human medicine,
Particularly as feed additives, was introduced in 1971493.As a result, no antibiotics of
human clinical importance are used for growth promotion in agriculture in the U.K.,
although closely related antibiotics were not restricted by legislation, and a veterinarian
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must prescribe all antibiotics given to animals either therapeutic or prophylactict'". The
USA has consistently refused to follow the recommendations of the Swann report using
the argument of economic saving in favour of the use of antibiotics to promote growth,
increase feed efficiency and to decrease waste production29,296. Since 1977, however,
the Food and Drug Administration (FDA) has called for greater restriction in the use of
both penicillin and tetracycline alone or in combination in animal feed. The US
congress has opposed the FDA proposal basing their argument on the lack of evidence
that antibiotic resistant bacteria of animal origin were frequently transmitted to humans
although it was accepted that antibiotic use in animals may select for resistant
bacteriar'".
Following the Swedish governments publication of the feedstuffs Act in January 1986
Sweden introduced a restriction on the use of antibiotics in animal feed, excluding the
treatment, prevention or cure of diseases, meaning there use for growth promotion
should not be allowed449• In March 1995 the first reports on the occurrence of avoparcin
and vancomycin resistance in enterococci (VRE) in pigs and poultry were published".
At this time Danish farming organisations agreed a voluntary ban on the use of
avoparcin. This was followed by a ban imposed by the Danish government and was also
reported to the European commission under directive 701524IEEC that allows member
states, as a result of new information, to temporarily suspend the use of an approved
feed additive if it constitutes a danger to animal or human health. The Danish ban was
based on; (1) cross resistance between avoparcin and vancomycin, a very important
antibiotic in human medicine, (2) the resistance was transferable, and (3) the use of
avoparcin as an AGP selects for VRE and these VRE can transfer to humans via the
food chain. Following the Danish decision to ban avoparcin Norway and Germany also
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banned its use in June 1995 and January 1996 respectivelyt". However, in May 1996
the European Union scientific committee on animal nutrition (SCAN) concluded that
there were insufficient data to support the ban of avoparcin and that further evidence
was required to establish the risk to human health, animal health or the environment.
Nevertheless, SCAN did accept that serious questions concerning the safety of
avoparcin had been raised and stated that its use should be reconsidered. Following this
the EU proposed that in a climate of uncertainty and to avoid any risk a temporary ban
should be placed on avoparcin as an AGP in all EU member states which came into
force in April 1997 under directive 97/6/EC242
On the 16th January 1998 Denmark banned the use ofvirginiamycin as an AGP due to
the risk on the selection of streptogramin resistance in enterococci in pigs and poultry.
This step was taken to protect the lifespan of synercid, a recently licensed streptogramin
used to treat multi drug resistant infections in humans 11,45. Pfizer, the producers of
virginiamycin, challenged this decision before the European court of justice but lost the
law suit when the court ruled that the ban on the product was not a disproportionate
measure given the need to protect public health. In December 1998 the agriculture
ministers of the EU member states voted in favour of the proposal to ban a further four
AGP. The use of virginiamycin, bacitracin zinc, tylosin phosphate and Spiramycin as
AGP were restricted, under directives 2788/98/EC and 2821/98/EC, from July 1999
allowing only the use of avilamycin, bamberimycin, salinomycin and monensin242,43o.
As of January 2006 the use of all remaining AGP has been restricted.
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1.S The debate
It is generally accepted that animals and humans constitute overlapping reservoirs of
resistance, and consequently the use of antibiotics in animals can impact on public
health472• Nothing in the area of antimicrobial use has generated a more vigorous debate
recently than the use of antimicrobials in animals, especially food animalsv",
Fundamentally two positions have emerged. The first states that resistance to antibiotics
of human importance has been generated in animals, is spread to humans with the
potential to cause major harm, and therefore action must be taken to minimize it. This is
the position adopted by regulatory officials in the European Union, Australia, Japan,
New Zealand, and other nations and is designated the PRECAUTIONARY
PRINCIPLE3l• The second position states that resistance to antibiotics of human
importance has been generated in animals, but the evidence that it has spread to
humans, caused infection and treatment failure of these infections is minimal or non-
existent, and that the ban on the use of antibiotics as growth promoters is unwarranted
and should be revoked=", This position is known as the PRINCIPLE OF PROOF,
which requires the gathering of evidence that a problem has emerged before taking
action, and has been adopted by the USA. Although within the USA there is still much
debate over this issue. The Food and drug administration (FDA) have recommended
that the use of penicillins and tetracyclines as AGP should be severely restricted but
Congress has overruled the FDA and after a review of these recommendations the
National Academy of Science (NAS) concluded that no restrictive action should be
taken on the use of AGP in animals.l34
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While both positions agree that resistance to antibiotics of human importance has been
generated in some food animals evidence of harm to humans has been harder to find.
Simply showing that a growing proportion of commensal and pathogenic bacteria
isolated from food animals are resistant to antibiotics is not enough to prove a threat to
human health3o•
Casewell et al report that following the ban of AGP in Sweden there were signs of
adverse consequences for animal health and welfare resulting in economic
consequences for farmers. They also report that in Denmark since the late 1990's
poultry producers have been struggling with leg and skin problems among chickens and
indicate that these problems compromise animal welfare'". In contrast, Weirup has
reported that following the ban on AGP in Sweden there were no negative clinical
effects reported in slaughter pigs, cattle and turkey. However, he did note that there had
been an increased incidence of necrotic enteritis in chickens and diarrhoeal problems in
weaning piglets that was quickly resolved and concluded that under good production
conditions it is possible to reach good and competitive production without the use of
AGP481. Emborg has published data on poultry production, in Denmark, after the ban on
AGP and concluded that despite the fear of decreased productivity and increased
mortality it was possible to withdraw all use of AGP, from broiler production, without a
I· 116oss III output .
While the ban on AGP and the effect on animal welfare remains unresolved what is
clear is that there has been a marked increase in the therapeutic use of antibiotics in the
UK428and throughout Europe'".
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1.5.1 The evidence for the spread of antibiotic resistance from animal to human
Much of the evidence relating to the potential for transfer of a resistance problem from
animals to man comes from a consideration of the epidemiology of zoonoses, mainly
salmonella and campylobacter infection, and what have become known as indicator
organisms, enterococci and E. coli, which cause opportunistic infections in animals and
can cause disease in man which might be zoonotic58,72,87.
The important antibiotic resistant strains in this context are multiply antibiotic-resistant
salrnonella'r", macrolide and quinolone-resistant campylobacter+'t'?", glycopeptide and
streptogramin-resistant enterococci 184,206,432, and multiply antibiotic-resistant E.
coli284,348
The mechanisms of spread of antibiotic resistance from food animals to humans
remains debatable 446. As a result of exposure to antibiotics, the level of resistance
against antibiotics among bacteria belonging to the normal intestinal flora of humans
and animals increases. These bacteria not only constitute an enormous reservoir of
resistance genes for pathogenic bacteria, but also the level of resistance within the
endogenous flora is considered to be a good indication of the selection pressure exerted
by antibiotic use in that population and for the resistance problem to be expected in
pathogens 449.
When animals become colonised with resistant organisms, these orgamsms can
eventually reach humans through the food chain by direct contact or contamination of
water or crops from animal excreta 488.
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Animal to human transmission of antibiotic resistant pathogens and the role of antibiotic
use in food animals in the emergence of these bacteria are controversial subjectsl'".
However, there are two potential mechanisms of resistance transfer; (i) resistant strains
spread, and (ii) horizontal gene transfer (HGT).
1.5.1.1 Resistant strain spread
Most investigations on the transfer of resistant bacteria from animals to humans concern
Gram negative food infections caused by bacteria such as Salmonella spp and
Campylobaeter spp.
1.5.1.1.1 Salmonella spp
Non-typhoid Salmonella infections are the principle cause of food poisoning world
wide with an estimated annual incidence of 1 billion cases and 3 million deaths'". In the
USA alone Salmonella strains cause an estimated 1.4 million infectionsf", mostly in
children and the elderly, with 16,000 hospitalizations and approximately 600 deaths
each year13S,170,324. The economic costs due to food-borne Salmonella infections in the
USA are estimated at $2.4 billion per year1SO•
While the majority of infections result in asymptomatic or self-limiting diarrhoeal
illness'?", severe, life-threatening septicaemias and other deep-seated infections do
occur, particularly among the immunocompromisedt'", neonates and the elderly480 and
require effective antibiotic therapy'". Despite legislation targeted at controlling the
overall use of antimicrobials in food-producing animals, in recent years there have been
significant increases, within developed countries, in the occurrence of antimicrobial
resistance in non-typhoidal Salmonella spp including multidrug-resistant (MDR) S.
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concern is the development of resistance to key antimicrobials such as extended
spectrum cephalosporins (ESC)114 and the fluoroquinolones because of the importance
of these antimicrobials in the treatment of systemic infections in children50 and
adults324, respectively. Cases of infection in humans caused by both ESC and
quinolone-resistant Salmonella spp acquired from animals and subsequent treatment
failure have been reported135,297.
The results of a study by Winokur et al on animal and human MDR Salmonella
concluded that while they could not definitively prove the spread of MDR Salmonella
from an animal source to humans the genetic relatedness of the plasmids identified and
their prevalence in animal isolates was at least suggestive'l'". Fey et al investigating a
ceftriaxone-resistant Salmonella infection in a child whose father had treated cattle
infected with the same clone concluded that while the infection was transmitted from
cattle to child the route of transmission was not through the food chain and remained
unresolved". Melbak et al have reported an outbreak of MDR Salmonella enterica
serovar Typhimurium DTl04, in humans, from contaminated pork. Those infected had
contracted the organism through occupational contact and consumption of contaminated
meat, there was also one case of nosocomial transmission in which the patient died.
They identified the likely reservoir of the outbreak clone in two swine herds that had
been processed at the incriminated abattoir297. In contrast, a review by Piddock
concluded that although Melbak et al had shown that the same strain type as in the
outbreak could be isolated from two pig farms, there was no evidence of quinolone use
on the farms and that the pigs may have acquired the quinolone resistant strain from
another, source possibly human=". While Melbak proposed that the strain had been
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transferred to those infected Via the food chain, Piddock suggests that, although
unlikely, those infected had acquired their strains from another source and that it was a
coincidence that the strain types were the same. While it is accepted that Salmonella
enterica serovar Typhimurium DTI04 is a zoonotic pathogen and humans usually
become infected by eating contaminated food, often poultry, it is not widely accepted
that quinolone-resistant strains of this same serovar and type are transmitted through the
food chain338.
1.5.1.1.2 Campylobacter spp
Infections caused by Campylobacter spp., particularly Campylobacter jejuni and
Campylobacter coli, are among the commonest causes of human gastroenteritis in the
world273. Campylobacterioses are zoonotic diseases with domestic animals such as
poultryIOI,337,403,pigs99,328,364and cattle25, and companion animals such as cats and dogs
acting as reservoirs. As these organisms may be transferred from animals to humans
through the food chain, the emergence of antibiotic resistance, especially
fluoroquinolone resistance in Campylobacter spp is of particular concern66. There are
two opposing views on the use of fluoroquinolones in animals and resistance detected in
Campylobacter spp isolated from human infections. Engberg et al have reported that
fresh raw meat, especially poultry, is a major source of campylobacter infection and that
the emergence of fluoroquinolone resistance in humans has often coincided with or has
followed the approval of fluoroquinolones in veterinary medicineI19,l2o. Gaudreau et al
has reported that many European countries and the USA have shown an increase in the
levels of fluoroquinolone resistance in Campylobacter spp, especially C. jejuni, since
their introduction, between 1987-1993 in Europe and 1995 in USA, for the treatment
and prevention of disease in poultry 149.
54
Endtz et al have proposed that ciprofloxacin resistant campylobacter emerged in
poultry after quinolones were used in the treatment of infected flocks and that these
bacteria entered the food chain and have caused infections in humans 118. In contrast,
prior to the introduction of the fluoroquinolone, enrofloxacin, into veterinary medicine
fluoroquinolones were widely used in human medicine in a number of countries
without the emergence of resistance in Campylobacter spp in humans 199. However,
Ishihara et al reported that a fluoroquinolone resistant campylobacter was isolated, in
Japan, from a diarrhoeal patient in 1989 two years before the introduction of
enrofloxacin into veterinary medicine'I".
1.5.1.1.3 Enterococci
In addition to being a member of the normal faecal flora of humans and animals
enterococci have the ability to cause a wide range of serious nosocomial infectionsf".
Of particular concern has been the acquisition of resistance to many antimicrobial
agents, especially the glycopeptides. Glycopeptide-resistant enterococci (GRE) were
first discovered in Europe in 1986250 and in the USA in 1987365• It has been proposed
that the emergence and spread of GRE in Europe has been due to the use of avoparcin,
since the mid 1970's, as an AGP in animal husbandry'i". GRE frequently contaminate
meat and meat products. These organisms have been shown to survive gastric passage
and colonise the gut of humans'P". However, the role that non-human sources and
reservoirs may play in the spread of Enterococcus spp remains controversial'f".
The finding of genetically related GRE isolates in food animals, meat products=", and
hospital in and outpatients suggest that clonal transmission between animals and
humans can occur and may contribute to colonisation and subsequent infection in
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humans377• van den Bogaard et al 448 and Stobberingh et al 413 have both reported
indistinguishable ORE in the faeces of Dutch turkey farmers and their flocks. Lu et al
reported an outbreak of E. faecium infection in pigs and farmers with indistinguishable
pulsed field gel electrophoresis (PFOE) pattems272• Jensen et al, on the basis of analysis
of vanX variants on Tn1546 in E. faecium from humans, pigs and chickens, argue that
the spread of entrococci is from animal to man and not vice versa203• In contrast, Song
et al, based on PFOE and polymerase chain reaction (PCR) detection of the
glycopeptide resistance genes vanA and vane, reported that there was a low incidence
of vancomycin resistant enterococcus (VRE) colonisation in humans, despite a high
recovery rate from raw chicken meat, and that there was little evidence to suggest that
the transmission of VRE from animals to humans occures'". Seo et al compared VRE
from humans, poultry and pigs and reported that there was no difference in the rates of
VRE isolation in food animals regardless of whether avoparcin was used389. Using
repetitive extragenic palindromic PCR (rep-PCR) to compare the genetic relatedness of
high level VRE isolated from animals and humans, they reported that isolates from
animals were heterogeneous while human isolates showed significant similarity and
reported that no genetic relatedness existed between human and animal isolates of
VRE389
1.5.1.1.4 E. coli
E. coli are part of the normal micro flora of the gastrointestinal tract of mammals and
birds. Certain strains of E. coli, 0157:H7, 026, 0111, 0103, 0105 and 01 in man and
02 and 078 in poultry, F5 in calves, and 0149 from pigs have been associated with
gastrointestinal and systemic disease, some being zoonotic36,68. Multiply antibiotic
resistant non-pathogenic E. coli from the gut of animals have been shown to
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contaminate meat at slaughter and eggs during laying446. However, opinions differ as to
whether strains from animals are able to colonise the human intestinal tract. Dupont et
all13 concluded that while E. coli from animals are able to colonise humans this
colonisation is transient and that animals are not an important source of resistant
coliforms. Smith402 also concluded that animal strains of E. coli were poorer than
human strains at colonising the alimentary tract of humans and that animals are not an
important source of antibiotic resistant E. coli. Shooter et aP95 found significant
differences in '0' serotypes of animal and human E. coli and concluded that E. coli
from animals may differ from those of humans. In contrast, Linton et aP66 have shown
that antibiotic resistant E. coli isolates from chickens were able to colonise the intestinal
tracts of human volunteers. Ojeniyi320 has also reported the direct transmission of
antibiotic resistant E. coli from poultry to their attendants. van den Bogaard et al 446,
investigating the antibiotic resistance patterns and clonal relationship of E. coli isolates
from poultry and humans, concluded that the results of the study strongly indicate that
the transmission of resistant clones of E. coli from poultry to humans commonly occurs.
1.5.1.2 Horizontal resistance gene transfer
Concern over the safety implications of antibiotic-resistant bacteria in foods has also
focused on the question of how likely such bacteria are to transfer antibiotic resistance
genes to human intestinal bacteria during their passage through the intestinal tract and
what might happen to the transferred genes once they enter the colonic flora315. Studies
have reported evidence of horizontal resistance gene transfer among organisms in soil,
in water'", on the skin and in the intestine of laboratory rodents27,258,314 and in
experimental abcesses", Phillips et al proposed that the ultimate defence of those who
support the farm-to-clinic hypothesis is that provided animal organisms reach the
57
human faeces, they need to survive for only brief periods to pass on their antibiotic
resistance genes to resident organisms. However, they cast doubt as to whether
horizontal gene transfer (HGT) occurs, between organisms of animal origin and those of
the human gut flora336• It has been well documented that antibiotic resistant bacteria
from livestock can and do enter the food supply and have been isolated in meat intended
for sale in shops and that these organisms not only pass through but can also colonise
the intestinal tract of humans 70,380,480. A study undertaken by Davison reports that the
ability of bacteria to exploit new environments and to respond to new selective
pressures can be more easily explained by the acquisition of new genes by HGT rather
that the sequential modification of gene function by the accumulation of point mutation
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Several studies have shown that the transfer of antibiotic resistance genes, by HGT, can
and does take place between a variety of Gram-positive and Gram-negative bacteria.
Nikolich et al investigated tetracycline-resistant Bacteroides spp, a major constituent of
the human gut flora, and Prevotella ruminocola, the predominant genus of the
micro flora of ruminants and other farm animals, and concluded that extensive natural
gene transmission had occurred and that among the exchange events was the recent
transfer of a tetQ allele between members of these two genera315,368. Oppegaard et al has
reported the horizontal transfer of a multi-drug resistance plasmid between E. coli in
cattle and humans325• In a retrospective study Salyers et al sequenced resistance genes,
tetQ and ermF, found in colonic bacteria. They concluded that since the 1970's there
had been a significant increase in the carriage of these genes in Bacteroides spp.
Sequence analysis of these genes few sequence differences in all the tetQ and ermF
genes examined, indicating horizontal transfer of these genes, in the human colon,
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possibly from an animal source over a time period that is short in evolutionary terms368•
They also found the HGT of macrolide resistance genes ermB and ermG genes
previously exclusively found in Gram positive bacteria, had entered Bacteroides spp.
between 1970 and 1990368.
In Germany, Witte found the HGT of plasmid mediated streptothricin resistance, a drug
used as an AGP in pigs with no human use, in E. coli from urinary tract infections and
in Salmonella spp and Shigella spp from cases of diarrhoea in humans49o• Hunter et al194
and Chaslus-Dancla et al69 have both reported the horizontal transfer of apramycin
resistance, conferring cross resistance to gentamicin, kanamycin and tobramycin,
encoded by aminoglycoside 3-N-acetyltransferase IV (aacC4) between bacteria, both
commensal and zoonotic pathogens, from animals to humans. Salauze et al provide
evidence of the horizontal transfer of hygromycin B resistance, linked to an aacC4 as an
operon with an association with 1S140 and conferring cross resistance to other
aminoglycoside antibiotics, encoded by hygromycin B- phosphotransferase 4 (hphB)
between animal and human isolates of E. coli, Salmonella spp, Klebsiella spp and
Serratia Spp367.
In conclusion, both HGT and clonal expansion occur and contribute to the spread of
antibiotic resistance; however, the extent to which each mechanism contributes to the
observed rise in antibiotic resistance is unclear. HGT may be sufficiently common to
drive the dissemination of antibiotic resistance alone, with clonal expansion working
only to amplify the genes within individual organisms. HGT may be a rare occurrence
with clonal expansion of bacteria with antibiotic resistance genes accounting for the
growth in the levels of antibiotic resistance 41.
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1.6 Staphylococcus aureus
1.6.1 History and taxonomy
Staphylococci are a ubiquitous and diverse group of organisms that are widely
distributed in a variety of natural environments ". Natural populations are associated, in
high concentration, with the skin, skin glands and mucous membranes, of warm
blooded animals. Staphylococci are also found in the genito-urinary and upper-
respiratory tracts, in animal products, and other environmental sources such as soil, sea
water, fresh water, dust and air and have the ability to persist in a variety of adverse
environments 177.
The first reports of staphylococci were published by Recklinghausen, Waldeyer, Birch-
Hirschfeldt, Klebs and Hueter in 1871 and 1872. They reported the presence of round
elements in pus, kidney, blood and abscesses of infected patients. In 1880 Pasteur
published the results of a study into the causes of furuncles, osteomyelitis and puerperal
fever. From cases of puerperal fever he isolated "en longs chapelets de grains" now
classified as streptococci and in furuncles and osteomyelitis he reported the presence of
"le petit vibrion pyogenique" or staphylococci by modem classification 343.
The name staphylococcus was first used by the Scottish surgeon, Alexander Ogston in
1881, from the Greek nouns "staphyle", a bunch of grapes and "coccus", a grain or
berry, as a common name for cluster-forming cocci'. However, it is Rosenbach who is
acknowledged for introducing the common name of staphylococcus in 1884. Prior to
this many other bacteriologists had used the terms monad, micrococci or microsporon to
describe this group of organisms seen in diseased tissue 234.
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Rosenbach first assigned staphylococci into species based on colony colour. The
yellow-orange colony type he called Staphylococcus pyogenes aureus (Staphylococcus
aureus) and the white colony type Staphylococcus pyogenes albus (Staphylococcus
albus). This characteristic was also recognised and suggested by Elek, Verneiul and
Ogston. A third staphylococcal species, S. citrus, a lemon coloured colony type, was
added by Passet in 1885. This method of classification proved unacceptable mainly
because pigmentation is genetically unstable in many staphylococcal strains343.
Elek expressed the opinion that the medical bacteriologist is not very concerned as a
rule with classification or nomenclature. To him the broad division into pathogens and
non-pathogens overrides other considerations, and further subdivision matters only if it
aids the recognition of a pathogen or enables him to trace the source of infection. The
biologist aims to fit the pathogen into the general order of living creatures, caring little
about disease and the microbial features that enter into its causation. The classification
of staphylococci is much bedevilled by this fundamental difference in aim 234.
By the early 1900's most bacteriologists were aware that staphylococci were present in
a variety of natural environments as well as resident on most animal species including
humans. At this time most weight was placed on the identification of S. aureus from
the commensal staphylococcus, S. albus. Methods used to identify S. aureus were at
this time unreliable even though the coagulase test was available. However, this test
remained un-noticed until 1925 when Von Daranyi indicated the value of the coagulase
test in the identification of S. aureus'". Although the coagulase test was available and by
the mid 1920's was being promoted its use was not routinely accepted until the 1930's
when the link between coagulation of plasma and pathogenicity became generally
61
accepted=", Evans in 1948 reported the observation that S. aureus were able to ferment
mannitol anaerobically. This reaction together with the coagulase test was used in the
7th edition of Bergey's manual to identify S. aureus. The genus staphylococcus was
recorded as a member of the family Micrococcaceae and comprised of only two species
S. aureus (coagulase positive and fermented mannitol anaerobically) and S. epidermidis
(coagulase negative and unable to ferment mannitol) 1.
In the late 1800's bacteriologists were separated into two camps; those who wished to
classify staphylococci on the basis of pathogenicity, and those who wished to place
staphylococci into a universal order of bacteria. At this time all cocci were incorporated
into a single family the "coccaceae" with staphylococci, streptococci and gonococci in
one sub-division and the non-pathogenic micrococci in another. By the early zo"
century the coccaceae were split into two sub groups; the paracoccaceae which
included staphylococci and streptococci and the metacoccaceae that was composed of
micrococci and sarcinas 486. The separation of staphylococci from micrococci, although
discovered and reported between 1882 and 1900 was not generally accepted until the
1950's when Evans proposed that staphylococci and micrococci could be separated
based on there requirement for oxygen. Those species that were facultative in there
requirement for oxygen were placed in the genus staphylococcus and those that were
obligate aerobes were classified as micrococcus 1• In 1965 the first meeting of the
subcommittee on staphylococci and micrococci, introduced by the International
Association of Microbiological Societies, met and set the criteria for the separation of
staphylococci from micrococci based on the ability of staphylococci to produce acid
anaerobically from glucose in a peptone-yeast extract medium using bromo-cresol
purple as a pH indicatorr".
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Since 1965 the taxonomic position of staphylococci remained in flux. However the
introduction of newly developed genetic investigations allowed taxonomists to clearly
demonstrate that although staphylococci and micrococci are both catalase positive,
Gram-positive cocci, their guanine and cytosine content as a molar percentage is
significantly different with staphylococci having a G+C mol% content of 30-39 while
members of the genus micrococcus had a much higher G+C content of 63-73 mol%
indicating that these genera are not closely related234• Numerous other testing methods,
including haemolytic activity178, digestion of gelatine and milk234 serological
examinatiorr ", agglutination 108, precipitation reactions, cell wall analysis", nucleic
acid hybridization studies'", comparative analysis of 16S rRNA sequences=' , rRNA
gene restriction site polymorphism analysis" and Polymerase Chain Reaction (PCR)
based methods283,495 have also been used in an attempt to clarify staphylococcal
taxonomy. Kloos et al and Schleifer et al have both reported and stressed that the
genera staphylococcus and micrococcus have no close relationship to one another,
according to phylogenetic concepts, however to date both remain in the one family the
Micrococcaceae together with stomatococcus and planococcus234,371.
The 7th Edition of Bergey's Manual of Systematic Bacteriology, published in 1957,
described only two species of staphylococci. It wasn't until 1974 that the 8th Edition
listed a third species S. saprophyticus although this species had been described and
proposed in 195139°. Since 1975 the genus staphylococcus has undergone extensive
revision with investigations into new environments and different animal hosts brining
about the addition of new species to the genus staphylococcus 177.
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1.6.2 S. aureus colonisation
1.6.2.1 Human colonisation
S. aureus colonises the skin and mucosae of humans and several animal species.
Although numerous body sites can be colonised a study by Kluytmans et az236 has
reported that the desquamated epithelial cells of the anterior nares (vestibulum nasi)
represent the dominant ecological niche for S. aureus as the elimination of nasal
carriage leads to loss of carriage in other areas. The rate of S. aureus nasal carriage in
the general population ranges from 30% to 70%264. Based on longitudinal studies nasal
carrier status has been divided into three categories: persistent carriage, intermittent
carriage, and non-carriage. These studies have shown that approximately 20% of the
general population (range 12-30%) are persistent nasal carriers, 30% (range 16-70%)
are intermittent carriers, and 50% (range 16-69%) are non-carriers. Persistent carriers
are often colonised by a single S. aureus strain over long periods while intermittent
carriers may carry different strains over time477. The S. aureus load is also higher in
persistent nasal carriers and increases further if carried both in the nose and perineum.
Carriage of S. aureus in the nose appears to play a key role in the epidemiology and
pathogenesis of infection=", a view strengthened by showing a correlation between
colonisation densities of S. aureus at the carriage site and the risk for the development
of infection479• Host characteristics have been shown to substantially co-determine S.
aureus carrier state and that an optimal fit between the host and bacteria is essentiat236•
This view is further supported by a report by Wertheim et al which has shown that S.
aureus extra-nasal carriage rates are higher in nasal carriers than in non-carriers (Figure
1.6) and that carriage is also higher in those with immunosuppressive illness such as
diabetes, HIV, and end stage liver and kidney disease477•
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Figure 1.6 S. aureus carriage rates per body site in adults477
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Studies comparing carriage and infecting isolates of S. aureus have demonstrated that
individuals are usually infected by their own carriage strain, and temporary eradication
of carriage following the use of topical mupirocin has been shown to reduce
infections=". Also carriage rates vary between ethnic groups, with increased rates in
Caucasians especially men and are age dependentl'". Prevalence rates of S. aureus
colonisation in neonates and children are consistently higher than those from adultsand
may reach 50_100%349. Peacock et aP3! report that infant nasal carriage rates varied
significantly with age, falling from a high of 40-50% during the first eight weeks to
21% at six months. Kloos has also shown an age dependent variation in nasal carriage
reporting that in pre-adolescent children the nasal carriage rate for S. aureus is often
higher than in adults and that the populations are often more dispersed over the child's
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1.6.2.2 Animal colonisation
Ecological studies of S. aureus colonisation of animal skin have been reported
infrequently in the literature. In a study by Kloos, on the natural populations of the
genus staphylococcus, he reported that S. aureus was not the most common colonising
Staphylococcal species from a range of animal species with the exceptions of rabbits,
hares and chicken='". The predominance of S. aureus colonisation in chicken has also
been confirmed by Aarestrup and Shimizu et aP93 who have shown carriage rates in
excess of 30%. In contrast, Nagase et aP09 have reported a skin carriage rate, in poultry,
of only 3.8%.
Kloos has also reported that cattle are able to support populations of S. aureus on
udders, in teat canals and in milk but was infrequently recovered from the nares. In
sheep and pigs S. aureus populations have been identified colonising both the nares and
udders234 with one study recording a skin colonisation rate of 41.7% in pigs309. In a
study by Shimizu et aI, the S. aureus colonisation rate in horses was 30% and Loeffler
et aI, while not giving any specific figure reported that S. aureus was the predominant
species isolated from horse393,27o. In contrast, Kloos concluded that horses could carry
populations of S. aureus but their residency status remained unclear''". As early as
1959, Mann reported as. aureus nasal carriage rate of 23% in dogs and proposed that
the household pet was an important carrier, and therefore reservoir of S. aureus
infection for man281• Other reports have indicated that dogs are able to support nasal
populations of S. aureus that have been shown to be closely linked to human dog
handlers28o• A more recent and worrying development has been the isolation of
methicillin resistant S. aureus (MRSA) in companion animals which have acted as a
reservoir of infection to their owners280,168,431.
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1.6.3 S. aureus strain characterization
1.6.3.1 Characterization of human strains
The ability to discriminate between different strains of a bacterial species has several
applications, including investigations of bacterial species evolution241,321, bacterial
virulence'f", and disease transmissiorr'". Naturally, an understanding of the dynamics
of spread and an identification of transmission or outbreaks are of interest not only to
epidemiologists but also to microbiologists and those involved in patient and animal
management. Staphylococcal strains may vary considerably in virulence and
epidemiological potentialf". To control the spread of staphylococcal infection the
sources of contamination and mechanisms of transmission need to be identified. Studies
of the pathogenicity and epidemiology of staphylococci depend on the availability of
typing schemes that can differentiate between strains. Numerous phenotypic and
genotypic methods have been used for typing S. aureus isolates (Table
1.4)197,381,175,,286,104,362,88,237,444,47,450,300,245,122.
Table 1.4 Phenotypic and genotypic methods of S. aureus characterization
Phenotypic methods Genotypic methods
Antibiograms Multilocus enzyme electrophoresis (MLEE)
Biotyping PFGE
Bacteriophage typing Multilocus restriction fragment typing (MLRFT)
Plasmid profiling with Multilocus variable number tandem repeat
restriction endonucleases analysis of polymorphisms (VNTR)
Amplified fragment length polymorphism (AFLP)
Random amplification of polymorphic DNA (RAPD)
Arbitrary primed PCR
Sequence of the 16S rRNA
Endonuclease digestion of the variable region of the
coa gene
Protein A gene polymorphism
Coagulase gene polymorphism
Sequence of the protein A (spa) gene
ITS-PCR
Multilocus sequence typing
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The discriminatory powers of most of the phenotypic methods of characterization have
been shown to be restricted and ambiguous. This was also reported by Tenover et al
who concluded that several studies suggest that phenotypic markers, such as biotyping,
antibiotic susceptibility patterns, and bacteriophage typing, are more likely to change
over time than those detected by molecular typing schemes, such as PFGE, MLST, and
spa typing 423.
Molecular typing of S. aureus has been used to examine both the long-term or global
epidemiology and short-term or local epidemiology. Understanding the genetic structure
of a global population over time gives insights into the evolution of bacterial lineages
and transmission dynamics and also provides a framework with which to study bacterial
pathogenesis=". Bacterial population analysis of S. aureus indicates that phylogenetic
lineages are not always randomly distributed within clinical isolate populations. Within
the S. aureus species discrete lineages or subtypes exist due to the selective pressures
imposed by antibiotic use and other ill defined environmental factors307• In recent years,
the use of nucleotide sequence variation at multiple housekeeping loci have become
increasingly popular for strain characterization, as it has the advantage of inferring
levels of relatedness between strains and the reconstruction of evolutionary eventsv'''.
For example, the majority of MRSA have expanded clonally and globally upon the
acquisition of the mec determinant and have been shown to have methicillin-susceptible
S. aureus (MSSA) counterparts with identical multilocus sequence typing (MLST)
types'". This indicates that methicillin resistance probably arose in genetic backgrounds
that were inherently fit with a decreased drug susceptibility allowing an extension of the
niche occupied by the bacterium to include the antibiotic rich hospital environment'<.
MLST has identified five major pandemic clonal lineages of S. aureus that are widely
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distributed and account for a large proportion (70%) of isolates, indicating that they
represent successful lineages in terms of ability to cause infection, to persist, and to
spread from one geographic site to another, including across continentsr". These five
major pandemic clonal complexes (CCs) or lineages are CC5 (New York/Japanese,
South German and Paediatric clones), CC8 (Archaic, Brazilian and Hungarian clones),
CC22 (EMRSA15 clone), CC30 (EMRSA16 clone), and CC45 (Berlin clone) (Figures
1.7, 1.8, 1.9, 1.10, 1.11)123.Additionally, CC1 represents a lineage strongly associated
with emerging community acquired MRSA infections. A number of other lineages can
be found among the S. aureus species that are never or occasionally MRSA or
infrequently isolated in general'!".
Figure 1.7 Evolutionary origins of CC5 genotypes. Arrows indicate either the
acquisition ofSCCmec, or a change of Multilocus Sequence Type123•
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Figure 1.8 Evolutionary ongms of CC8 genotypes. Arrows indicate either the
acquisition of SCCmec, or a change of sr125,157,356
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Figure 1.9 Evolutionary origins ofCC22 genotypes. Arrows indicate either the
acquisition of SCCmec, or a change of ST356
EMRSA-15
Figure 1.10 Evolutionary origins of CC30 genotypes. Arrows indicate either
the acquisition ofSCCmec, or a change ofST124,125,132
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Figure 1.11 Evolutionary origins of CC45 genotypes. Arrows indicate either the
acquisition of SCCmec, or a change of ST356•
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Although genes encoding essential housekeeping functions are commonly viewed as the
most reliable markers, the precise importance of gene function in predicting the utility
of intra-species markers has not been systematically investigated'f.
Clones of S. aureus have been shown to anse 15 times more frequently by point
mutation of the housekeeping genes than by homologous recombination I32. However,
Robinson et aI, using MLST and sequence data from an additional eight surface protein
encoding genes (seven sas genes and the gene that encodes immunoglobulin G binding
protein A (spa)) has shown that three significant recombination events have occurred
within the five major MRS A CCs. These recombination events were between ST8 and
ST30 to form ST239* (Figure 1.8), ST30 and ST145/STI0 to form ST34 and ST39 and
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ST145/ST10 to form ST42357• Khun et at have also shown homlogous exchange events
in core and acessory gene alleles between isolates of distant phylogenetic lineage241.
In a study by Wright et at they report that genotyping of S. aureus strains by five
different methods (PFGE, MLEE, MLST, spa and eoa typing) genotypes that were so
strongly correlated with agr types that the former could be used to predict the latter
unequivocally (Figure 1.12). They hypothesise that there is a direct relationship
between agr groups and clone phylogeny based on the finding that with exceedingly
rare exceptions, no MLST pattern occurred in more than one agr group491.
Figure 1.12 Evolutionary divergence of the agr locUS491
S. aureus
agrll
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The hypothesis that agr groups delineate fundamental subdivisions within S. aureus was
rejected by Robinson et al who mapped agr groups on to a phylogenetic tree based on
the sequence analysis of the seven MLST housekeeping genes and seven additional
genes that encode putative surface protein genes (SAS genes) by Shimodaira-Hasegawa
and parametric bootstrap tests. They were unable to reject the hypothesis that S. aureus
was subdivided into two groups consisting of multiple CCs and multiple agr groups358.
Kuhn et al compared the partial sequence data from the seven MLST housekeeping
genes, six core adhesins (elfA, eljB, fnbA, map, sdrC, and spa) and four accessory
adhesion genes (ebpS,JnbB, sdrD, and sdrE). Gene trees constructed from concatenated
sequences of these core and highly variable accessory genes have shown that the
variable genes were at least as informative for phylogenetic reconstruction as the slowly
evolving housekeeping genes'?'.
Cooper et al investigated a diverse range of S. aureus by MLST and supplemented this
data with a further 33 gene loci. These supplementary genes were grouped into three
functional classes: information pathway genes, housekeeping genes and cell
envelope/cellular process genes. They also included characterization data of conserved
genes of unknown function and orphan genes. These data were concatenated and used
to produce an unrooted Bayesian tree82. This tree was broadly consistent with the
phylogenetic tree produced by Robinson et al and confirmed the division of S. aureus
into two main groups with group I being subdivided into groups la and Ib82,358. In
contrast to the MLST data on the evolution of CC30 and CC45 by Enright et ali25, data
produced by Cooper et al suggest that ST30 and ST45 share a common ancestor and
conclude that there is little evidence to justify the current emphasis on the use of
housekeeping genes for phylogenetic, systematics, or epidemiological studies as there
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data suggests that the MLST genes for S. aureus rate amongst the poorest phylogenetic
markers. They do not advocate changes to the established MLST scheme as it has
proved to be successful in understanding the population structure of S. aureus and for
assigning isolates into particular lineages'".
A study by Lindsay et al, on a collection of S. aureus associated with community-
acquired invasive disease and carriage in healthy individuals using microarray has
shown that genes termed core-variable genes, that encoded known or putative virulence
and resistance genes, were able to clearly discriminate distinct lineages that closely
matched the MLST clonal clusters CCI, CC5, CC8, CC9, CCI2, CCI5, CC22, CC25,
CC30, CC45, and CC51. They note that MLST is able to detect further differences
(STs) within each CC that were not corroborated by microarray and suggest that this
may be due to the enormous amount of variation seen in the S. aureus genome, so that
relying on only a few markers placed increased weight on minor differencesf".
1.6.3.2 Characterization of animal strains
There are limited data available on the systematic characterization of the natural
population structure of S. aureus strains isolated from animal species with the exception
of those isolates causing mastitis in cattle. Over the past 40 years bacteriophage and
biotyping have been used to discriminate S. aureus from cattlel03• Due to poor
reproducibility and an inability to type all isolates, however, these techniques are no
longer used and have been superseded by molecular typing methods, including PFGE,
MLST, spa, binary, and agr typing, that are commonly used in the characterization of S.
aureus from humans344,401,498.
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Cross-infection between animals and humans in the household, veterinary hospital and
farm setting has been described. Weese et al have shown the cross-infection of horses
and humans with strains of MRSA, with indistinguishable PFGE patterns, and
concluded that this data provides evidence that horse to horse and horse to human
transmission of S. aureus is possiblel'". This conclusion is consistent with data
published by Malik et al where, based on MLST, MRSA isolated from canine sources
were shown to be ST239 SCCmec type III belonging to CC8, a well recognised human
MRSA lineage mainly confined to health care settings, indicating the dog became
colonised and infected through a household or other close contact with a human MRSA
carrier279• These studies contrast with the conclusion of Carter et al who indicate that
genetic studies have shown that strains of S. aureus remain closely associated with their
animal host with little transfer between species". This conclusion is consistent with
characterization studies of S. aureus strains isolated from animals, predominantly cattle,
that have shown that relatively few clones of S. aureus are responsible for the majority
of cases of bovine mastitis and that these clones and their derivatives are adapted not
only to the bovine mammary gland but also to the bovine environment and have
achieved worldwide distributiori'?'. Van Leeuwen et al have demonstrated that S.
aureus strains from humans can cross-infect domestic animals, poultry, pet animals' and
vice versa, however, it has been determined that separate host specific lineages of S.
aureus exist and the potential of cross-species pathogenicity of these lineages remains
unanswered''P.
Kapur et aI, have also concluded that while cattle herds could be colonised by several
distinct S. aureus clones and that some of these clones are closely related to isolates
recovered from humans many were not suggesting host specialisation. They concluded
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that the successful transfer of S. aureus between humans and animals under natural
di . 1· . d216con itions was imite .
Studies by Smith et ai, using MLST, have independently reported that the majority of
cases of bovine mastitis caused by S. aureus clustered within a single clonal complex
(CC97) concluding that this constitutes a host adapted S. aureus strain400,401.This
hypothesis of host adaptation was further developed by Smith et al where analysis of
CC97 diversification suggested that there was a roughly equal chance of housekeeping
gene alleles changing by point mutation and recombination indicating an altered
population structure of bovine S. aureus compared with that of human isolates where
point mutation is more frequently involved in clonal diversification'?'. Host specific,
host adapted or tissue adapted S. aurueus strains have also been reported by Larsen et
ai, using phage and ribotypingr"; Gilot et al using agr restriction fragment length
polymorphism (RFLP)156, Riamundo et al using RFLP of the 3' end of the coa gene in
bovine strains344, Rodgers et al using biotyping and PFGE in poultry strains'", and by
Katsuda et ai, Schlegelova et ai, and da Silva et al using RFLP of the 3' end of the coa
gene in caprine, and bovine strains218,370,398.Also, in a study by Strommenger et al they
report the isolation of an MRSA ST22 (spa type 032) from an animal with a similar
PFGE restriction pattern to those of human strains and suggest that these animal strains
represent a sub population ofST22 that may have adapted to pet animals415.
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1.6.4 Host specificity
The concept of host restriction/adaptation/specificity is not new and has previously been
reported in staphylococci with S. hyicus causing disease only in pigs471,S. intermedius
causing disease in dogs'", and S. lentus preferentially colonizing sheep, and goats234.
Host specificity has also been reported among serotypes of Salmonella spp, producing
disease in their natural hosts, including S. typhi (human/chimpanzee), S. gallinarum
(avian), S. abortusovis (sheep), S. typhisuis (pig), S. abortusequi (horse), serovars of S.
choleraesuis (pig), and S. dublin (COW)442.The host specific adhesins (K88, 987P, and
K99) of E. coli are associated with a relatively small number of 0 serogroups (06, 08,
09,015,020, 025, 045, 063, 078, 0101, 0138, 0141, 0147, 0149, and 0157) that
cause disease specifically in piglets, calf, and lamb22s. A study by Willems et al has
shown the existence of host specific vancomycin resistant Enterococcus faecium
genogroups that are associated with particular hosts and environments'f". However,
Heuer et al doubt Willems conclusion as it implies that hospitalized patients and
community based humans be regarded as different hosts185. Although the precise
mechanisms of host adaptation have not been elucidated it has been suggested that host
specific serotypes have adapted to the physiology of their natural hosts and developed a
means to capitalize on it442.
The evolutionary processes in S. aureus restricting or expanding invasiveness in
different hosts are ill defined+". However, Peacock et al suggest that the numbers and
combinations of certain virulence genes may be significant contributors to pathogenic
potential=". Molecular studies of S. aureus strains isolated from human patients and
bovine mastatic milk have indicated that such strains differ and that bovine and human
reservoirs represent two separate sub-populations of this species that rarely cross
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infecr'". Classification of S. aureus isolates by AFLP of the coagulase gene allowed
Schlegelova et al to describe host specific dominances of genotypes between bovine
mastatic strains and human strains37o• Data from a study by Carter et al investigating the
relationship between S. aureus, based on coagulase gene polymorphisms, from humans
and cows was consistant in general with the theory of host specialisation't'. Host
restriction of S. aureus has also been shown between poultry and poultry farm personnel
by Rodgers et al where poultry and humans carried their own specific S. aureus biotype
and PFGE type with no evidence of cross colonisation=", Many S. aureus strains have
disseminated widely among humans. These same strains have the potential to colonise
and infect many different host species. Conversely, host specific and even tissue
specific S. aureus strains have been identified causing disease in varied host species'?",
It has been suggested that the presence of combinations of virulence factors plays an
important role in host and tissue specificity in S. aureus colonisation and infection452.
The effect of these genes has been shown to be cumulative, each independently
multiplying the odds of disease. Host factors such as genetic predisposition via one or
more susceptibility genes or acquired factors including the presence of intravenous
devices or surgical wounds may also play an important role for S. aureus colonisation
and infection 452.
1.6.5 Pathogenicity
While S. aureus forms part of the normal bacterial flora of humans and animals it is also
responsible for a wide range of conditions. These range from minor infections of the
skin to wound infections, bacteraemia, infections of the central nervous system, the
respiratory and genito-urinary tracts and infections associated with intravascular devices
and foreign bodies in humans and is also one of the most frequent cause of contagious
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mastitis in cattle, sheep and goats, leg and joint infections in poultry57 skin infections in
bbi 181 d f i c.' • ild 422 d . . I 387ra Its an a range 0 mtections InWI , pet an sportmg aruma s .
1.6.5.1 Disease in humans
S. aureus is the most common cause of hospital acquired infection, causing clinical
disease in 2% of all patient admissions'?", It is also a major cause of wound infections
and has the invasive potential to induce osteomyelitis, endocarditis and bacteraemia
which is increasing and has more that doubled across Europe in the last 25 years'!", The
increase in nosocomial infection has coincided with a growing rate of community
acquired disease as a proportion to hospital acquired infection. It has been suggested
that part of this effect may however be better explained by host susceptibility, due to
immunosuppression, and an aging populationf".
Within the community setting, minor infections of the skin caused by S. aureus are
common while severe invasive disease is relatively rare. Deresinski has reported an
increase in the isolation of S. aureus causing community acquired cutaneous infection
in children'l'", Several outbreaks of community-acquired skin infections have been
reported as a result of infection with MRSA that have acquired the Panton-Valentine
leukocidin gene (PVL)303,419.These new strains are associated with a particularly lethal
form of haemolytic pneumonia in children with a mortality rate of 40%415. The
acquisition of both multiple antibiotic resistance and PVL in S. aureus strains that
spread rapidly in the community suggests that S. aureus is becoming more virulent and
of greater concern to medical professionals+" .
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Lindsay et aP64have reported that the S. aureus genome is comprised of core, accessory
and foreign or lost genes. The core genome makes up ~75% of the S. aureus genome
and is highly conserved with the majority of genes associated with central metabolism
and house keeping functions. However, supplementing these genes are genes of the
accessory genome, that makes up the remaining ~25%, and while they are non-essential
for growth or survival they consist of a plethora of virulence genes implicated in S.
aureus pathogenicity. The relative importance of host factors versus bacterial virulence
determinants in disease pathogenesis is unknown, but it is widely held that bacterial
factors including binding proteins, toxins, exoenzymes, enterotoxins and capsule
biosynthesis are involved in the process332• Many of the virulence factor encoding genes
are located in discrete genetic elements that are mobile or were once mobile, are strain
specific, and can transfer horizontally between strains264• These genetic elements
include plasmids, transposons, converting bacteriophages, and, most recently described,
pathogenicity islands and resistance islands275• A number of regulators are involved in
the production of these virulence determinants in S. aureus. These include the accessory
gene regulator (agr) and staphylococcal accessory regulator (sar). The agr locus has
been shown to be required for virulence by several infection models and regulates
virulence in concurrence with the transcriptional regulator SarA encoded by the- sar
IOCUS148,200,392,451. Evidence has shown that some elements are able to move frequently
while others move infrequently if at all265. Many of the genetic elements that carry the
genes responsible for virulence and resistance functions have been shown to be
associated with a limited number of S. aureus lineages or clonal types264• Therefore the
distribution and horizontal gene transfer of these lineages and elements can have
important clinical implications.
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1.6.5.2 Disease in animals
1.6.5.2.1. Disease in poultry
S. aureus is the only staphylococcal species considered pathogenic in poultry and is one
of the most frequent causes of infection in poultry worldwide5.57,35,5,220,340.Themost
common infections caused by S. aureus in intensively reared poultry are those affecting
bones, tendon sheathes, leg joints, skin, sternal bursa, yolk sac, heart, vertebrae and
eyelid. Granulomas of the liver and lungs and septicaemia especially in laying birds,
during periods of hot weather, are also common and may resemble fowl cholera5,22o.
These conditions have been shown to be closely associated with poor management
conditions resulting in moist or wet litter that facilitates skin entry of S. aureus.
1.6.5.2.2 Mastitis in cattle
S. aureus is one of the major intramammary pathogens isolated from cattle with
subclinical and clinical mastitis, leading to significant economic loss to the dairy
industry due to rejected milk, reduced milk quality, early culling, drug costs, increased
veterinary expenses, and labour costs to the farmer405. Infected cows' udders are the
main reservoir from which S. aureus is transmitted to other cows in the herd;: and
prevention of transmission from cow to cow reduces mastitis incidence 497. Many
sources of S. aureus have been reported, including housing materials and fodder,
equipment and air, bovine skin, non-bovine animals, and humans350. Teat skin has been
suggested as an important reservoir for intramammary infection, while human to bovine
transmission has also been proposedi'".
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1.6.5.2.3 Disease of other animal species
S. aureus has been shown to cause a wide variety of infection in a range of animal
species. Mastitis and cutaneous abscess in sheep, goats, and broiler rabbit is often
associated with S. aureus39,456,457. In a study by Hermans et ai, S. aureus infection in
rabbits could be divided into two groups; those caused by low virulence strains resulting
in chronic infection, and those caused by high virulence strains resulting in an epidemic
spread of disease!". An investigation of ovine mastitis caused by S. aureus has shown
that most cases are caused by a few closely related genotypes, which are widely
distributed'f". These infections, caused by S. aureus, have a significant economic
impact for those farming these animal species. S. aureus has also been reported as the
cause of postoperative wound infections in horses174,387,466,wound infections in dogs
and cats256,and also an infection of the spleen and lymph nodes in a sea1158,318
1.6.6 Antimicrobial resistance
1.6.6.1 Antimicrobial resistance in S. aureus from humans
S. aureus has always been a stumbling block for antimicrobial chemotherapy, since it
has overcome all the therapeutic agents that have been developed in the past 60 years188.
Penicillin was introduced in 1944 and at that time 94% of all S. aureus were
susceptible; by 1950 the rate of resistance was over 50%, and by the 1980's the rate of
penicillin resistance exceded 90%268. Data supplied by the Scottish MRSA reference
Laboratory over the period 1997-2003 shows that the most frequently detected
resistances among human S. aureus are to penicillin, erythromycin, gentamicin, fusidic
acid, ciprofloxacin and trimethoprim (Table 1.5). Of all the resistance traits S. aureus
has acquired methicillin resistance is clinically the most important, as it has provided S.
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aureus with a mechanism that has made all members of the largest and most useful
family of antibiotics, the ~-lactams, obsolete as therapeutic agents'I". The emergence
and global spread of MRS A has been viewed as a process of accelerated evolution
driven by the selective pressure of immense quantities of antibiotics introduced into the
hospital environment'".
While MRSA have been acquired almost exclusively in hospitals, long term care
facilities, and other institutional settings, the recent reports of community acquired
MRSA has led to the speculation that the epidemiology of S. aureus is changingl'".
Unlike hospital strains, which are typically multiresistant, these community-acquired
strains are more susceptible to antibiotic groups and often only resistant to the ~-
lactams. This lack of resistance suggests a community origin, as the antibiotic selective
pressure is much lower in this environment'f.
The growing prevalence of MRSA as a cause of serious nosocomial infection has
increased the use of the glycopeptide antibiotic vancomycin over the past three
decades'V. As a result, vancomycin-intermediate S. aureus (VISA) strains that exhibit
two different resistance mechanisms have emerged. The first, reported in Japan in
1996186 and subsequently in the United States in 1997425, is believed to be due to a
thickening of the cell wall that produces intermediate vancomycin resistance (VISA).
There are two types of VISA, firstly VISA with an MIC 2:4~glml and secondly hetero-
VISA (h-VISA) with an MIC :::;2ug/ml with a resistant sub-population able to grow at
higher vancomycin concentrations. h-VISA develop during continued glycopeptide
exposure and are thought to be precursors of VISA 192. Intermediate vancomycin
resistance in S. aureus has also now been reported from France, Korea230, South Africa,
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and Scotland, while isolates with h-VISA resistance appear to be a global problem425•
The second, first noted in 2002, is identical to the mechanism seen in vancomycin-
resistant enterococcus, involving the van genes143• The emergence of MRSA with
reduced susceptibility or high level glycopeptide resistance has increased the awareness
of the now limited number of therapeutic options for serious S. aureus infections.
Table 1.5 Frequency of antibiotic resistance (%) in human S. aureus in Scotland
Antibiotic
Time period
1997-1999 2000-2001 2002-2003
Penicillin 11.7 21 38.6
Erythromycin 13.5 18.7 14
Clindamycin 4.2 0.8 4.5
Gentamicin 1.3 14.9 1.8
Fusidic acid 2.3 7.6 12.3
Chloramphenicol 0.5 0.2 0
Ciprofloxacin lOA 4.7 10.5
Trimethoprim 3.6 11.5 5
Sulphamethoxazole 404 2.5 2
Tetracycline 904 9 14.3
Rifampicin 0.3 004 1
1.6.6.2Antimicrobial resistance in S. aureus from animals
Antimicrobial agents are widely used in the treatment of S. aureus infection in domestic
and pet animals. These agents are similar and in many cases identical to those used in
humans, including aminoglycosides, ~-lactams, glycopeptides, macrolides, quinolones,
streptogramins and tetracyclines. With the exception of S. aureus mastitis in cattle,
there are only a few studies that have determined the frequency of resistance in S.
aureus from other animal species5,158,190.
Penicillins and aminoglycosides have been the most frequently used antibiotics in the
treatment of bovine mastitis worldwide and are consequently the most frequently
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reported resistance, in S. aureus, from bovine intramammary infections85,306. However,
the frequency of resistance to penicillins and aminoglycosides varies considerably
between countries with penicillin resistance rates of between 44% and 71% reported
from Brazil, Germany, Ireland, the UK and the USA, while isolates from Germany have
been shown to have one of the highest rates of resistance to gentamicin (51%t76. In
contrast, rates of resistance in bovine isolates from Scandinavia and Japan are low and
have been attributed to a more restrictive antibiotic policy in these countries459.
Mastitis is also a significant problem in domestic sheep and rabbits. A study by Goni et
at of antibiotic resistance in S. aureus isolated from sheep and rabbits noted that isolates
from sheep were mostly susceptible to the antibiotics tested, including aminoglycosides,
chloramphenicol, tetracycline, trimethoprim, and erythromycin, but the majority of the
rabbit isolates were resistant to various combinations of tetracycline, streptomycin and
erythromycin I58.
A large number of antibiotics have been used for therapy in the production of poultry.
Aarestrup et at have investigated the frequency of resistance in S. aureus from poultry
to a range of antibiotics and found no resistance to the aminoglycosides or
glycopeptides but a surprisingly high rate of resistance to ciprofloxacin (30%),
erythromycin (24%), and tetracycline (47%) 5.
In domestic pet dogs S. aureus is a common cause of wound infection with antibiotics
used in their treatment. Few studies have investigated the frequency of resistance in
canine isolates of S. aureus. Hoekstra and Paulton examined 867 isolates and found that
93.4% were resistant to at least one of the antibiotics tested and 67.3% were resistant to
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~2 antibiotics. The most frequently seen resistances observed were to cloxacillin
(68.2%), lincomycin (78.4%), penicillin (74.2%), and trimethoprim-sulphamethoxazole
(74.4%), while agents such as tetracycline, and the newer quinolones were still effective
in the treatment of deep seated wound infections 190.
Methicillin-resistant S. aureus is a well known human pathogen and a new emerging
problem in veterinary medicine. Cases of animal infection and carriage are increasingly
reported worldwide and recent studies have emphasized occupational health
implications to both farmers and veterinary staffl68. E-MRSA 15, the most prevalent
human MRSA strain in the UK, has been reported from 9% of dogs in a small animal
veterinary practice in the UK270. The origin of this strain remains unknown in
companion animals although it has been proposed that MRSA isolated from campanion
animals originate from humans. Recent reports of the isolation of MRSA (ST398) from
pigs, horses, dogs and humans in the Netherlands, Denmark, Germany and Austria are
raising concern'". The origin of ST398, whether human or animal, is presently unknown
although it is generally believed that this S. aureus lineage has originated from
. 193461I' kn h h hi . k . I h I h bpigs ' . t IS not own w et er t IS stram represents a ns to amma ea t, ut
several cases of severe infection in humans have been documented and it may therefore
represent a significant threat to human health".
1.7 Aims and objectives of this study
The primary objective of this study is to examine the influence antimicrobial use in
animals may have had on human clinical S. aureus.
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To test this hypothesis firstly the genetic population structure of isolates of S. aureus
recovered from animals will be assessed, using phenotypic and molecular techniques,
and compared with data from human clinical isolates of S. aureus (Chapter 2).
Secondly, the genetic relationships and potential host adaptation of selected S. aureus
strains from animals and humans will be examined using a variety of recognized
virulence determinants (Chapter 3). Thirdly, the frequency of antimicrobial resistance in
S. aureus isolated from animals will be determined (Chapter 4) and finally, the presence
and relative frequency of genes encoding tetracycline, and macrolide resistance in
animal and human S. aureus, the presence of structural variation in the tet(K) genes and
the transferability of tet(K) resistance plasmids from animal strains to S. aureus 8325-4
will be investigated (Chapter 5).
88
Chapter 2 Strain Characterization
2.1 Introduction
Outbreaks of infection caused by S. aureus continue to be a problem in human and
veterinary medicine28,494,495, Staphylococcal strains vary considerably in virulence and
epidemiological potential. To control the spread of staphylococcal infection, sources of
contamination and mechanisms of transmission have to be identified498, Identifying
strains among outbreak isolates is a major step in determining the source of the outbreak
and in determining subsequent control measures28,424,
Characterization may be done for taxonomic purposes, phylogenetic analysis directed at
determining relatedness of target organisms, delineating steps in the evolution of a
, f h 1 1 idemi 1 f h ' ,82 125target organism, or or t e mo ecu ar epi e io ogy 0 pat ogemc strains= ,
Pathogenic and epidemiological studies depend on the availability of typing schemes
that differentiate between strains belonging to the same bacterial species498, Typing
methods are a major tool for the epidemiological characterization of bacterial
pathogens, allowing the determination of the clonal relationships between isolates based
on their genotypic or phenotypic characteristics, Recent technological advances have
resulted in a shift from less discriminatory phenotypic typing methods, such as
serotyping, biotyping, phage typing, and antibiotic resistance typing, to molecular
methods such as restriction fragment length polymorphism (RFLP), pulsed field gel
electrophoresis (PFGE), PCR amplification of the 16S-23S intergenic spacer region
(RS-PCR), and with the availability of affordable gene sequencing methods multilocus
sequence typing (MLST) and spa typing62, Although these are technically demanding
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and more expensive than phenotypic methodologies they are able to generate highly
reproducible results and are extremely discriminatory for S. aureusI33,301,424. In
considering the subtype of an organism, an evaluation of all available data such as
biochemical reaction profiles, serotype, bacteriophage type, antibiotic susceptibility,
presence or absence of surface appendages, and virulence factors should be considered
with reliance on a single parameter for characterization avoided.
The objective of this part of the study is to assess the population genetic structure of
isolates of S. aureus recovered from animals using a variety of molecular techniques
used to characterize human S. aureus, and to determine the genetic relationships among
these S. aureus isolates and compare these with data from human clinical isolates of S.
aureus.
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2.2 Materials and methods
2.2.1 Bacterial strains
A total of 261 Staphylococcus aureus (233 domestic, wild and companion animal and
28 human clinical) isolates were characterized in this study. Two hundred and thirty
three of these isolates, collected between 1996 and 2001, were from three Scottish
regions; Grampian, Highland, Southwest Scotland, and from Northern Ireland (Table
2.1), and 28 human MR and MSSA, collected between 2000 and 2005, from across
Scotland (supplied by the Scottish MRSA reference laboratory) (Table 2.2).
Table 2.1 Distribution of S. aureus isolated from animal from Scotland and Northern
Ireland
lrimimw
GqWickxaim Inemxk Unprin WId
RiIIip;
grse
lam GM Iaib MIk Hg T~ llirIm D:g Hne Rm:t RItti<g: Hmat I"Wk SNrI"Wk
Gal]in 45 25
SliIY.et SrtIarl LV; 1 l! 2
Hgbrl 7 2 3 6
NrthmIrelarl 48 1 3 1 1 1
Tad 48 92 1 (6 7 2 1 10 3 2 3 6 1 1
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Table 2.2 Human S. aureus isolates
Year MSSA MRSA
2000 3 2
2001 1 3
2002 4 1
2003 2 1
2004 3 1
2005 1 6
Total 14 14
2.2.2 Disc diffusion susceptibility testing
Disc diffusion susceptibility testing using the following antimicrobials; amikacin
(30llg), chloramphenicol (10!J,g), ciprofloxacin (lug), clindamycin (2!J,g), erythromycin
(S!J,g), fusidic acid (10!J,g), gentamicin (10!J,g), kanamycin (30!J,g), linezolid (10!J,g),
mupirocin (S!J,g), oxacillin (l ug), penicillin (1 unit), quinupristinldalfopristin (l Sug),
rifampicin (2!J,g), streptomycin (10!J,g), sulphamethoxazole (2S!J,g), teicoplanin (30!J,g),
tetracycline (10!J,g), tobramycin (10!J,g), trimethoprim (S!J,g), tylosin (30!J,g) and
vancomycin (S!J,g) (Oxoid, Basingstoke, UK) was performed following the
recommendations of The British Society for Antimicrobial Chemotherapy (BSACio.
Four morphologically similar colonies were touched, with a sterile loop, and transferred
into 2ml of sterile distilled water (Biomerieux, France). The organism suspension was
adjusted to McFarland O.S turbidity standard (1- 2 x 108 colony forming units (cfu/ml)
using sterile distilled water and a working solution produced by performing a 1:10
dilution (1 x 107 cfu/ml). Isosensitest agar plates (ISA) (Oxoid, UK) were inoculated,
allowed to dry prior to the application of antibiotic discs and incubated at 3S-37°C in air
for 18-20 hours. For oxacillin susceptibility testing ISA supplemented with 2% NaCI
was used and incubated at 30°C in air for 24 hours. After incubation the zones of
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inhibition were measured and susceptibility interpretation made based on BSAC
criteria.
2.2.3 Phage typing
The standard phage typing procedure, as described by Blair and Williams42, was used
with the 23 phages of the international phage set (IPS) for typing human strains of S.
aureus and four local experimental phages 88A, 90, 83C, and 932 at 100 times the
routine test dilution (lOOX RTD). A Sml nutrient broth was inoculated with 3-4 colonies
of test isolate and incubated for 24 hours at 37°C. Following incubation the broth was
poured onto separate Brain Heart Infusion Agar (BHIA) (Oxoid, UK) plates containing
0.04M CaCho Excess broth was removed and plates dried prior to spotting with 10~1 of
bacteriophage. Plates were incubated for 24 hours at 30°C. Phage patterns were
interpreted according to established criteria (Table 2.3). All phage typing was
performed at the Health Protection Agency, Staphylococcal Reference Laboratory,
Collindale, London. Phage typing data was classified into phage clusters and phage
types by lytic group and individual lytic pattern respectively.
Table 2.3 Phage typing interpretation criteria
Plaque number Recorded value
<5 1
6-19 2
20-49 3
>50 8
Confluent lysis 9
Inhibition reaction 0
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2.2.4 PFGE Typing
Genetic relatedness and characterization of the isolates using PFGE typing of SmaI
(Gibco, UK) digested DNA was carried out by a modification of the protocol previously
published by Tenover et al. (1995). A colony was inoculated in a Brain Heart Infusion
broth (BHIB) and incubated overnight at 37°C without agitation, centrifuged at
12000rpm, and the pellet washed in 0.8 ml NET buffer (10 mM Tris, 1 mM EDTA, 10
mM NaCl), mixed with 20J,l1of achromopeptidase (IOunits/ul) (Sigma, UK), and an
equal volume of 2% SeaPlague agarose (Flowgen, UK). The cell/agarose suspension
was loaded into block moulds (BioRad, UK) and allowed to solidify at 4°C. Cells were
lysed by incubation at 50°C for 3 hours in lysis buffer (6 mM Trizma base, 100 mM
EDTA, 1 M NaCI, 0.5% Brij 58, 0.2% sodium deoxycholate, 0.5% lauroyl sarcosine).
The blocks were washed three times for 10 minutes in TE buffer (10 mM Trizma base,
1 mM EDTA) at room temperature. One quarter of each block was digested with 30
units of SmaI for 3 hours according to the manufacturer's instructions and loaded into
the wells of 1% PFGE certified agarose gel (BioRad, UK). Electrophoresis was
performed in 0.5 x TBE buffer (pH 8) (Invitrogen, UK) by the contour-clamped
homogenous electric field method with a CHEF system (BioRad). The fragments were
separated with a linear ramped pulse time of 6.8 seconds - 63.8 seconds over a period
of 23 hours at 14°C. Gels were stained with 1 ug/ml. ethidium bromide (Sigma, UK)
solution for 30 minutes, visualised using UV transillumination and digitally
photographed. PFGE pattern analysis was performed visually using the Tenover
criteria424 using GelCompar software (Applied Maths). Dendograms were calculated by
the unweighted pair group method by using arithmetic averages (UPGMA). A similarity
cutoff value of70% was used to define a cluster'l'".
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2.2.5 PCR amplification of the 16S-23S intergenic spacer region (RS-PCR)
2.2.5.1 DNA extraction
Genomic DNA from S. aureus strains was extracted following the method of Kobayashi
et aP38 and Leonard et aP57. Three to five colonies were suspended in NET buffer (10
mM Tris, 1 mM EDTA, 10 mM NaCl) containing 10 units of achromopeptidase (Sigma,
UK) and incubated at 50°C for 10-15 minutes.
2.2.5.2 RS-PCR
Molecular typing of Staphylococcus aureus using RS-PCR was performed as described
by Kumari et a/243, Couto et al83 and Lee & Park253 using the primers previously
published by Jensen et aP05.Two microlitres of extracted DNA was added to 12.5 ,....1of
Reddy Mix PCR Master mix (abgene, UK) (0.2 mM of dATP, dCTP, dGTP, dTTP, 3
mM MgCb, 0.625 units Taq polymerase, 20 mM Trizma base, 50 mM KC1) and 25
pmol of primers Gl 5' GAA GTC GTA ACA AGG 3' and Ll 5' CAA GGC ATC CAC
CGT 3'. Tissue culture grade water (Sigma, UK) was added to give a final volume of25
,....1. Cycling conditions consisted of 34 cycles of denaturation at 95°C, annealing at
55°C, and extension at noc for 1 minute each, followed by a final extension cycle of
72°C for 7 minutes. Six microlitres of PCR product was loaded into 1.5% Mastgel GP
agarose (Mast Diagnostics). Electrophoresis was performed in 0.5 x TBE buffer (pH 8)
at 100 volts for 10.5 hours. The patterns of the PCR products were compared with the
NCTC reference strain 10442.
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2.2.6 Discriminatory power
The discriminatory power of typing methods was determined using the Simpson index
of diversity formula, as shown by Hunter, which reads:
1 s
I
J=l
nj(nj-l)
D= 1-
N(N-I)
Where D is the index of discriminatory power, N the number of unrelated strains tested,
S the number of different types, and nj the number of strains belonging to ther type,
assuming that all strains will be classified into mutually exclusive categoriesl'".
2.2.7 Cophenetic correlation
The cophenetic correlation between isolates was determined usmg the following
formula (Gel Compar™).
c =
1: .. (y ..- ~)(Z"-Z)J'<), J) ,; , I)
Where Yij is the distance between objects i and j in Y, Zij is the cophenetic distance
between objects i and j, from Z (:,3) and y and z are the average of Y and Z (:,3),
respectively.
96
2.2.8 Multilocus sequence typing (MLST)
The nucleotide sequences of internal fragments of seven housekeeping genes were
obtained using the primers shown in Table 2.4: carbamate kinase (arcC), shikimate
dehydrogenase (aroE), glycerol kinase (gIp), guanylate kinase (gmk), phosphate
acetyltransferase (pta), triosephosphate isomerase (tpi), and acetyl coenzyme A
acetyltransferase (yqiL) 122.
Table 2.4 MLST PCR primers
Gene Sequence(5'-3')
arcG forward TTGATTCACCAGCGCTATTGTCreverse AGGTATCTGCTTCAATCAGCG
araE forward ATCGGAAATCCTATTTCACATTCreverse GGTGTTGTATTAATAACGATATC
gIp forward CTAGGAACTGCAATCTTAATCCreverse TGGTAAAATCGCATGTCCAATTC
gmk forward ATCGTTTTATCGGGACCATCreverse TCATTAACTACAACGTAATCGTA
pta forward GTTAAAATCGTATTACCTGAAGGreverse GACCCTTTTGTTGAAAAGCTTAA
tpi forward TCGTTCATTCTGAACGTCGTGAAreverse TTTGCACCTTCTAACAATTGTAC
yqiL forward CAGCATACAGGACACCTATTGGCreverse CTGTGAGGAATCGATACTGGAAC
Chromosomal DNA was extracted by the method of Jordens and Pennington'"?
modified for use with S. aureus. A I III loop full of organism was added to 50111of TE
buffer (20mM EDTA, 10mM Tris-HCI) containing 10mM of lysostaphin (Sigma, UK)
and heated at 37°C for 15minutes then 95°C for 15minutes. A further 150111 of TE
buffer was added, vortexed for 5-10 seconds followed by centrifugation at 4000 rpm for
20 minutes. PCR was carried out in 25111 reactions containing 2111of extracted DNA,
100nmoi of each forward and reverse primer pair, 12111of Reddy mix PCR master mix
(abgene, UK)(0.2 mM of dATP, dCTP, dGTP, dTTP, 3 mM MgCh, 0.625 units Taq
polymerase, 20 mM Trizma base, 50 mM KCI), and lOpl of tissue grade water (Sigma,
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UK). PCR was performed in a PTC-200 DNA engine (MJ Research, USA) with an
initial 5 minutes denaturation at 95°C, followed by 30 cycles of denaturation at 95°C for
60 seconds, annealing at 55°C for 60 seconds, and extension at 72°C for 60 seconds,
with a final extension step of 72°C for 5 minutes then held at 4°C122.
The PCR products were precipitated with 60J,t1of 20% polyethylene glycol 8000-2.5 M
NaCI solution, vortexed for 5-10 seconds, centrifuged at 1000 rpm for 30 seconds
followed by incubation at room temperature for 30 minutes. PCR products were
centrifuged at 3000 rpm for 30 minutes at 4°C and the supernatant removed. PCR
products were resuspended in 150J,t1of cold 70% ethanol and centrifuged at 3000 rpm
for 30 minutes at 4°C and ethanol removed. The DNA was reprecipitated in 12J,t1of
tissue grade water (Sigma, UK), centrifuged at 1000 rpm for 15 seconds, vortexed for
10-15 seconds three times then stored at -20°C.
Each PCR product was sequence tagged with BigDye fluorescent terminators (BigDye®
Terminator v3.l, Applied Biosystems, USA) using the primers from the initial
amplification with the addition of 2J,t1of BigDye. PCR was performed in a PCT -200
DNA engine (MJ Research, Boston, Mass.) with 25 cycles of 96°C for 10 seconds,
50°C for 3 seconds and 60°C for 2 minutes, followed by a reduction in temperature of
0.I°Cs-1 with a final hold at 4°C. Prior to sequencing each PCR product was purified in
12J,tl of tissue grade water and 52J,tl of 1:25 sodium acetate (Sigma, UK):95% ethanol
solution, vortexed, centrifuged for 15-20 seconds at 1000 rpm and frozen at -20°C for
30 minutes. Each product was centrifuged at 3500 rpm for 30 minutes and the liquid
phase removed. The DNA was further precipitated in 150J,t1of70% ethanol, centrifuged
at 3500 rpm for 30 minutes, the ethanol removed, and DNA resuspended in tissue grade
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water. The elongation products were loaded into a 5% Long-Ranger gel (Cambrex,
Rockland, ME) and the sequence of each strand determined with an ABI Prism 3700
DNA sequencer (Applied Biosystems, UK).
The sequences for each locus were compared to the allele sequences in the MLST
database (http://www.mlst.net). Alleles without a match in the database were submitted
for registration. MLST typing was carried out at the Department of Molecular
Epidemiology, Imperial College, London. Sequence types were clustered into groups
using eBURST employing the relaxed group definition with five of seven loci (i.e.
members of a group differ by a single or two loci).
2.2.9 spa typing
2.2.9.1 DNA extraction
Chromosomal DNA was extracted following the method previously described in section
2.2.8
2.2.9.2 spa gene typing
Amplification of the polymorphic region X of the protein A (spa) gene was performed
by PCR and the sequence of both strands determined. Two microlitres of extracted
DNA was added to l Zul of Reddy mix PCR master mix (abgene, UK)(0.2 mM of
dATP, dCTP, dGTP, dTTP, 3 mM MgCh, 0.625 units Taq polymerase, 20 mM Trizma
base, 50 mM KCI) and 100nmol of primers spa (F) AGA CGA TCC TTC GGT GA and
spa (R) CAG CAG TAG TGC CGT TTG. Tissue grade water was added to a final
volume of 25J.l1.The PCRs were performed in a PTC-200 DNA engine (MJ Research,
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USA) with an initial denaturation at 95°C for 3 minutes followed by 35 cycles of 95°C
for 30 seconds, 50°C for 60 seconds and 72°C for 60 seconds, a final extension at 72°C
for 10 minutes then held at 40C 173 •
2.2.9.3 spa peR amplified product purification
The amplified products were purified following the method previously described in
section 2.2.8
2.2.9.4 spa amplified product sequence tagging
The amplified products were sequence tagged using the method described in section
2.2.8. and the primers used in section 2.2.9.2.
2.2.9.5 spa gene sequencing
spa gene sequencing was performed following the method in section 2.2.8. The
sequences of both spa strands were determined using SeqManII ver 5.0 (DNAStar,
USA) sequence analysis software. spa types as well as BURP clonal complexes (spa-
CCs) were assigned using the Ridom Staph Type software version 1.4.1 (Ridom GmbH,
Wurzburg, Germany). Applying the algorithm BURP, spa types were clustered into
different groups with the calculated cost between members of a group less than or equal
to eight. The calculated cost describes the distance between two spa types which is
calculated with a pairwise alignment between two spa types, and takes into account
possible duplications, deletions and mutations of spa repeats. spa types shorter than five
repeats were excluded from analysis because no reliable deduction about ancestries can
be made from these types. spa types were submitted to the Ridom spa server database
(http://spa.ridom.de/spatypes.shtml) to determine possible associations with MLST. All
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spa typing was carried out at the Department of Molecular Epidemiology, Imperial
Colllege, London
2.2.10 agr rcn
Amplification of the agr genes I-IV was performed by multiplex-Pf'R (m-Pf'R)
following the protocol of Gilot et al156 using the primers agrI, agrII, agrIII, agrIV and
pan, controls, and cycling conditions listed in Table 2.5. m-Pf'R was performed in a
23!!1 mixture containing 2!!1 of template DNA, 2!!1 primer mix (25pmol) (MWG
biotech, Germany), 12.5 !!l of Reddy Mix peR Master mix (0.2 mM of dATP, deTP,
dGTP, dTTP, 3 mM Mgeh, 0.625 units Taq polymerase, 20 mM Trizma base, 50 mM
Kel) (ABgene, UK) and 6.5!!1 tissue grade water (Sigma, UK) in a Techne Genius
thermal cycler. peR products were separated by gel electrophoresis using six
microlitres of peR product loaded in a 1.5% Neuseive agarose (Cambrex, UK) gel in a
0.5% TBE solution (Gibco, UK) at 140V for 90 minutes. Following electrophoresis all
gels were stained with lug/nil. ethidium bromide (Sigma, UK) solution for 30 minutes
visualised by uv transillumination (UVP, UK) and the image stored digitally using
VisionWorks 32 software. The size of each peR product was determined by
comparison with the control strains and a lOO-bp molecular weight ladder (Gibco, UK).
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2.3 Results
2.3.1 Antibiotic resistance phenotypes
Antibiotic susceptibility testing of 233 S. aureus isolated from animals using a panel of
22 antibiotics (section 2.2.2) distinguished 32 different resistance phenotypes with a
discriminatory value (D) of 88.2% (Table 2.6). Thirty isolates were susceptible to all
antibiotics tested. Eight antibiotics (fusidic acid, kanamycin, linezolid, mupirocin,
oxacillin, quinupristinldalfopristin, teicoplanin, and vancomycin) did not contribute to
characterization as all isolates were uniformly susceptible. Fourteen resistance
phenotypes contained only a single isolate (Table 2.7). The remaining 17 phenotypes
contained between two and 53 isolates. Five resistance phenotypes (RP), RP3, RP16,
RP19, RP22 and RP24, accounted for 71.4% of resistant isolates with RPI6 the most
common (53 isolates).
Table 2.6 Diversity indices for phage typing, resistance phenotyping, RS-PCR, PFGE
MLST and spa typing data
Typing method No. of Discriminatory power
types found (D)
Resistance phenotype 32 88.2%
Phage typing 46 83.5%
RS-PCR (2:1band difference) 27 86.2%
PFGE (2:1 band difference) 74 93.1%
RS-PCR and PFGE 84 93.6%
MLST 18 91.4%
spa typing 25 95.4%
MLSTandspa 43 96.7%
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Table 2.7 Antibiotic resistance phenotypes
Resistance
phenotype (RP) Antihiogram No of isolates (%)
1 AK 1 (0.4)
2 Cip 4 (1.7)
3 Cip,P 12 (5.2)
4 Cip,S,P 2 (0.9)
5 Da,S,P 1 (0.4)
6 Da,T 1 (0.4)
7 Da,T,Tob,P 1 (0.4)
8 Da,Ty,P 1 (0.4)
9 E,Da,T,Cip,Ty 1 (0.4)
10 E,Da, T,Cip, Ty,P 1 (0.4)
11 E,Da,T,S,Ty,P 5 (2.1)
12 E,Da,T,S,Ty,W,P 1 (0.4)
13 E,Da,T,Ty 1 (0.4)
14 E,Da,T, Ty,P 6 (2.6)
15 E,Da,Ty,P 1 (0.4)
16 P 53 (22.8)
17 Rd,P 1 (0.4)
18 RI 2 (0.9)
19 RI,P 43 (18.4)
20 S 2 (0.9)
21 S,P 5 (2.1)
22 T 17 (7.3)
23 T,Ch 2 (0.9)
24 T,Cip 20 (8.6)
25 T,Cip,P 2 (0.9)
26 T,CiQ,S,P 4 (1.7)
27 T,P 6 (2.6)
28 T,S,P 4 (1.7)
29 T,S,W,P 1 (0.4)
30 T,W,P 1 (0.4)
31 Ty 1 (0.4)
32 Fully susc~tible 30 (12.9)
AK, amikacin, Ch, chloramphenicol, Cip, ciprofioxacin, Da, clindamycin, E, erythromycin, P, penicillin, Rd, rifampicin, S,
streptomycin, RI, sulphamethoxazole, Tob, tobramycin, W, trimethoprim, Ty, tylosin
2.3.2 Bacteriophage typing
Bacteriophage typing was performed on 79 of the 233 (34%) isolates. Nineteen (25.3%)
isolates were non-typable, 16 isolates failed to lyse with any of the phages and three
isolates were lytic. All isolates were classified into seven phage clusters, comprising 46
different phage types and a D value of 83.5%. Five phage clusters (representing 52% of
isolates) contained isolates susceptible to phages of two or more lytic groups (Figure
104
2.1). All isolates within phage cluster four (group II phages) were of bovine origin.
Isolates within phage cluster five (group III) were from a mixture of animal species,
including chicken, milk and pig.
Figure 2.1 Phage typing clusters
6.3%
6.3%
• Phage cluster I (Group lIlII)
• Phage cluster 2 (Group l/Il/III/Misc)
I!!!IPhage cluster 3 (Group l/III/Misc)
• Phage cluster 4 (Group II)
DPhage cluster 5 (Group III)
.Phage cluster 6 (Group III/Mise)
.Phage cluster 7 (Group Mise)
oNon-typable
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2.3.3 16S-23S intergenic spacer region rcn (RS-PCR)
Amplification of the 16S-23S intergenic spacer region identified 27 RS-PCR (PR) types
(Figure 2.2). The discriminatory power of this method was 86.2% which was lower but
not appreciably different to resistance phenotyping (Table 2.6). Thirteen PR types
(48%) contained only a single isolate. Five PR types (PRl, 3, 4, 7, and 23) accounted
for 81.9% of isolates (Table 2.8 and Figure 2.3). The PRI type was comprised of 48
isolates. Eighty one percent of which were of avian origin from Highland, Northern
Ireland and Southwest Scotland regions. The PR3 and PR7 types contained 60 (25.8%)
isolates. The majority of these isolates (81.6%) were from milk samples from Grampian
and Southwest Scotland. The remaining predominant PR types (PR4 and 23) were of
bovine origin from Grampian. Only PR 1 and PR3 were found across all four locations
(Figure 2.4).
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Table 2.8 Predominant PR types including animal species and geographical location
.~.""
PR type Animal species Grampian Highland Northern Ireland Southwest Scotland
Chicken 33 1
Cow 8 1
PR1 Partridg_e 1
(n = 48) Phillips goose hawk 1
Pig 1
Turkey 2
PR3 Chicken 4
(n = 28) Milk 1 18
Pheasant 5
PR4 Cow 30
(n = 38) Milk 3
Pig 4
PR7 Cow 2
(n = 32) Milk 15 1 14
PR23
Cow
(n = 45) 45
Total 59 11 40 80
Figure 2.3 PR banding patterns of predominant PR types
NCTC
10442 PRI PR3 PR4 PR7 PR23
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Figure 2.4 Geographical distributions of the predominant PR types
2.3.4 Pulsed field gel electrophoresis (PFGE)
Based on visual inspection 74 PF types were recognized among the 233 S. aureus
isolated from animals. This gave a discriminatory value (D) of 93.1% (Table 2.6). To
confirm visual grouping cluster analysis of all PFGE patterns, was performed using Gel
compar= software and resulted in a dendogram comprising 20 clusters using a 70%
similarity cut off level (Table 2.9). Eighty four percent of these isolates were distributed
in only four PF clusters (A, D, M and T) (Figure 2.5).
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Table 2.9 PF groups and subtypes of233 animal S. aureus isolates
PF group* No of subtypes No isolates
A 14 53
B 2 2
C 1 3
D 19 87
F 1 1
G 1 3
I 2 4
J 2 3
K 1 2
L 2 2
M 6 9
N 1 2
0 2 2
P 2 3
Q 2 4
R 1 1
S 1 1
T 9 42
U 2 6
Y 3 3
Total 74 233
* PF groups at a 70% similarity cut off value
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Figure 2.5 Dendogram of PFGE patterns of the 233 animal S. aureus strains. The four
major PF clusters are colour coded and subclusters are indicated Roman numerals. The
70% and 80% similarity levels are indicated by red and blue lines respectively.
2.3.4.1 PF group A
Fifty three (22.7%) isolates formed PF group A (Table 2.10). This group included 14 PF
A subtypes (Figure 2.6). The 14 PF subtypes forming PF group A produced a single
cluster at a 70% similarity level, and formed four clusters at 80%. Cluster Ai contained
nine subtypes, Aii one, Aiii one, and Aiv three respectively and had between one and
six band differences from the most prevalent subtype (A7) (Table 2.10). With the
exception of two isolates, one from a cow from Grampian region and one from a
chicken from Southwest Scotland, all isolates within the Ai cluster were from avian
sources from Northern Ireland. PF subtype AB, also of avian origin from Northern
Ireland, had four band differences from the predominant PF A subtype and seperated
from the Ai cluster at an 80% similarity level and formed a separate branch (Aii) on the
dendogram. The seperation of clustres Ai and Aii from Aiii and Aiv at between 70%
and 80% appears to be both geographic and animal source derived. Isolates within
Cluster Aiii (PF subtype A12) and Aiv (PF subtypes A14, 15 and 16) were all from
locations other than Northern Ireland and sources other than chicken (Figure 2.7).
Isolates within PF group A belonged to one of five PR types. PR types 1 and 2
accounted for 94% of isolates and 13 of the 14 PF A subtypes. Within this group only
isolates belonging to PF A subtype A7 (the predominant group A subtype) were
represented by more than one PR type (Table 2.11).
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674kb
324kb
208kb
175kb
135kb
80kb
-10kb
Al A2 A3 A5 A6 A7 A8 A9 AIO AI2 AI3 AI4 AI5 A16
Figure 2.6 PFGE banding patterns representing the 14 PF subtypes forming PF group A.
Lane 1 represents the molecular weight standard NCTC 10442.
Table 2.10 Band differences of PF subtypes in PF group A
. Band difference
PF subtype from the predominant PF subtype
(A7)
Al 4
A2 6
A3 4
AS 6
A6 1
AS I
A9 I
AIO 3
Al2 6
AI3 4
A14 6
Al5 6
AI6 3
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Figure 2.7 Geographical distribution ofPF A subtypes
Chicken
Animal sp,
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Table 2.11 Correlation between PR type and PF group A subtypes
PR type
H .~~",. "'~'< PFsubtype ..... , ,",;fi'~. ··'~~E, a
1 AI, A2, A6, A7, A8, A9, A12, A14, A15
2 A3, A5, A13, A16
14 Ala
20 A7
21 A7
2.3.4.2 PF group D
Eighty seven (37%) isolates formed PF group D. This group included 19 PF D subtypes
(Table 2.12). At a similarity value of 70% all subtypes formed a single cluster and at an
80% similarity value formed four clusters (Di, Dii, Dii and Div) containing between 3
and 7 PF subtypes (Figure 2.5). All PF D subtypes had between one and six band
differences from the most predominant PF D subtype (D9) (Table 2.12).
Table 2.12 Band differences among PF group D subtypes
Band difference
PF subtype from the predolTIinant PF
subtype (D9)
01 3
02 4
05 1
06 4
07 1
08 2
012 3
013 4
014 2
015 1
016 6
017 2
018 6
019 4
020 3
021 5
022 5
028 5
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Isolates within PF group D belonged to one of six PR types (PR3, PR5, PR7, PR8,
PR16 and PR23). The PR type 7 contained the largest number of PF D subtypes. The
PR types 5 and 8 belonged to singleton PF subtypes D28 and D8 respectively. Four PF
D subtypes D6, D9, D12 and D15, representing 68% of the isolates within this group,
belonged to more than one PR type. The PR type 3 was the only PR type represented in
each of these PF D subtypes (Table 2.13).
Table 2.13 Correlation between PR type and PF group D subtypes
PR type PF D Subtypes
3 D2, D5, D6, D9, DI2, D14, DIS
5 D28
7 D6, D7, DB, DIS, D16, D17, D18, D19, 020, D21, D22
8 D8
16 DI2
23 D9
Eighty six of the 87 isolates in PF group D were of bovine origin (cow 47 and milk 39)
from the Grampian region (13), Northern Ireland (1) and Southwest Scotland (72). The
remaining single isolate (PR5, PF subtype D28) was from a chicken from Northern
Ireland. PF subtypes Dl and D28 were exclusive to Northern Ireland. Three PF
subtypes (D2, D6 and D13) were common to bovine isolates from Southwest Scotland
and Grampian region, three PF subtypes were exclusive to isolates from Grampian
region and 11 PF subtypes were exclusive to isolates from Southwest Scotland (Table
2.14).
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Table 2.14 Geographic and animal source distribution ofPF group D subtypes
PFG D subtypes Grampian
Northern Ireland Southwest Scotland
Cow Milk Chicken Milk Cow Milk
01 1
02 1 6
05 3
06 3 3
07 1
08 1
09 45 1
012 2
013 2 1
014 I
015 1 4
016 1
017 1 3
018 1
019 1
020 1
021 1
022 1
028 1
Figures ID bold are subtypes common to more than one region, FIgures ID blue are subtypes found ID both cattle and milk
None of the isolates belonging to PF group D were from Highland region. Within PF
group D two subc1usters, Dii (subtypes D13, 14 and 28) and Div (subtypes Dl, 2, 5 and
12), contained PF subtypes from across the remaining three regions (Table 2.14).
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2.3.4.3 PF group M
Nine isolates (4%) formed PF group M. This PF group included six PF subtypes and
produced a single cluster at a similarity value of 70% (Figure 2.5). At an 80% similarity
value isolates within PF group M produced four PF clusters (Mi, Mii, Miii and Miv).
Due to the small number of isolates comprising PF group M there was no predominant
PF subtype. All isolates differed from each other by five bands or less (Table 2.15 and
Figure 2.9).
PF group M was found only in avian isolates from the Highland region (five pheasant)
and Northern Ireland (four chicken). Two PF subtypes (Ml and MS) were common to
both locations (Figure 2.10)
All isolates within PF group M belonged to PR type 3.
Table 2.15 Band differences among PF group M subtypes
PF group M
Subtype
Ml M2 M3 M4 M5 M6
Ml 1 3 4 1 1
M2 3 4 3 1
Subtype M3 1 5 5
M4 4 2
M5 2
119
674kb
324kb
208kb
17Skb
13Skb
80kb
-lOkb
Ml M2 M3 M4 MS M6
Figure 2.9 PFGE banding patterns representing the 6 PF subtypes forming PF group M.
Lane 1 represents a molecular weight standard NCTC 8325.
Figure 2.10 Geographic distributions of PF group M subtypes
region
M2
M4
M6
M3
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2.3.4.4 PF group T
The PF group T accounted for 42 (18%) isolates and formed a single cluster, comprised
of nine PF subtypes (Figure 2.11), at a 70% similarity value (Figure 2.5). At an 80%
similarity value isolates within PF group T formed two clusters (Ti and Tii). Isolates
within this group were represented predominantly by bovine sources (cow and milk)
from Grampian region. All PF subtypes had five or less band differences from the
predominant PF subtype (Table 2.16). Isolates within PF group T belonged to one of
three PR types (PR 4, PR 127i and PR 127iv/vi/vii). There was a very close association
between PR type and PF subtype in PF group T with 88.1% of isolates within this group
also belonging to PR type 4 (Table 2.17). Other than PF group T PR type 4 was only
detected in one further PF subtype (PF subtype Y2).
Table 2.16 Band differences between PF T subtypes.
PF subtype Band difference
from the predominant PF subtype (T8)
rt 2
T2 1
T3 5
T4 3
T5 3
T6 5
T7 2
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Table 2.17 Association between PF T subtype and PR type
674kb
324kb
208kb
175kb
135kb
80kb
~10kb
PR
PF T subtype
1 2 3 4 5 6 7 8 9
4 1 1 3 5 2 2 21 2
127i 1
127iv/vi/vii 1 3
I'
1 T1 T2 T3 T4 T5 T6 T7 T8 T9
Figure 2.11 PFGE banding patterns representing the 9 PF subtypes forming PF group T.
Lane 1 represents a molecular weight standard NCTC 8325.
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2.3.4.5 Minor PF groups
Nine Pulsed field groups (Figure 2.12) representing 19 distinct PF patterns and
containing between two and six isolates were classified as minor PF groups clustering at
a similarity cutoff value of 70% (Figure 2.5). Five of these minor PF groups (PF groups
J, L, P, Q and U) remained as single clusters at an 80% similarity level. These minor PF
groups included isolates from all regions, animal type (companion, livestock and wild),
and eight of the 14 animal sources represented in this study (Table 2.18).
Four of the minor PF groups (PF groups B, I, J and Y) belonged to multiple PR types.
Isolates belonging to PR types 1 and 7 were found in more than one PF group (Table
2.18).
1 B I J LOP Q U Y
674kb
324kb
208kb
175kb
35kb
80kb
~10kb
Figure 2.12 Examples of the PFGE banding patterns representing the nine PF groups
forming minor clusters. Lane 1 represents a molecular weight standard NCTC 8325.
Letters above lanes indicate the minor PF group designation.
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Table 2.18 Minor PF groups
MinorPF
PF subtypes (n) Similarity value
PR Geographic
Animal source
groups type region
B
Bl (1) 78% 22 SWS Cow
B2 (1) 1 G Cow
II (3) 138 SWS Horse
H Parrot (2)I 76%
12 (1) 13 NI Chicken
11 (1) 11 H Pheasant
J 84% 1 Cow
J2 (2) NI
17 Horse
L Ll (1) 93% 15 H Pig
L2 (1) G Milk
0
01 (1)
74% 19 G Cow
02 (1)
P PI (1) 84% 7 G MilkP2 (2)
Ql (1) H Pig
Q 82% 12 G MilkQ2 (3)
SWS Lamb
V VI (4) 90% 7 SWS Milk
V2 (2)
YI (1) 94% I5QR SWS MilkY Y2 (1) 76% 4 G CowY3 (1) 1
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2.3.4.6 Singleton PF types
Seven PF patterns representing 12 isolates were classified as singleton PF types (Table
2.19 and Figure 2.13)
Table 2.19 Singleton PF types
Singleton PF types PR type Geographic Animal
region source
Cl (3) I G Cow
FI (1) 121 G Milk
GI (3) 3 and 6 SWS Milk
KI (2) 3 SWS Milk
NI (2) III SWS Milk
G Unknown
RI(1) 10 H Partri<!ge
SI (I) 16 SWS Horse 'I
1 C F G K N R S
80kb
674kb
324kb
208kb
175kb
135kb
~10kb
Figure 2.13 PFGE banding patterns representing the seven singleton PF types. Lane 1
represents a molecular weight standard NCTC 8325, Letters above lanes indicate
singleton PF pattern
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2.3.4.7 RS-PCR and PFGE data summary
All S. aureus isolated from animals could be type by RS-PCR and PFGE. RS-PCR
typing produced 27 PR types, of which five (PR1, PR3, PR4, PR7 and PR23) were
predominant, and had a discriminatory power of 86.2%. PFGE typing produced 74
distinct PF banding patterns representing 19 PF groups each with between one and 19
PF subtypes and a discriminatory power of 93.1%. Combining the data of both RS-PCR
and PFGE typing did not markedly increase the discriminatory power (Table 2.6).
Eighty percent of isolates were distributed amongst four PF groups (PF groups A, D, M
and T). PF groups A and M contained isolates predominantly of avian origin from
Northern Ireland and Highland region respectively and PF groups D and T contained
isolates predominantly of bovine origin predominantly from Southwest Scotland and
Grampian region respectively. There was a very close relationship between the
predominant PR types and PF groups (Table 2.20).
Table 2.20 Correlation between the predominant RS-PCR types and PFGE groups
PR type PF group Animal source Geographic region
1 A Avian NI
3 DandM Bovine and Avian G,H, NI and SWS
4 T Bovine G,H
7 D Bovine G, NI, SWS
23 D (subtype 9) Bovine SWS
G. Grampian, H, Highland, NI, Northern Ireland, SWS, Southwest Scotlaod
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2.3.5 MLST, spa and agr typing
Further characterization of a subset of 49 S. aureus isolates, from the animal isolate
collection, was performed. These isolates were selected based on an initial visual
analysis of PFGE patterns. Nineteen isolates had PFGE patterns that are commonly
found in human clinical S. aureus isolated in Scotland. The remaining 30 isolates
included a selection of PFGE subtypes from 11 of the 13 animal sources and all four
geographic locations. Twenty eight human S. aureus isolates were selected for
comparison with the animal isolates. These were selected to include PFGE patterns that
were indistinguishable to those found amongst the animal isolate collection and a
selection of other common human Scottish PFGE types.
2.3.5.1 MLST of animal isolates
A total of 18 different STs were identified among the 49 animal isolates tested (Figure
2.14). The discriminatory power (D) of this method was 91.4% (Table 2.6). Of the 18
STs identified seven (STs 385, 692, 773, 774, 814, 815, and 816) were not found in the
MLST database and were classified as novel, of which three also had novel alleles (glpF
108, glpF 109, and aroE 140) (Table 2.21). Four of the STs detected (ST5, ST22, ST30
and ST47) have previously been described within four of the five major MRSA lineages
(CC5, CC22, CC30 and CC45).
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Table 2.21 MLST allelic profiles among the animal S. aureus isolates.
ST
"r
arcC aroE glpF g pta tpi
5 1 4 1 4 12 1
9 3 3 1 1 1 1
15 13 13 1 1 12 11
22 7 6 1 5 8 8
25 4 1 4 1 5 5
30 2 2 2 2 6 3
47 10 11 8 6 10 3
71 18 1 1 1 1 5
97 3 1 1 1 1 5
133 6 66 46 2 7 50
188 3 1 1 8 1 1
385 1 89 1 1 4 5
692 12 89 1 1 4 5
773 16 16 12 1 13 13
774 4 1 1 39 1 1
814 12 89 108 1 4 5
815 3 1 109 1 1 5
816 18 140 45 2 7 14
Numbers in purple represent novel STs, and numbers in red represent novel alleles
eBurst (eBurst Ver3) analysis of the 49 STs one major clonal complex (CC97)(14
isolates) (Figure 2.15), one minor CC (CC814) (3 isolates), and 13 singleton STs. A CC
is defined as a group of isolates which shared at least five of the seven alleles with one
other ST in the group: ancestral clones were assigned on the basis of differing at a
single locus from isolates with the highest number of matching genotypes 125. The major
CC had an identifiable ancestral ST (ST97); the minor CC was restricted to two STs
(ST814 and ST692) which differed from each other at a single locus; Singleton clones
are STs which did not share five of the seven alleles with any other ST. Of the 13
singleton STs seven were represented by more than one strain and were assigned as
singleton clones (clones with no clonal variants) 132. The largest singleton clone in this
data set was ST9, which was represented by nine isolates, followed by ST5 represented
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by seven isolates, and ST22, ST2S, ST47, ST133 and ST816 represented by two strains
each.
Four STs (STS, ST9, ST71 and ST97) were predominant and accounted for 60% of all
isolates examined. Seven of the 49 isolates tested belonged to STS. Six of these isolates
were from avian sources from Northern Ireland (Figure 2.16).
Figure 2.1S BURST diagram of CC97. The predicted clonal ancestor is in the central
ring, SLVs are in the outer ring.
(I) 815
97
(5)
71
( ) number of isolates within the given ST
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Figure 2.16 Distribution of the four predominant STs
8T71
Milk
ST97
Milk and Cow
Nine isolates belonged to ST9. These isolates were from cattle (7) from the Grampian
region and pigs (2) from the Highland region. The ST71 comprised of five isolates all
from milk sources from Grampian (2) and Southwest Scotland regions (3). Eight
isolates belonged to ST97. These isolates were from Milk (7) from the Grampian and
Southwest Scotland regions and a cow from Southwest Scotland.
Eight STs were represented by only a single isolate. The remaining 10 STs contained
between two and nine isolates (Table 2.22). These STs not only contained more than
one isolate but were also detected from more than one animal source
Five of the animal species represented in this study belonged to more than one ST, with
a maximum of five STs detected among isolates from cattle.
131
<l.>
U
~ __.
0~ 0
~
P-<
en
Cl).......
(\j-0
[/'J
• .-<
Cl)s::
0
§
...J::.......
Ij) -:...
0
8
OJ)s::·s.~
.......s::
0u
[/'J
f--<
ir:
4-<
0
s::
.9.......
;:::l.s:·c......
[/'Jcs
('-l
('-l
('-l
Cl)-.g
f--<
132
"0 "0C c
~8 ""8'"
(fJ (fJ
I
, UI If
Cophenetic correlation analysis of each PF subtype was performed (Figure 2.17). The
cophenetic correlation for a cluster tree is defined as the linear correlation coefficient
between the cophenetic distances obtained from the tree, and the original distances (or
dissimilarities) used to construct the tree. Thus, it is a measure of how faithfully the tree
represents the dissimilarities among observations. Cophenetic correlation supported the
separation of strains into clusters.
2.3.5.2 spa typing of animal isolates
spa gene sequence analysis, of the 49 animal isolates tested, resulted in the detection of
25 spa types varying in length between one (t528) and 16 (t1428) repeats, including 10
types (t1418, t1419, t1420, t1421, t1422, t1423, t1428, t1429, t1430 and NEW) not in
the Ridom database. Using the algorithm BURP, Ridom Staph'Type'' software, spa
types were grouped together if the calculated cost between members of a group was less
than or equal to eight and formed four spa clonal complexes (spa CC) (spa CC267,
CC1430, CC78 and CC2) and 10 singleton spa types414• Since clustering parameters
excluded spa types shorter than five repeats spa types' t026, t524 and t528 were
excluded from BURP grouping. The most frequent spa types were t337 (seven isolates),
t002 (five isolates), and t224 (five isolates) (Table 2.23).
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spa CC 267 contained seven spa types, including three novel spa types (t1418, t1421 and
tI429), one novel spa repeat (r118) and varied in length between seven (t1429) and 12
(t527) repeats (Figure 2.18). spa types within this clonal complex were closely associated
with isolates belonging to MLST CC97 and isolates of bovine origin (cow and milk) from
southwest Scotland (Table 2.24).
Figure 2.18 BURP analysis of spa CC267 (the calculated cost between spa types is also
included).
t177
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Table 2.24 Association between animal source and geographic region within spa
CC267
io:. sp type (no
Animal source
Geographic
isolates) region
t224 (1) Milk SWS
t267 (1) Milk G
t527 (2) Milk SWS
t1421 (1) Cow SWS
t1418 (1) Milk SWS
tl77(1) Chicken NI
t1429 (2) Cow, Horse NI
spa CC 1430 comprised of three spa types, including two novel spa types (t1419 and the
predicted founder t1430) varying in length between seven (t1419) and nine (t337) repeats.
spa types within spa CC1430 clustered at a cost of less than or equal to three (Figure 2.19).
This spa CC contained only bovine isolates belonging to MLST CC9.
Figure 2.19 BURP analysis of spa CC1430
t337
Blue spot indicates the spa type ofthe predicted ancestral strain
spa CC78 comprised of two spa types, both isolates from companion animals (ST25) from
different geographic locations, and included one novel spa type (tI423). spa type t1423
differed from t78 by the insertion of an additional r12 and r41 in the repeat succession
(Table 2.25) and clustered at a calculated cost of less than or equal to one (Figure 2.20)
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Table 2.25 spa repeat pattern alignment for spa CC78
Geographic
spa type spa repeat pattern allignment Animal source region
t078 04-21-12-41 - - 20-17-12-12-17 Horse SWS
t1423 04-21-12-41-12-41-20-17-12-12-17 Parrot H
Figure 2.20 BURP analysis of spa CC78
t1423
t78
spa CC2 comprised of two spa types (1002 and t306). spa type t306 differed from t002 by
the insertion of an additional r17 in the repeat succession (Table 2.26) and clustered at a
calculated cost of less than or equal to one (Figure 2.21). All isolates within spa CC2
belonged to ST5.
Table 2.26 spa repeat pattern alignment for spa CC2
spa type spa repeat pattern allignment
t002 26-23-17-34-17-20-17-12-17 - 16
t306 26-23-17-34-17-20-17-12-17-17-16
138
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Figure 2.21 BURP analysis of spa CC2
306 t002
spa type t1422 and the unassigned new spa type differed from each other by a single spa
repeat (r34). As no type allocation was available for the new spa type cluster analysis by
BURP was not possible. Although the repeat succession data indicate that they are closely
related (Table 2.27).
Table 2.27 spa repeat alignment of spa type t1422 and a new unassigned spa type
spa type spa repeat pattern alignment
t1422 26-23-12-34-21-17-34-34-25-17
NEW 26-23-12-34-21-17-34 - 25-17
Since clustering parameters excluded spa types shorter than five repeats, three spa types
(t026, t524 and t528) were excluded from BURP analysis. spa type t026 (repeat pattern 08-
16-34) was represented by two isolates, one cow and one unknown animal source from
Grampian and SWS respectively.
Visual inspection of spa type's t524 and t528 showed a clear similarity in repeat patterns
(Table 2.28). spa typing was unable to cluster these isolates within a spa cc.
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Table 2.28 spa repeat alignment of spa types t524 and t528
spa type spa repeat pattern alignment
t524 4 17
t528 4 -
2.3.5.3 agr typing animal S. aureus
The agr group I was the most frequent agr group among the selected S. aureus of animal
origin followed by group II (41%) and group III (4%). Only a single strain was agr group
IV (Figure 2.22).
Figure 2.22 agr groups of animal S. aureus
4% 2%
41% 53%
.group I
.group II
II group III
Ogroup IV
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2.3.6 Concordance between molecular typing methods.
Using MLST data as a reference method, an evaluation of the concordance between typing
methods for the animal S. aureus strain collection was determined. Regarding the isolates
of singleton clonal complexes CC22, CC25 and CC47 typing results were identical for spa
typing, PFGE, RS-PCR and agr typing (Table 2.29). The CC97 contained ST71, ST97 and
ST815. These STs belonged to six different spa types of which four were clustered within
spa CC267. spa types t524 and t528, both ST71, contained less than five spa repeats and
were excluded from BURP analysis. Four PF groups (PF D, PF G, PF P and PF U) and five
PR types (PR3, PR6, PR7, PR8 and PR23) were represented in this CC. Isolates belonging
to PF group D subtype 9 and PR23 accounted for 45% of all isolates within CC97. All
isolates within CC97 were agr group I. The singleton clonal complex CC5 was represented
by spa CC2, containing spa types t002 and t306, two PF groups, PF A and PF C, four RS-
PCR types, PR 1, PR2, PR14 and PR20, and all belonged to agr group II. Three of the
seven isolates within CC5 belonged to spa CC2, PF group A and PR type I. Nine isolates
comprised the singleton clonal complex CC9. This CC was represented by spa CC1430,
containing spa types t337, tl419 and t1430, a single PF group, group T, that formed a
single dendogram cluster of isolates at a >80% similarity value, two PR types, PR4 and
PRI27iv/vi/vii and all belonged to agr group II. The PF subtype T9 however, although
clustering with the other PF T subtypes at a similarity level of 74%, belonged to STI5, spa
type t84, PR type 127i and agr group II. A single isolate belonging to STI88 clustered
within PF group D, spa CC267 and belonged to PR type 3 and agr group I. These data are
consistent with the inclusion of this strain within the MLST CC97. This ST is a triple locus
variant of both ST97 and ST71 and a four locus variant of ST815 and was therefore not
clustered within CC97 (Table 2.29). Three isolates formed CC692. This CC was
represented by spa types tl422 and a new spa type, a single PF group, group M, that
141
formed a single dendogram cluster at a >70% similarity level and belonged to PR type 3
and agr group r. Three isolates clustered at an 80% similarity value in PF group 1. These
three isolates, belonged to ST385 and ST816, which differed at all seven loci, spa types
t213 and t1429 which had only a single spa repeat in common, and three distinct PR types
(Table 2.29).
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2.3.7 MLST, spa and agr typing of selected human S. aureus
Twenty eight human S. aureus were selected for characterization by MLST, spa typing,
and agr typing, and correlation with animal S. aureus strains. These isolates were
chosen based on their similarity to isolates from animals based on RS-PCR and PFGE
patterns.
A total of IS STs were detected among the 28 human S. aureus (Table 2.30). eBurst
(eBurst Ver3) analysis two minor groups (CCS and CC8), containing five isolates each,
and 11 singleton STs (Table 2.31). Seven of the STs detected (STS, ST8, ST22, ST30,
ST4S, ST12S and ST247) have been previously described with all five of the major
MRSA lineages (CCS, CC8, CC22, CC30 and CC4S).
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Table 2.31 Minor groups and singleton STs detected among the 28 human S. aureus
Singletons
ST1, ST15, ST20, ST22,
ST25,ST30
ST45, ST49, ST109,
ST123,ST789
Minor groups
ST5-------------ST 125
ST8-------------ST247
----------- indicates a SLV difference
Sequence analysis of the X region of the spa gene resulted in the detection of 23 spa
types varying in length between five (t209) and 12 (t1431 and t1432) repeats including
three types not found in the Ridom database (Table 2.25). Five spa types, t002, t008,
t078, t1432 and t1433, were detected more than once. The new spa type t1433 has
subsequently been reported in an isolate from the Netherlands (Ridom SpaServer
database last viewed 16.12.07). Fifty percent of human isolates belonged to agr group I,
and was the most frequently detected agr group, followed by group II (32.1%), and
group III (14.3%). Only a single strain (STI23) belonged to agr group IV (Table 2.25).
These data were combined with the data generated from the animal S. aureus isolates
and compared to determine strain similarity between isolate populations.
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2.3.8 Correlation of characterization data between animal and human S. aureus
isolates
Of the 28 STs identified, among the 77 isolates examined, 13 STs were found only
among animal strains, 10 STs only among human strains and five STs (ST5, ST15,
ST22, ST25 and ST30) common to both populations (Figure 2.23). A sixth ST, ST45,
detected in a human isolate was a SLY of ST47 found in an animal isolate. eBURST
analysis of the combined animal and human ST datasets one major CC (CC97), three
minor CCs (CC5, CC47, and CC814) and 18 singleton STs. Fifty percent of the STs
identified were single isolate and nine STs comprised of between two and nine isolates.
Two ofthe minor CCs (CC5 and CC47) contained isolates from both human and animal
sources. CC5 comprised of 12 isolates, seven animal and five human, and included ST5
and the SLY ST125. CC47 was comprised of four isolates, two human and two animal,
and included ST45, only identified from human isolates, and the SLY ST47, only
identified from animal sources.
Figure 2.23 STs identified among human and animal S. aureus including those common
to both strain collections.
Human
STl**, ST8*,
ST20**, ST4S,
ST49*., STI09**,
ST123**, ST12S,
ST247*., ST789**
ST9, ST47, ST71,
ST97, ST133*,
ST188**, ST38S**,
ST692**, ST773·.,
ST774·*, ST814·,
ST81S·., ST816*
• Singleton STs, •• Singleton STs that were also single isolate
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2.3.8.1 spa typing and based upon repeat pattern analysis (BURP)
Using the algorithm BURP, Ridom Staph Type" software, spa types were grouped
together if the calculated cost between members of a group was less than or equal to
eight and formed eight clusters (spa CC2, spa CC8, spa CCI2, spa CC78, spa CC84,
spa CC223, spa CC267 and spa CC1430) and 15 singleton spa typesl". The most
frequent spa types were t002 (six animal and two human isolates), t337 (seven animal
isolates), and t224 (five animal isolates). Since clustering parameters excluded spa
types shorter than five repeats, three types (t026, t524 and t528) were excluded from
BURP grouping. Five clusters, spa CC2, spa CCI2, spa CC78, spa CC84 and spa
CC223 contained isolates from human and animal sources. spa CCs 267 and 1430
(Figures 2.18 and 2.19) were exclusive to animal isolates and spa CC8 contained only
human isolates (Figure 2.24). spa CC8 was represented by five human S. aureus
isolates. Four isolates, t008 (two isolates), t064 (single isolate) and t190 (single isolate)
were ST8. The remaining isolate belonged to spa type t051 and was ST24 7, a DL V of
ST8. All isolates clustered at a calculated cost of'<S (Figure 2.24).
Figure 2.24 BURP analysis of the identified spa types in spa CC8
tOSl
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spa CC2 contained five spa types, with only t002 common to human and animal
isolates (Table 2.32). These isolates grouped at a calculated cost of::;3 (Figure 2.25).
Table 2.32 Correlation between spa type and ST in spa CC2
ST
Number of isolatesspa type ,
v Animal Human,
t002 5 2 5
t067 125 1
t306 5 2
t311 5 1- . ~
t579 5 , . 1
Figure 2.25 BURP analysis of the identified spa types in spa CC2
6
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spa CC12 was represented by three isolates, two human isolates (t1432) and a single
companion animal isolate (t012), clustering at a calculated cost of:Sl (Figure 2.26).
These isolates had identical ST (ST30) and were grouped together by RS-PCR (PR16)
and PFGE (PF 16).
Figure 2.26 BURP analysis of the identified spa types in spa CC12
tOl2 tI432
F-=-':....=-----I 1 I-------l
spa CC78 was represented by four isolates; two companion animal isolates, one horse
from Southwest Scotland and one parrot from Highland, and two human isolates. Three
isolates belonged to 1078, this included both human isolates (PF 138 and ST25) and the
parrot isolate (Figure 2.27). Both animal isolates belonged to PF subtype 11, which on
visual inspection was indistinguishable from Scottish MRSA R~ference Laboratory
(SMRL) PF138 banding pattern identified in human S. aureus, which belongs to the
ST25 clonal lineage. The horse isolate, also belonged to ST25, exhibited a novel spa
type (t1423) which differed from t078 by the insertion of an additional 12-41 repeat
within the repeat succession which resulted in a calculated cost of:Sl between the two
spa types.
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Figure 2.27 BURP analysis of the identified spa types in spa CC78
78 1423
spa CC84 was represented by four isolates, three human and a single bovine isolate
from Grampian region, and by three spa types, including t084 the predicted founder of
this spa CC (Figure 2.28). The human isolates belonged to PRlPF type 127 using the
SMRL nomenclature and belonged to the same ST as the animal isolate (Table 2.33).
On visual inspection, of the RS-PCR and PFGE banding patterns, the animal isolate
belonging to PF subtype T9 (Figure 2.11), was classified as SMRL PR 127 and PF127.
Figure 2.28 BURP analysis of the identified spa types in spa CC84
Table 2.33 Burp analysis of the identified spa types in spa CC84
~ No .isolates, ST~,). fPa type Animal
t084
15 t085 1
t346 1
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Isolates belonging to spa CC223 included two human and two animal isolates, one pig
from Highland and one milk from Grampian region (Figure 2.29). Although both spa
types within this spa CC contained the same number of spa repeats, repeat number four
in the repeat succession differed with the deletion of r25 and insertion of r31 within
t1433 (Table 2.34).
Figure 2.29 BURP analysis of the identified spa types in spa CC223
1433
Table 2.34 spa repeat variation in isolates belonging to spa CC223
Isolate source spa type ~im spa repeat succession
Animal t223 26-23-13-23-05-17-25-17-25-16-28
Human t1433 26-23-13-31-05-17-25-17-25-16-28
The animal strains, belonging to PF group L, on visual inspection were classified using
the SMRL nomenclature as PR type 15 and PF type 15 and were indistinguishable from
human isolates.
Using the spa typing parameters described in the materials and methods, all isolates
were grouped together as expected regarding their evolutionary origin, as reflected by
MLST analysis, although in most cases a variety of spa types corresponded to a single
MLST ST (Table 2.35).
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Table 2.35 Distribution of spa types among animal and human S. aureus isolates where
isolates belonging to the same ST had different spa types
ST spa types
5 t002, t067, t306, t311, t579,
8 t008, t064, t 190
9 t337, t1419, t1430
15 t084, t085, t346
22 t223, t1433
71 t524, t528
97 t224, t267, t527, t1421
2.3.9 Relationships between ST, spa type, agr type and PRlPF types among animal .
and human S. aureus isolates
Five STs (ST5, ST15, ST22, ST25 and ST30) were common to both human and animal
S. aureus isolates examined in this study. Although ST45 (human isolate) and ST47
(animal isolate) were not common to both isolate collections these strains both belong
to MLST CC45. These STs together with ST5, ST22, and ST30 represent four of the
five major contemporary epidemic S. aureus clonal lineages. A high level of
concordance between the four typing and clustering methods was demonstrated (Table
2.36). As the BURP algorithm excludes spa types with less than 5 repeats, isolates
belonging to ST45 and ST47 (PF 111 and PF subtype NI respectively and both agr type
I) were not clustered together by spa type. The spa type t026, belonging to ST47, shares
spa repeats r8, r16 and r34 with spa types t050 and t060 and could be clustered based
on visual inspection of the repeat successions (Table 2.37).
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Table 2.36 Correlation between ST, spa type, agr type and PRlPF types common to
animal and human S. aureus
,
PRlPF tyi_e..ST , spa CC 1. spa types agr type
Human Animal
51125 CC2 t002, t306, t311, t579 II 105 105
15 CC84 t084, t085, t346 II 127 127
22 CC223 t223, t1433 I 15 15
25 CC78 t078, t1423 I l38 l38
30 CC12 t012, t1432 III 16 16
45/47 * t026, t050, t060 I III 111
* BURP analysis excludes spa types with <5 repeats therefore did could not place these spa types within a spa Cc.
Table 2.37 Comparison ofST and spa types ofPF type IIIINI isolates
I~
. - (
Isolate source PF type S1' Allelic profile spa type
t Repeat succession
Human III 45 10-14-8-6-10-3-2 t065 09-02-16- 34-13-17- 34-16-34
t050 08-16-02-16- 34- 34-17 -34-16-34
Animal NI 47 10-11-8-6-10-3-2 t026 . 08-16-34
There was good overall correlation between the five molecular characterization methods
used (RS-PCR, PFGE, spa typing, MLST and agr typing). Based on the visual
inspection of the RS-PCR and PFGE banding patterns, of the human and animal isolate
collections, three PRlPF types common to both groups belonged to different STs, spa
types and for two out of three agr groupings (Table 2.38).
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2.4 Discussion
The epidemiology of infectious disease relies on typing methods as tools for the
characterization and discrimination of isolates based on either their genotypic or
phenotypic characteristics'j". These methods can be used to establish clonal
relationships between strains and to trace the geographical dissemination of bacterial
clones. While there are numerous methods for typing S. aureus, not all methods divide
groups of strains in a similar fashion. The methods used in this study have been used
widely for the characterization of S. aureus from humans but have been infrequently
used to characterize S. aureus from a range of livestock, companion or wild
animals270,301,401.
2.4.1 Characterization methods
2.4.1.1 Phenotypic characterization
Phenotypic characterization of S. aureus isolates by the antibiotic resistance pattern has
been used as a first step in strain monitoring. It is a simple, fast and inexpensive method
of survey but lacks sufficient discriminatory power. This lack of discriminatory power
was apparent in this study where the antibiogram method identified 32 resistance
phenotypes with a discriminatory value of 88.2%. Although, this level of discrimination
was almost three times higher than that reported by Aarestrup et al in an investigation
of S. aureus from bovine mastitis in Denmark 7• The poor discriminatory power of
antibiogram typing is attributed to the fact that two strains with no epidemiological link
can have the same antibiogram while two isolates of the same clone can acquire and
lose plasmid mediated antibiotic resistance and exhibit different phenotypes'",
1,,7
Therefore, like the use of antibiograms to characterize human S. aureus, antibiograms
are an unsuitable method for the characterization of S. aureus isolated from animals.
Phage typing has been used for typing human S. aureus and has been the standard
method for typing S. aureus from cases of bovine mastitis since the early 1960's
42,381,497. In studies by Slanetz et a1399, St George et al412 and Frost et al145 the level of
non typable isolates from bovine sources, when using the 23 phages of the international
phage set (IPS) for typing human strains of S. aureus, was high. The frequency of non
typable S. aureus isolates from animals in this study was also high at 24% resulting in
the lowest discriminatory value (83.5%) of all the methods used to characterize S.
aureus isolates from animals. Studies by Vintov et al, of bovine S. aureus from 10
different countries, has shown a similarly high (23%) level of phage nontypability'j". In
contrast, Aarestrup et al', Zadoks et at97 and Capita et aro have all reported very high
levels of phage typeability (93%) for S. aureus isolates from bovine and poultry and
concluded that the use of the internationally recognized and well investigated human set
of phages gives the possibility to compare the occurrence of different phage types
among livestock animals.
There was an overall low level of correlation with other typing techniques indicating a
poor level of concordance between phage typing and DNA-based techniques a point
also noted by Grundmann et a1165• Due to the many drawbacks, which include limited
typeability, limited technical reproducibility and a lack of biological reproducibility,
phage typing is also not a suitable method for the characterization of S. aureus from
animals and has been superseded by DNA-based typing techniques.
2.4.1.2 Molecular characterization
Amplification of the variable region between the 16S and 23S rRNAs by RS_PCR83 has
been shown to successfully characterize S. aureus isolates from human clinical
sourcesi'". This method is based on the observation of PCR products corresponding to
the short intergenic regions between the genes for the ribosomal 16S and 23S RNA159•
Dolzani et al reported that RS-PCR had a 100% type ability level, was reproducible and
almost as discriminatory as PFGE for outbreak isolates of MSSA and MRSA with a
discriminatory value of 92%111. In this study RS-PCR was able to type all isolates,
resulting in 27 different PR types, and a discriminatory value (86.2%) lower than that of
antibiogram resistance phenotype and PFGE. In an attempt to increase the.
discriminatory capacity of this method some authors have used endonuclease digestion
of the amplified RS-PCR products/'". Couto et al suggest that the restriction of
amplicons with restriction enzymes is not necessary". Kumari et at also came to the
same conclusion indicating that the endonuclease digested fragments are very small and
present difficulties in the interpretation of banding patternsi". The low discriminatory
capacity of this technique renders it ill suited for the characterization of S. aureus
isolated from animals.
PFGE, of SmaI-digested genomic DNA, is the most commonly used method for
studying the microepidemiology (local or short term) and macroepidemiology (national,
continental or long term) of S. aureus from humans172. It has also proven invaluable for
the characterization of S. aureus isolates from humans, cases of bovine497,498 and
ovine 456 mastitis, from infection in poultry286,360,361 and pigs 193, and MRSA from
companion animals415,467. The criteria for interpreting PFGE band patterns, as
published by Tenover et aI, categorizes isolates as indistinguishable (no band
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differences), closely related (one to three band differences), possibly related (four to six
band differences), or different (more than six band differences) and was developed to
analyze discrete sets of isolates obtained during epidemiologic studies of potential
outbreaks spanning short periods of time (1 to 3 months) and a narrow geographic
distribution424. It has also been argued that the stability of PFGE may be sufficient for
its reliable application to long term epidemiological studies43,172. Although, some
authors have argued that the stabilities of PFGE markers may be insufficiently reliable
for long term studies: high degrees of genetic variation leading to multiple PFGE
banding patterns have been observed for pandemic clones with long evolutionary
histories. This has been attributed to heterologous selective pressure in the.
environment':' and to the fact that large chromosomal fragments undergo faster
variation than smaller ones that lead to a progressive drift of PFGE patterns over
timel72.
All isolates could be typed using this technique and visual inspection of the banding
patterns of the 233 animal S. aureus isolates resolved 74 pulsed field patterns resulting
in a discriminatory value of 93.1%. This level of discrimination is consistent with data
published by Cookson et al80 and Hallin et all72 for typing S. aureus from humans and
Zadoks et ar97 and dos Santos et all12 for typing S. aureus from bovine sources. The
level of concordance between PFGE and RS-PCR was high. Although, combining both
methods did not significantly increase the overall level of discrimination.
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PFGE grouped all isolates into 20 groups, each containing between one and 19
subtypes, at a 70% cut-off value which equated to Tenover's criteria for possibly related
(:'S6bands differencejt'". Four PF groups (PF groups A, D, M and T) accounted for 84%
of the isolates. There was a clear association between PF group and animal and
geographic source. PF groups A and M were predominantly from avian sources from
Northern Ireland and Highland region respectively, while PF groups D and T were from
bovine sources the Grampian region and Southwest Scotland. In contrast, a recent work
by Faria et at has shown that to meet the Tenover criteria for possibly related required a
similarity cut-off of 80% and one of95% for closely related (1-3 bands difference). The
presence of these limited number of PF groups among this collection of isolates .
suggests that a limited number of clones are responsible for infection from avian and
bovine sources. This is in agreement with the findings of others. Aires-de-Sousa et at
and Cabral et at have both reported that only a limited number of clones were
responsible for cases S. aureus mastitis in cattle, goats, sheep and buffalo, and infection
in ostrich in BrazilI5,59. Also Jergensen et at and Merk et at have observed that a limited
number of S. aureus genotypes were responsible for bovine, ovine and caprine mastitis
and that these genotypes were also isolated from bulk milk from these species"! ,305 .
Despite the practical disadvantages, which include the high set up cost, its labour
intensiveness, the unique technical skills required and difficulties with inter-laboratory
comparisons, PFGE was able to type all animal S. aureus and cluster them into
epidemiologically related groups.
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spa typing is a single polymorphic locus sequence based typing method 172. The
sequence variations in this region arise from deletion and duplication of the repetitive
units and also by point mutation, duplications or deletions within the repeat
succession322. Shopsin et al has noted that the mutational rate within this region was
sufficiently low to allow for adequate discrimination between S. aureus strains396• Kahl
et aPl2 has confirmed the conclusion of Shopsin et al by investigating the mutational
rate within the X region in 10 patients with cystic fibrosis who were persistently
colonized with a single S. aureus clone, determined by PFGE. They calculated that one
genetic event occurred every 70 months with deletions being most common.
The major advantage of spa typing over PFGE is its ability to be applied to both local
and global epidemiological studies. While spa typing does not have the resolving power
of PFGE subtyping it has several advantages in terms of speed, ease of use, ease of
interpretation and data management and dissemination 239. While all isolates could be
typed by spa, de Sousa et al have reported that on rare occasions no amplification of the
spa X region occurred. This lack of amplification is thought to occur due to sequence
mutation within the primer binding region'r. Koreen et aP39, typing S. aureus from
humans, and Moodley et aPOI, typing MRSA from companion animals, have both
shown the same level of typeability as was seen in this study. Sequence analysis of the
X region of the spa gene resulted in the detection of 25 distinct spa types including 10
novel types, among the 49 isolates tested, and had a discriminatory value of 95.4%. This
high level of discrimination has also been shown in data published by Strommenger et
atl4 on human and animal S. aureus and Faria et al129on S. aureus from humans form
19 different countries collected over a fifty year period. All spa types were classified
into four spaCCs, 10 singleton spa types and three excluded by BURP analysis as they
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had less than five spa repeats. spa typing was shown to be similarly discriminating and
concordant with PFGE in the characterization of the animal isolates of S. aureus in this
study:
MLST resolved eighteen different STs among the S. aureus isolates from animals
including seven novel STs (ST385, ST692, ST773, ST774, ST814, ST815 and ST816)
and three novel alleles (glpF 108, glpF 109, and aroE 140) and had a diversity value of
91.4%. Joo et al suggest that the identification of novel STs and alleles may be evidence
of selection pressures that create specific localized variants of S. aureui09• Therefore, it
would not be unusual for animal isolates to possess novel alleles compared to the .
sequences of those strains isolated from humans. They also suggest that there may be a
limited cross-over of animal and human strains which could also explain the presence of
novel STs and alleles, with the isolated populations diversifying independently. The
identification of the novel STs ST692, a SLY ofST814, due to the presence of the novel
allele glpF I08, and ST385, a DLV of ST692, and ST815 a SLV of ST97 and a DLV of
ST71 could indicate the presence of localized, independently diversifying, clonal
variants within this strain collection. Alternatively Smith et al suggest that the presence
of novel STs and alleles may be merely due to the investigation of new populations, and
as most analyses have focused on human clinical isolates, increased sampling and
further analysis of other S. aureus populations would be likely to yield novel alleles4ol•
163
The initial findings of a study of human S aureus strains by Feil et al and Day et ai,
based on MLST, showed S aureus to be highly recombinogenic. Although this
conclusion has now been amended due to sequencing errors132. The revised data set
demonstrated that S. aureus has a predominantly clonal population structure, and the
findings of this study on S aureus isolated from animals agree with this finding.
MLST provides unambiguous results that are electronically portable and therefore
suitable for global surveillance studies via the internet'". A major disadvantage of
MLST, however, is that phylogenetic relationships and resolution of clones can be
masked by the use of slowly evolving housekeeping genes. Zhang et al have suggested .
that more rapidly evolving genetic loci should be used to resolve deeper relationships
and provide a higher level of strain discrimination 499.
DNA-based typing schemes came to very similar conclusions as PFGE and the
combining of different techniques did not increase the discrimination of the Saureus
strains from animals to a large extent. This contrasts with data from Aarestrup et al and
Smith et al who have shown an increase in the discriminatory power of phenotypic and
genotypic methods when combined7,401. Moreover, it appears that PFGE patterns could
theoretically predict MLST clonal complexes, pointing to the presence of a largely
congruent phylogenetic signal in different regions of the staphylococcal genome''".
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The characterization of S. aureus from animals has shown high overall agreement
between MLST, spa and PFGE typing methods. Previous work on bovine and human S.
aureus isolates has also demonstrated high overall agreement between genotypic typing
methods4ol,497.
Four allelic groups of agr have been characterized in S. aureus (numbered I-IV). Wright
et aI, using five different genotyping methods to characterize S. aureus strains,
concluded that their results were so strongly correlated with agr that the former could
be used to predict the latter unequivocally'i". Of the 49 isolates examined, by agr
multiplex peR, group I (53%) was the most prevalent, followed by agr II (40.8%), agr .
III (4.1%) and a single isolate agr IV. Gilot et al have shown an identical distribution of
agr groups among S. aureus isolated from cattle 156. In contrast to this clear prevalence
of agr groups I and II in animal S. aureus strains, Jarraud et al have shown an even
distribution of agr groups among S. aureus isolated from humans/'" .
In a study by Wright et al they concluded that with exceedingly rare exceptions no
MLST pattern occurred in more than one agr group. Data from this study has also
shown that strains belonging to the same MLST type also belonged to the same agr
group. They also suggest that the same holds true for PFGE and spa typing491• This was
not the case here where isolates belonging to a common PF group or spa type could
belong to different agr groups. The hypothesis of Wright et aI, based on the observation
that no multilocus sequence type generally occurs in more than one agr group, that the
divergence of agr groups in S. aureus preceded the development of nucleotide
polymorphisms currently used for strain typing and that the species was
phylogenetically structured according to agr has now been refuted. Robinson and
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colleagues have shown that Staphylococcal clonal complexes themselves can belong to
at least two subspecies groups both containing agr I and III. Therefore, because of
recombination, agr I and III are not monophyletic and the species cannot be
phylogenetically structured according to agr (Figure 2.30)358.
s. QJlTeIU
subspecies group!
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subspecies group 1
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staphylococcal
species
Figure 2.30 Model for the evolution of agr. The clone phylogeny (or species tree) is
shown as a bold outline. The agr phylogenies are shown as thin lines within the clone
phylogeny. Different agr groups are shown as shaded nodes358.
As mentioned by Tenover et at no single typing method appears to be clearly superior
in all cases423• Although, the current ability of spa typing to distinguish both
molecularly and epidemiologically linked strains rapidly and easily makes it particularly
well suited for the initial screening that may be used to identify and direct
epidemiological studies.
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2.4.2 Clones found among animal S. aureus
A subset of 49 animal isolates was selected and further genotyped by MLST and spa
typing. This collection included 11 of the 13 animal sources, 15 of the 20 PF groups and
38 PF subtypes.
Fifty three isolates formed PF group A representing 14 PF subtypes. PFGE subtyping
differentiated strains between different animal and geographic sources. The only
exceptions to this were PF subtypes A7 and A12. PF subtype A7, the predominant
subtype was detected in chicken and bovine in three different locations but not
Highland and A 12 was detected in pig and bovine from Grampian and Highland
regions. Similar results have been reported by Zadoks et al and Annemuller et al where
PFGE was able to differentiate S. aureus strains within and between bovine herds in the
Netherlands and GermanY2,498. Cluster analysis of these isolates was supported by
MLST (CC5) and spa typing (spa CC2). The majority of isolates within PF group A
were from avian sources including livestock and wild birds. Aires-de-Sousa et al have
also reported the presence of S. aureus belonging to ST5 in bovine milk samples. In that
study they suggest that this isolate, a genetic background mainly associated with cases
of human disease, may have been the result of human contamination'". It is possible that
the detection of ST5 strains, from cattle and pig sources from Grampian and Highland
regions may be as a result of human contamination. In a study by Gilot and van
Leeuwen they have shown that the transfer of S. aureus strains between humans and
livestock animals although possible was an infrequent eventl56. The majority of isolates,
however, within PF group A were isolated from multiple avian sources and geographic
locations. This data casts doubt over the suggestion that these strains may have been as
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a result of human contamination and indicate the possible presence of an avian adapted
S. aureus clone.
Isolates belonging to ST9, spa CC1430 and PF group T, were found among cattle and
pigs, suggesting that S. aureus from these animal sources do not represent separate
genetic populations. These findings agree with those of Merk et ai, who genotyped S.
aureus from cases of bovine, caprine and ovine mastitis in Norway. They found that a
small number of closely related genotypes are responsible for the majority of cases of S.
aureus mastitis and that these genotypes exhibit little or no host preference among these
speciesl'". A study by van Leeuwen et al reported that mastitis-related S. aureus from
diverse hosts were genetically clustered suggesting tissue specificity not host
speciflcity'Y. Contrasting with this conclusion is a study by Smith et al who reported
that a single MLST CC (CC97) was responsible for the majority of cases of bovine
mastitis. This CC, with ST97 as the predicted ancestor, comprised of 14 ST which
included ST71 and ST25. These data are consistent with those of this study where all
isolates belonging to CC97 were isolated from bovine sources. Unlike Smith et al, ST25
was not found to be associated with bovine species but companion animals in this study.
ST25 has previously been identified as the ancestral clone of a CC and is a DLV of a
DLV of ST97. This ST was placed as a satellite strain among CC97 with ST127 as an
intermediary'?'. No intermediary strain was found between STs 25 and 97 in this study
which explains why eBURST did not cluster these isolates. Although, an unrooted
Bayesian tree produced by Feil et al supports the closer relationship of ST25 and ST97
than to other ancestral strains132. Aires-de-Sousa et al have also reported the isolation of
isolates belonging to CC97 (ST747) from mastatic cattle in Brazill5•
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The minor MLST CC, CC814 contained two novel STs from strains of avian origin
(chicken and pheasant) that were geographically separated. These isolates also belonged
to two novel spa types (t1422 and new). Visual inspection of the unassigned new spa
type, by the insertion of an additional r34 within the t1422 repeat succession, clearly
links these isolates. The data from MLST and spa typing supports the clustering of
these isolates within PF group M. It appears that this CC is divided across animal
species and geographic lines.
PF group Q comprised of two subtypes, both of which belonged to ST133 and spa type
t1428. No reports of human colonization or infection with this clone could be found
although cases of bovine and caprine mastitis have been reported caused by ST133
(http://www.mlst.net).
According to the criteria proposed by Tenover et ar24 it must be emphasized that these
criteria apply only to epidemiologically related isolates recovered within a short time
frame «3 months) and a narrow geographic distribution, this is underlined by the
observation that isolates assigned to the same PF group could belong to a different ST.
This was the case for two sets of STs in this part of the study. A single isolate of ST774
was assigned to the same PF group as isolates within CC97 and differed at four of the
seven MLST loci. Also the isolates that formed PF group J, a single isolate of ST385
and two isolates of ST816 differed at all seven loci. Melles et al in a study comparing
MLST, PFGE and amplified fragment length polymorphism (AFLP), for typing S.
aureus, have also shown a small number of isolates assigned to the same PFGE group
that belonged to different CC293. Jergensen et al have also shown that isolates, from
bovine bulk milk, assigned to the same PF group belonged to different STs that differed
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from each other at all seven loci2ll. Also, isolates that belong to identical STs could also
belong to different PF groups. Isolates within PF groups A and C both belonged to ST5
and spa CC2 and isolates belonging to PF groups D, G, P and U all belonged to MLST
CC97. Melles et at concluded that PFGE, which does not include an amplification step,
is a less useful method for long term epidemiological surveillancef".
2.4.3 Genotypic comparison of human and animal S. aureus strains
Twenty eight human S. aureus were selected for genotypic characterization and
comparison with animal strains based on their RS-PCR and PFGE banding pattern
similarity to those found among animal strains.
Six STs were common to both animal and human isolates with four of these STs (ST5,
ST22, ST30 and ST45) representing four of the five major contemporary epidemic
MRSA clonal lineages. Cluster data obtained by MLST, spa typing, PFGE analysis and
agr typing demonstrated a high degree of congruence. Koreen et at has also shown a
high level of congruence between genotyping methods and concluded that this indicated
a low level of recombination, a predominantly clonal population structure, and the
presence of a phylogenetic signal within S. aureui39. Similar results have been reported
for clonal complexes containing major MSSA and epidemic MRSA isolates, such as
CCS, CC8, CC30 and CC4S98,239. Although, agr typing has been shown to be a more
variable characteristic in some studies'".
Isolates belonging to CC5 corresponded to spa CC2, containing four different spa types
and agr type IIand PF type IDS. STS is an old and globally spread lineage which is the
predicted founder of CCS and is the genetic background to the New York/paediatric
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MRSA clone and represents most of the MRSA with reduced susceptibility to
vancomycin 404.
Four isolates, two animal and two human, were ST22, agr type I with EMRSA15
patterns. These isolates also belonged to spa CC223 containing two spa types (t223
both animal isolates and t1433 both human isolates). The spa types within this CC
clustered at a calculated cost of::;1 indicating a closely related clonal lineage. This clone
rapidly emerged and spread during the 1990s and is today widely disseminated in
hospitals in the UK (EMRSA 15) and in Germany (Bamim epidemic MRSA)153. ST22
MRSA has also been isolated from companion animal derived infections that belong to
the same clonal lineage as those found among the human population, in hospitals and
the community, and represent a transmission risk to human handlers270,301.
Isolates belonging to ST25 have been reported, together with STI and 30, as a
significant cause of community acquired disease in humans and has also been reported
as the cause of disease among bovine sourcesI22,400.Smith et al and Feil et al have both
suggested a closer relationship between ST25 and ST97 than to other ancestral strainsl32
. With the exception of agr typing, none of the genotypic methods used in this study
linked these clonal backgrounds.
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Four isolates of ST30, three human and one companion animal, were detected. This
clonal background has been identified as a successful internationally distributed MSSA
lineage, associated with invasive disease in humans and has been isolated from bovine
milk and animal bedding samples from the USA 401. ST30 is closely related to the
EMRSA16 pandemic clone (ST36) responsible, together with EMRSA15 (ST22), for
95% of MRSA bacteraemia in the UKI4,19,122.
A study characterizing toxic shock syndrome toxin 1 positive MSSA from Germany has
the presence of isolates belonging to ST45, the genotypic background to the Berlin
MRSA clone249• These isolates belonged to spa and agr types common to the human.
isolates of ST45 detected in this study. Two animal isolates of ST47, a SLY of ST45,
belonged to the same agr type as the human strains. As the animal isolates had less than
five spa repeats in the sequence these were excluded from the BURP analysis, although
visual inspection shows them to be closely related to the human strain spa types.
In conclusion, this study has shown that PFGE, MLST and spa typing can be
successfully applied to characterize S. aureus isolated from animals. MLST and spa
typing data were easier to interpret than banding patterns generated by PFGE. spa
typing was superior in discriminatory power than both MLST and PFGE. Combining
spa and MLST increased the number of types found and the discriminatory power
although the routine use of both methods would be prohibitively expensive. Therefore,
spa typing represents a suitable single genotyping technique for the characterization of
S. aureus isolated from animals.
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A large number of S. aureus types were found among the animal isolates, but four types
were predominant and were very closely associated to an animal source and geographic
region.
Six of the observed STs were common to the animal and human isolate collections.
These STs have previously been reported from cases of human disease and from healthy
carriers. The presence of isolates assigned to these STs in animals could reflect human
contamination. This is, however, not conclusive as many of these strains have been
reported previously in cases of animal infection 136,211.
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Chapter 3 Host specificity
3.1 Introduction
S. aureus can colonise and infect a variety of members of the animal kingdom,
including mammals, reptiles, and birds452• Studies have addressed the molecular basis of
host specificity among S. aureus strains. These have examined gene polymorphisms
with multilocus enzyme electrophoresis, PFGE, binary typing and shotgun sequencing
and have shown that S. aureus strains from humans can and do cross-infect domestic
and companion animals270,467-469,497,498. The concept of host specificity among bacterial
genera is not new. For example, S. enterica serotypes Dublin and Rostock are known to
be host specific for bovine and Choleraesuis for swine442• Willems et at have shown
host specificity in E. faecium strains based on amplified fragment length polymorphism
analysis of vancomycin resistant strains from humans and a range of domestic and
companion animals483. Devriese et at have also concluded that E. faecium, with
different carbohydrate requirements, were associated with different host species and
suggested that certain enterococci are host specific102•
Most of the work examining the possibility of host specificity of S. aureus strains has
been performed on isolates from cases of bovine mastitis. Numerous methods have been
used, including phenotypic, phage typing and antibiogram, genotypic, determining gene
polymorphisms with MLEE, PFGE and binary typing, MLST and spa typing and the
detection of specific virulence factors, such as toxins, adhesins and global regulators,
using molecular techniques63,299,305,370,398,401,452,497,498. Although some strains identified
in these studies were closely related to isolates recovered from humans, many were not,
and it has been suggested that the successful transfer of S. aureus between humans and
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domestic animals under natural conditions is limited. Reports of S. aureus from
companion animals, as a source of infection in humans, are becoming more
frequent270,466,467. The molecular basis of host specificity in S. aureus remains
unknown 183.
The purpose of this study was to determine the genetic relationship between S. aureus
isolates from animals and human by examining a number of recognized virulence
determinants.
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3.2 Materials and methods
3.2.1 Bacterial strains
Two strain collections were used; the first strain collection comprised 49 animal strains
(Table 2.19), the second strain collection consisted of 28 human S. aureus strains (Table
2.24). Both collections were characterized to clonal level in chapter 2.
3.2.2 Virulence factor peR
For both strain collections, the genes coding for adhesins, the global regulator agr,
staphylocoagulase, enterotoxins, haemolysins and exoprotein toxins were amplified
using the peR primers and amplification conditions outlined in Table 3.1 and Table 3.2.
peR amplification was performed on a Techne Genius thermal cycler. A positive and
negative control was included in each peR run.
Table 3.1 peR reaction mixes
peR reaction Template Primer peR Ready-to-go bead Tissue grade Total
mixture DNAQ sequence" mastermix" reaction tubed water" volume
peR-l 1fll 1ul 12.5fll 8.5fll 23fllrca-z 1fll 1ul 1 21 ul
multiplex
25fllpeR 2fll 2fll 1 21fll
"Template DNA was extracted as described in section 2.5.1
bprimer sequences- peR reaction mixture 1 and 2, 0.5111of each forward and reverse primer and multiplex peR,
0.5111of each forward and reverse primer added to a microtube. 2111of primer mix used in multiplex peR. All primers
were prepared at 50pmol concentration.
'Reddymix peR mastermix (ABgene, UK) (0.2 mM of dATP, acrr, dGTP and dTTP, 3 mM Mgel2, 0.625 units
Taq polymerase, 20mM Trizema base and 50 mM
dSupplied by Amersham pharmacia, UK
"Supplied by Sigma, UK
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3.2.2.1 Gel electrophoresis
Electrophoresis was performed using six microlitres of PCR product loaded in a
1.5% Neuseive agarose (Cambrex, UK) gel in a 0.5% TBE solution (Gibco).
Staphylococcal enterotoxin genes were seperated at 180V for 210 minutes and
all other virulence factor genes were separated at 140V for 90 minutes.
Following electrophoresis gels were stained with lug/nil. ethidium bromide
solution (Sigma, UK) for 30 minutes visualised by uv transillumination (UVP,
UK) and the image stored digitally using Vision Works 32 software. The size of
each PCR product was determined by comparison with the appropriate control
strain and molecular weight ladder (Gibco, UK).
3.2.2.2 Restriction endonuclease digestion
Endonuclease digest reactions were performed in a 20f..t1sample containing 12f..t1
of tissue grade water (Sigma,UK), 5f..t1of PCR product, 2f..t1of appropriate
REact® buffer and 1f..tl of restriction endonuclease. Digest products were
analysed by gel electrophoresis using the method outlined in section 3.2.2.1.
3.2.3 Biofilm assay
The production of biofilm was detected following the method of Vasudevan et
at55• Three colonies of each test isolate was added to a 2ml tryptone soya broth
containing 0.25% (w/v) glucose (TSBG) and incubated overnight at 37°C.
Following incubation 5f..t1of overnight broth suspension was added to 195f..t1of
sterile TSBG in a "U" bottom polystyrene tissue culture well (Nunc GmbH,
Germany). Cultures were incubated overnight at 37°C followed by three washes
in phosphate buffered saline (PBS). Each well was stained for 5 minutes using
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200lli of 1% crystal violet, washed three times with PBS, and dried at 37°C. The
absorbance of each well was determined at 570 nm (Titrec plate reader). A
positive control, S. epidermidis (ATCC 35984), negative control, S. epidermidis
(ATCC 12228), and three wells containing only TSBG were included in each
biofilm assay. The mean absorbance value for the wells containing only TSBG
was subtracted from each unknown absorbance to correct for background
effects. Strains were considered biofilm positive if the corrected absorbance
value was ::::0.1.Biofilm assays were performed in triplicate.
3.2.4 Statistical analysis
The distribution of virulence factors from animal and human S. aureus strains
were compared using Fisher's exact test. P values of less than 0.05 were
considered significant452.
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3.3 Results
3.3.1 Distribution of virulence factors
3.3.1.1 agr RFLP
The 1,070-bp variable region of the agr operon that includes AgrD, the gene
responsible for the group specific autoinducing peptide, was amplified by PCR
with primers Bl and C2 (Figure 3.1). Among the 77 S. aureus isolates
investigated 54 (70.1%) of the strains tested produced two amplicons of 1,070bp
and approximately 650bp (type A), 20 (26%) isolates produced an amplicon of
1,070bp (type B), two isolates produced an amplicon of approximately 650bp
(type C), and no amplicon was produced from a single isolate (type D) (Figure
3.2).
VARIABLE REOION
.....
81
1000 bp
Figure 3.1 Schematic map of the S. aureus agr operon. agrA and agrC encode
the response regulator and receptor histidine protein kinase components of a
two-component signal transduction pathway, whereas agrB and agrD combine
to generate the activating ligand for the receptor. Small arrows indicate position
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of the Bland C2 pnmers used to amplify the variable region of the agr
operon I 56
1 2 3 4 5
lkb
500bp
IOObp
Figure 3.2 Presentation of agr BIC2 PCR products. Lane 1, 100bp
molecular weight ladder; Lane 2-5 correspond to isolates 01.9732.Y (type
B), 02.4275.G (type A), 04.1 039.F (type C) and 02.4290.M (type D)
A variation in the distribution of B1C2 amplicons was detected between the
animal and human S. aureus strains (Figure 3.3). Isolates within the animal
strain collection exhibited a higher frequency of type A amplicons, while
isolates from the human strain collection exhibited a higher frequency of type B
amplicons. The 650bp type C amplicon was detected only from human strains.
No amplicon (type D) was detected from a single animal isolate (Figure 3.3).
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Polymorphism of the agr locus was determined by AZul restriction profile
analysis after amplification of the variable region of the agr operon.
Endonuclease digestion of the 76 isolates producing an amplicon yielded eight
different restriction types (Figure 3.4). The frequency and distribution of the
different RFLP patterns among the agr groups are outlined in Table 3.4. Four
restriction types (types 4, 8, 12, and 13) were associated with single agr groups
and B 1C2 amplicon. The remaining three restriction types belonged to multiple
agr groups and in the case of restriction types 2 and 3 to more than one B 1C2
amplicon type (Table 3.4). Restriction types 2 and 3 were the most frequently
detected and accounted for 67.5% of isolates. Taken together, agr grouping (1-
IV), amplification of the B1C2 region (A-D) and subsequent endonuclease
digestion of the B1C2 amplicon (1, 2, 3, 4,6,8, 12 and 13), agr typing grouped
all isolates into 18 agr clusters, of which seven were single isolate (Table 3.4).
Cluster II-A-2 was the most frequent (31.2%), followed by cluster I-A-3
(27.3%). Five clusters, containing> 1 isolate, were represented by either animal
or human strains only.
184
1 2 3 4 5 6 7 8 9
lkb
500bp
IOObp
Figure 3.4 Restriction types of agr BIC2 PCR amplicons. Lanes numberd 1-9
correspond to isolates in table 3.3.
Table 3.3 Isolates represented in Figure 3.4
Lane Isolate number Restriction type ST Isolate source
1 02.4255.S 1 22 Milk
2 01.9706.Z 2 5 Chicken
3 02.7568.H 3 25 Human
4 02.4297.H 4 47 Cow
5 01.9747.H 6 30 Horse
6 01.977l.Y 8 22 Pig
7 02.2794.S 12 133 Lamb
8 01.9798.L 13 816 Horse
9 100bp molecular weight ladder
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Of the five STs common to the animal and human isolate collections four were placed
within the same agr cluster (Table 3.5). Isolates belonging to the remaining ST, STI5,
were placed within different agr clusters. ST45 (human strain) and ST47 (animal strain),
a SLY of ST45, although represented within the same agr-BIC2 type were separated
into different agr clusters following restriction analysis.
Table 3.5 agr clusters and associated STs
agr cluster Source Associated STs
I-A-3
Animal 25,71,97,188,692,814,815
Human 8, 20, 25, 789
I-B-3 Animal 71
Human 25,47
I-B-8
Animal 22
Human 22,45
II-A-2
Animal 5,9
Human 5,15,109
II-A-3
Animal 5,385,816
Human 49,125
II-A-6 Animal 15
II-B-6
Animal 30
Human 30
3.3.1.2 Exotoxin rca
The presence of five staphylococcal enterotoxin genes, sea, seb, sec, sed, and see and
five exoprotein toxin genes, eta, etb, lukS-pv, lukF-pv and tst was determined for the
two strain collections (Figures 3.6 and 3.7). Among the 77 S. aureus isolates
investigated, 28 (36.4%) isolates carried one or two enterotoxin genes. Seven isolates
187
(9.1%) (one animal and six human) contained the gene encoding SEA, eight isolates
(10.4%) (four animal and four human) contained the gene encoding SEC, and thirteen
isolates (16.9%) (ten animal and three human) contained the gene encoding TSST-l
(Figure 3.7). Four of the seven isolates containing SEA genes were simultaneously
positive for TSST -1, and one of the eight isolates containing SEC was also positive for
TSST-l. None of the 77 isolates harboured the genes encoding SEB, SED, SEE, ETA,
ETB or PVL.
1234567
seb --.
sea
etb
tst
see
Figure 3.5 Presentation of the genes encoding staphylococcal enterotoxin A, B, C, D
and E and epidermolytic toxins A and B. Nuclease gene (nuc) used as an internal
control. Lanes 1-7 correspond to isolates in table 3.6. * sec is a weak band with only a
nine base pair difference from the strong nuc band.
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Table 3.6 Isolates represented in Figure 3.5
Lane Toxin gene Amplicon size (bp) Isolate
I sea and seb 120, 163 S. aureus NCTC 10615
2 sec and tst 271,445 S. aureus NCTC 11963
3 100bp molecular weight ladder
4 sed 319 S. aureus NCTC 10656
5 see 178 FRJ 328
6 eta 741 eta
7 etb 629 etb
123456789
Ikb
.--nuc
IOObp
Figure 3.6 PVL gene PCR products; Lane 1, 100bp molecular weight
ladder; Lane 2, Mulvey positive control strain; Lane 3, Water control;
Lanes 4-9, correspond to isolates in Table 3.7.
Table 3.7 Isolates represented in Figure 3.6
Lane Isolate Animal source ST
4 01.9706.Z Chicken 5
5 02.4275.G Cow 15
6 01.9771.Y Pig 22
7 01.9761.B Parrot 25
8 01.9747.H Horse 30
9 02.2782.Y Unknown 47
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Eight of the 27 isolates (16 animal and 11 human), representing the STs common to
both strain collections, produced four toxin genotypes (Table 3.8). The sea gene was
overrepresented within the human strain collection (Fisher's exact test; P=0.027). A
single animal isolate of ST5 carried tst, all isolates belonging to ST15 were negative for
the presence of toxin genes, human isolates belonging to ST22 and ST25 carried sea
and animal and human isolates of ST30 carried sea and tst.
Table 3.8 Toxin profiles ofSTs common to animal and human strain collections
ST source No. isolates toxin profile
Animal 7 tst (1)
5
Human 4 Negative
Animal 1 Negative
15
Human 3 Negative
Animal 2 Negative
22
Human 2 sec (2)
Animal 2 Negative
25
Human 2 sea (1)
Animal 1 sea+tst (1)
30
Human 3 sea+tst (2), tst (1)
Animal 2 sec (2)
ST45/ST47
Human 2 sec (2)
..The number of Isolates that tested posinve for a toxin gene ISgiven In parentheses
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3.3.1.3 icaA and biofilm production
Seventy three (94.8%) isolates were positive for the presence icaA, responsible for
encoding polysaccharide intercellular adhesin (Figure 3.8). The four negative isolates
were all of bovine origin.
123456789
lkb
IOObp
Figure 3.8 icaA gene PCR products. Lane 1, 100bp molecular weight ladder; Lane 2,
EMRSA 16 positive control strain; Lane 3, Water control; Lanes 4-9, correspond to
isolates in Table 3.9. The difference in band thickness in lanes 7 and 9 is due to a
difference in the amount of DNA produced during PCR.
Table 3.9 Isolates represented in Figure 3.8
Lane Isolate Animal source ST
4 01.9706.Z Chicken 5
5 02.4275.G Cow 15
6 01.9771.Y Pig 22
7 01.9744.S Horse 25
8 01.9747.H Horse 30
9 01.4297.H Cow 47
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Of the strains tested 79.2% produced A570 >0.1 (corrected for medium background) and
were considered biofilm formers. Only three animal isolates were negative for biofilm
production and belonged to ST5 and ST97. In contrast, 13 (46%) of human strains were
negative and belonged to one of eight STs (STI, ST8, ST15, ST30, ST45, STI09,
STI23 and ST789) three of which were common to both isolate collections. Therefore,
biofilm production was overrepresented among the animal strains (Fisher's exact test;
P=<O.OOOI). Of the remaining two common STs both were positive for biofilm
production.
Combining icaA and biofilm production data generated four different result outcomes.
Fifty eight isolates were positive for both, three animal isolates were biofilm positive
but negative for icaA, 46.4% of the human strains were negative for biofilm production
and positive for icaA and a single animal isolate was negative for both (Figure 3.9).
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Of the 58 isolates positive for biofilm production and icaA, three STs (ST5, ST22 and
25) were found in both the animal and human strain collections. The single animal
isolates belonging to ST15 and ST30 were positive for both while all human ST15 and
ST30 isolates were biofilm negative and icaA positive. Two human isolates belonging
to ST45 were biofilm negative and icaA positive. Within the animal collection isolates
belonging to ST47, a SLY ofST45, were positive for both. Animal isolates belonging to
ST5 could belong to multiple result groups (Table 3.10). No other ST common to both
isolate collections was found across multiple result groups.
Table 3.10 The association between ST and the presence of icaA and biofilm
production.
Biofilm and icaA
Associated STs
result group Human strains Animal strains
5, 8, 20, 22, 25,
5, 9, 15, 22, 25, 30, 47,
Biofilm and 71,97, 133, 188,385,692,
icaA positive
49, 125,247,
773,774,814,815,816
Biofim positive 5, 71
and icaA negative
1,8, 15,30,45,
5Biofilm negative
109, 123, 789
and icaA positive
Biofilm and 97
icaA negative
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3.3.1.4fnbA peR
Fifty (64.9%) of the 77 isolates were positive for the fnbA gene, responsible for
encoding a cell wall adhesin (Figure 3.10). The fnbA gene was overrepresented within
the human isolates (P=<O.OOO 1) (Figure 3.11).
2 3 4 5 6 7 8 9
615bp
1.23kb
123bp
Figure 3.10 Presentation of fnbA gene PCR products. Lane 1, 123bp molecular
weight ladder; Lane 2, S. aureus NCTC 8325-4 positive control; Lane 3, water
control; Lanes 4-9 correspond to isolates in Table 3.11.
Table 3.11 Isolates represented in Figure 3.10
Lane Isolate Animal source ST
4 01.9796.B Phillips goose hawk 5
5 02.4275.0 Cow 15
6 01.977l.Y Pig 22
7 01.9761.B Parrot 25
8 05.1058.T Human 30
9 02.4297.H Cow 47
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Figure 3.11 Distribution of the JnbA gene among S. aureus isolates from animal and
human sources
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Of the STs common to both isolate collections those belonging to STI5, ST22 and
ST45/ST47 were positive forJnbA (Table 3.12).
Table 3.12 The association between ST and the presence ofJnbA
ST Animal isolates Human isolates
5 +/- +
15 + +
22 + +
25 +/- +
30 - +/-
45/47 +. +
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3.3.1.5 capS and cap8 peR
PCR amplification of the genes encoding capsular type 5 (cap 5) and 8 (cap 8) allowed
the detection of these genes in 92.2% of isolates (Figure 3.12 a and b). Six isolates were
negative for both cap 5 and 8. Of the remaining 71 isolates, 31 were positive for cap 5,
30 were positive for cap 8 and 10 positive for cap5 and cap8. The distribution of these
genes between animal and human isolates was not even. The gene encoding capsular
type 5 was significantly overrepresented among animal isolates (P=0.05) while cap8
was most frequently detected, but not significantly, among the human isolates (Figure
3.12).
a b
123456789 1 234 567
lkb
500bp
IOObp
Figure 3.12 a and b Presentation of cap 5 and cap 8 PCR products. 3.14a Lane 1,
100bp Molecular weight ladder; Lane 2, Reynolds strain positive control; Lane 3
water Control, Lanes 4-9 correspond to isolates in Table 3.13. Figure 3.12b Lane 1,
200bp molecular weight ladder; Lane 2 EMRSA 16 positive control; Lane 3, water
control, Lanes 4-7 correspond to isolates in Table 3.14.
198
Table 3.13 Isolates represented in Figure 3.12a.
Lane Isolate Animal source ST
4 01.9797.D Chicken 5
5 01.7817.X Human 15
6 01.9744.S Horse 25
7 04.1381.H Human 30
8 02.4615.V Human 45
9 02.4194.G Milk 97
Table 3.14 Isolates represented in Figure 3.12b
Lane Isolate Animal source ST
4 01.1000.N Human 5
5 02.4275.G Cow 15
6 01.9747.H Horse 30
7 05.1D17.P Human 45
Animal isolates belonging to ST5 and ST30 carried the cap5 and cap8 genes
respectively, while the same strains in the human collection carried cap8 and cap5
respectively. Two STs (STI5 and ST25) from the human isolate collection carried the
genes for both capsular types. Animal isolates belonging to ST22 did not carry the
genes for cap5 or cap8. Only isolates belonging to ST45/ST47 carried the same cap
gene (Table 3.15).
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Figure 3.13 Distribution of capS and cap8 genes among animal and human S. aureus
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Table 3.15 STs and distribution of capS and cap 8 genes of S. aureus from the animal
and human isolate collections
ST Animal isolates Human isolates
ST5 cap5 cap8
STl5 cap8 cap 5 and cap 8
ST22 cap 5 and cap 8 negative cap8
ST25 cap S cap S and cap 8
ST30 cap8 cap S
ST4SIST47 cap8 cap8
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3.3.1.6 Haemolysins (1, 13, y, and () detection
All isolates within the animal and human isolate collections were positive for
haemolysins a, y and () (Figure 3.14). Twenty nine (37.7%) isolates, 27 animal and 2
human, carried the gene for p-haemolysin and were represented by 10 different STs.
The overrepresentation of p-haemolysin in animal isolates was highly significant
(Fishers exact test P=O.OOOl). All isolates belonging to STS, STlS, ST22, ST2S
ST4S/ST47 were negative for p-haemolysin while isolates from both collections
belonging to ST30 were positive.
lkb 1 2 3 4
IOObp
Figure 3.14 Presentation of haemolysin a, P, y and ()multiplex peR products. Lane 1.
100bp molecular weight ladder; Lane 2, 04.7486.0 positive control strain; Lane 3,
01.9796.B; Lane 4, 02.2799.A
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3.3.1.7 5' eoa RFLP
peR amplification of the 5' variable region of the coa gene, using pnmers
eOAG 1 and 4, produced a 1.4kb amplicon in all 77 isolates (Figure 3.15).
Subsequent restriction analysis produced 18 RFLP patterns (Figure 3.16). Six
RFLP patterns were single isolate. Five RFLP patterns (A, C, E, G and M),
containing five or more isolates, were most common, and accounted for 62.3% of
isolates.
2 3 4
l.4kb
200bp
Figure 3.15 5' coa gene peR products. Lanes 1-3, isolates 01.9768.P, 02.2782.Y
and 02.4290.M; Lane 4, 200bp molecular weight ladder
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There was a very strong association between ST and RFLP pattern (Table 3.16). Animal
and human isolates belonging to ST5, ST15, ST22, ST25 and ST30 shared
indistinguishable RFLP patterns. Two STs, ST45 and ST47, produced an amplicon of
the correct size but were not digested using AluI (Figure 3.16).
Table 3.16 Association between ST and 5' coa RFLP pattern
Associated S~
RFLP pattern
Animal Human
A 71
Az 47 45
C 9
E 25,816 25
G 5, 133 5
K 814
M 71,97,816
T 30 30
U 8
X 15 15
y 22 22
Z 8
..
a STs contaming more than one Isolate
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3.3.1.8 3' coa peR
Amplification of the 3' end of the coa gene produced eight different amplicons. These
amplicons ranged in size from 261bp (3 repeats) to 828bp (10 repeats), reflecting the
number of 81bp repeat units contained in this part of the coa gene and an 18bp terminal
sequence (Figure 3.17).
1 2 3 4 5 6 7 8 9 10 11
Figure 3.17 Presentation of 3' coa PCR products. Lane 1, 100bp molecular weight
marker; Lane 2 NCTC 11047 negative control strain; Lane 3 NCTC 8325 positive
control strain; Lanes 4-11, correspond to isolates in Table 3.17
Table 3.17 Isolates represented in Figure 3.17
Lane Isolate Animal source ST
Numberof81bp
tandem repreats
4 02.4275.0 Cow 5 5
5 01.9771.Y Pig 22 6
6 02.4212.M Milk 9 3
7 01.9702.V Chicken 692 5
8 01.9762.X Pheasant 814 5
9 02.4297.H Cow 47 6
10 01.9796.B Phillips goose hawk 5 4
11 01.9744.S Horse 25 4
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3.3.1.9 Combined 5' and 3' coa data
Combining the coa 5' RFLP typing data with the coa 3' repeat unit data produced 32
coagulase gene types (Table 3.18).
Table 3.18 Coagulase gene types for all animal and human isolates
eoa 5' RFLP Number of eoa 3' 81bp tandem repeats
3 4 5 6 7 8 9 10
A 1 1 1 3
Ax 1
Ay 1
Az 4
C 9
E 3 1 1
G 4 1 7 1 2
K 2
M 8 5
p 1
R 1
T 2 1 1
U 3
V 1
W 1
X 1 3
Y 4
Z 1 1
16 17 5 12
.-
2 5Total 9 11
The combined coagulase typing data grouped ST5, STI5, ST22, ST25, ST30 and
ST45/ST47 into 12 coagulase types (Table 3.19). While restriction analysis grouped
these STs into distinct groupings, the number of 81bp repeat units was more variable.
Only isolates belonging to ST22 and ST45/ST47 formed single coagulase types.
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Table 3.19 Comparison of coagulase types among animal and human S. aureus isolates
belonging to the same ST
RFLPpattem
Number of81bp repeat units
4 5 6 7
Az ST45/ST47§
E ST25§ ST25t
G ST5§ ST5* ST5§
T ST30§ ST30t ST30t
X ST15§ ST15t
y ST22§
• +Animal and human Isolates, Human Isolates only, Animal Isolates only
In summary, all isolates were negative for the presence of the genes encoding
staphylococcal enterotoxins B and E, epidermolytic toxins A and B and PVL, and
positive for heamolysin c, 'Y and D. Four virulence factors were over represented within
the overall isolate collection. The genes encoding fibronectin binding protein ifnbA) and
staphylococcal enterotoxin A (sea) were overrepresented among the human isolates and
the gene encoding ~-haemolysin (hlg-b) and the production of biofilm was
overrepresented among the animal isolates.
The main aim of this study was to examine the presence and distribution of 20 virulence
factors in S. aureus strains common to both animals and humans. These included MLST
sequence types STS/12S, ST1S, ST22, ST2S, ST30 and ST4S/47.
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Twelve isolates, seven animal and five human, belonged to ST5 (Table 3.20). All
isolates within this group had a predominant agr BIC2 amplicon (type A) and exhibited
a type G 5' coa RFLP pattern. Animal isolates harboured the gene for capsular
polysaccharide type 5. Conversely, the human isolates harboured the gene for capsular
polysaccharide type 8. Ten of the 12 isolates had a common BIC2 RFLP pattern and
were negative for all toxin genes. Negative results for the presence of icaA were only
detected among isolates of animal origin.
Isolates belonging to ST15 (3 human and 1 animal) exhibited a predominant agr cluster
and coagulase type and were all negative for the presence of toxins. The single major
difference between animal and human isolates was in the presence of genes encoding
capsular polysaccharides (Table 3.20).
Sixteen isolates (7 animal and 9 human) belonged to ST22, ST25, ST30, and ST45.
Four isolates (2 animal and 2 human) of ST22 belonged to an identical agr cluster and
coagulase type. Only human isolates harboured sec and cap8. There was general
agreement of the results for isolates belonging to ST25. All ST25 were positive for icaA
and biofilm production, negative for ~-haemolysin and belonged to identical 5' coa
restriction pattern. Only human isolates belonging to ST25 carried the sea and cap8
genes. Isolates of ST30 belonged to an identical agr cluster, and carried the genes
encoding SEA and TSST-l. They also produced a common 5' coa restriction pattern,
but exhibited variation in the number of 3' coa tandem repeats. All animal isolates
harboured the cap8 gene only. Isolates belonging to ST45 harboured the sec gene and
belonged to an identical coagulase type. ST47, a SLY of ST45, contained animal
208
isolates only and produced a different agr B1C2 restriction pattern to those of human
origin and harboured the cap8 gene only (Table 3.20).
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3.4 Discussion
3.4.1 agr
Several authors have reported the existence of distinct restriction patterns within the agr
groups of S. aureus'", Polymorphism in the agr locus was first described by Ji et al and
has subsequently been used to characterize S. aureus isolates from animals'r'. In this
part of the study amplification of the agr B1C2 variable region produced four different
amplicon types and subsequent restriction analysis of these amplified products
identified only eight different restriction types. Gilot and van Leeuwen in an
examination of agr locus diversification, using AluI RFLP, has reported the presence of
only nine restriction types among 322 human and bovine S. aureus isolates'Y,
Combining agr grouping data from chapter two with B 1C1 amplicon and restriction
pattern data produced 18 agr clusters. Two clusters (II-A-2 and I-A-3) accounted for
58.5% of the isolates tested. The distribution of these predominant clusters was
relatively even between the animal and human isolate collections. In contrast, Gilot et
al have reported statistically significant differences in the distribution of agr restriction
b f bovi d h . . 155 S . .types etween S. aureus 0 ovme an uman ongm . orne restriction types,
containing only a few strains, were found to be unique to either the animal or the human
strain collections. This has also been reported by Gilot et a1156• Although, they conclude
that the variation in distribution of restriction types between bovine and human S.
aureus, suggests that the two populations are different and indicates that some types
probably expand in one or other population due to the possession of unique genetic
characteristics 156.
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Studies of S. aureus from bovine mastitis have limited numbers of agr restriction types.
The majority of which have belonged to one particular restriction type. It has been
concluded that this observation suggest the occurrence of host adapted or tissue adapted
S. aureus strains in which the agr restriction type may playa rolel56• In contrast, animal
and human isolates belonging to ST5, ST22, ST25 and ST30 showed identical agr
clustering while ST15 and ST45/ST47 only differed at the level of Ble2 restriction
digest.
3.4.2 Toxin profiles
Overall 36.4% of strains carried one or two toxin genes. Taken separately, 26.5% of
animal strains and 51.7% of human strains carried one or more toxin gene. These
findings are in contrast to data published by Morandi et aI, where 67% of S. aureus
isolated from different dairy sources were found to be positive for at least one toxin
gene304. It has been suggested that SEs carried on MGE are not randomly distributed
but are strongly associated with clonal lineages. Four toxin genes were detected among
the isolates tested. These were tst (11), sec (8), sea (7) and sed (1). Holtfreter et al
suggest that most SEs are predominantly transferred vertically while horizontal
transmission between different lineages is limitedl91• The SE genes from strains in this
study were also found in strains of divergent clonal lineages that do not share a
common ancestor.
The gene encoding SEA was overrepresented among isolates of human origin and has
been shown previously, by Aarestrup et al and Kenney et al, to be the predominant
enterotoxin type among human S. aureus6,224. sea and tst have been shown to be
significantly correlated to ST30, and were detected together among the animal and
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human S. aureus isolates belonging to ST30 but not in any other clonal background.
The gene encoding TSST -1 has been shown to be carried by a family of related S.
aureus pathogenicity islands (SaPI). It has been reported that these SaPIs do not spread
between different genetic backgrounds or the efficiency of transfer is low302• Waldron
et al suggest that barriers to horizontal transfer could be due to the incompatibility of
related bacteriophages, SaPIs and plasmids; varying susceptibility to transduction or
conjugation; or the presence of the Saul restriction modification system463• Only a
single animal isolate of ST5 and animal and human isolates of ST30 carried tst
suggesting that horizontal transfer of tst may be an infrequent event. Variations within
the toxic shock syndrome toxin gene have been shown by Ho et al189 and Lee et aP54.
They were able to show that a TSST protein from S. aureus isolated from a sheep
showed complete identity with classical TSST-l but exhibited a different isoelectric
point and was therefore termed TSST-lovin/54• No clonal background was given for
these isolates therefore the significance of this finding to animal isolates carrying tst, in
this study, is unclear.
Various studies have reported the presence of sec among animal S. aureus strains,
particularly those of bovine originI6,146. The sec gene was the second most prevalent
virulence gene detected. While there was no overrepresentation of the sec gene,
between the animal and human isolate collections, only isolates belonging to ST22 and
ST45/47 carried sec. The remaining common STs were all sec negative. As has been
shown with tst, the sec gene has been shown to be heterogeneous containing several
antigenic and sequence molecular variants, designated SEC1, SEC2, SEC3, SECbovine,
SECcanineand SECovine282,298,372. These variants have been classified on the basis of
minor antigenic differences and the animal host with which they are associated. Thus, it
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may not just be the presence or overrepresentation of a particular toxin gene that
determines possible host specificity, but the molecular structure or biochemical
properties of certain genes or proteins may determine host or tissue adaptation of S.
aureus strains, a concept also suggested by Zadoks et at97.
Among animal and human S. aureus strain collections, with a common clonal
background, there was a low rate of variation in virulence gene content. Diep et al have
also shown that there was an infrequent change in virulence gene detection in closely
associated S. aureus genotypes from humans 105. These data are in contrast to that of van
Leeuwen et al who have shown significant variations in virulence gene content between
S. aureus strains from cases of bovine mastitis and humans452•
All isolates were negative for the genes encoding SEB, SED, SEE, ETA, ETB and
PVL. In a study by Stephen et al none of the genes encoding SEB, SEE, ETA or ETB
were found in S. aureus isolated from cattle410• In contrast, human S. aureus strains
have been shown to carry the epidermolytic toxin genes, eta and etb, at a low
frequency". This has also been shown to be the case for s.. aureus isolated from a
variety of animal species 117,454.
While the genes encoding PVL were not detected in either animal or human S. aureus
isolates, in the present study, high levels of PVL positive community acquired MRSA
(CA-MRSA) have been reported in the USA caused by strain USA300 (MLST ST8)
and by community acquired MSSA37• Ellington et al suggest that this higher prevalence
has occurred against a background of increasing CA-MRSA rates within the USA
which has not been mirrored across Europell5• Clinically, PVL has been linked to
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necrotizing skin lesions such as furuncles and carbuncles and to a severe form of
necrotizing pneumonia especially in previously healthy young adults". Rankin et al
have reported the presence of PVL-positive MRSA among companion animals that
produced identical infections to those found in humans and make two possible
conclusions; companion animals infected by PVL-positive MRSA strains may act as a
reservoir of infection for humans, or these strains are human in origin and companion
animal are infected by their owners346•
3.4.3 Biofilm production
Seventy three (94.8%) isolates were positive for icaA, 79.2% of isolates positive for
biofilm production, and 75.3% were positive for both icaA and biofilm. The production
of biofilm was significantly overrepresented among strains of animal origin. The high
prevalence of biofilm producing S. aureus has also been reported from isolates causing
bovine mastitis. Over 50% of the animal isolates tested were of bovine origin and may
account for the overrepresentation. Animal and human strains belonging to ST5, ST22
and ST25 were positive for icaA and biofilm production as were animal isolates of
ST30 and ST47. Three animal isolates were icaA PCR negative yet were still able to
produce a biofilm. Evidence is now emerging for the existence of an icaA-independent
biofilm mechanism in S. aureus. The findings of O'Gara indicate that other surface
proteins, which typically function as antigenic determinants or in binding to
extracellular matrix proteins, may also act as biofilm adhesins'l". A report by Crampton
et al has shown that differences in biofilm production between the two strain
populations could be a result of the growth conditions used, lack of some biofilm to
adhere to the polystyrene microtitre plates due to possible differences in adherence
mechanisms or the presence of imperfections in the microtitre plate323. The biofilm
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assays were repeated in triplicate with all strains cultured on the same plate suggesting a
real difference between the two strain collections.
3.4.4fnbA
Staphylococcus aureus fibronectin-binding proteins A and B (FnBPs) are encoded by
one of two fnb genes ifnbA and fnbB)330. These proteins play an important role in S.
aureus pathogenesis by promoting bacterial attachment to intravenous catheters and
orthopedic prosthesis'f". Although S. aureus is considered an extracellular pathogen, it
has been well documented that the FnBPs also mediate bacterial invasion of cells379•
Fifty (64.9%) of the isolates tested were positive forfnbA. Of the STs common to both
isolate collections those belonging to ST15, ST22 and ST45/ST47 were positive for
fnbA. A study by van Leeuwen et al investigating host and tissue-specific traits in S.
aureus reported that the genes encoding adhesion proteins, includingfnbA, were evenly
distributed among human and veterinary strains452• In contrast, the presence of fnbA
among isolates in this study was significantly overrepresented among human S. aureus
strains. A low frequency of fnbA negative S. aureus isolates from humans, which were
able to bind fibronectin, has been reported by Peacock et aP3? These isolates carried
the fnbB gene. Therefore, it is possible that the fnbA negative animal isolates in this
study may harbour the fnbB gene.
3.4.5 Capsule typing
Capsular polysaccharides, most commonly those of serotype 5 or 8, are produced by
most human S. aureus isolates independently of their source 407. In a survey of clinical S.
aureus, from human patients in a trauma unit, Na'was was able to show that 87.7% of
isolates possessed a capsular polysaccharide, type 5 capsule (43.1%) or type 8 capsule
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(44.6%)308. Studies on the prevalence of encapsulated strains in cattle, sheep and goats
have shown a different situation, with variable prevalence of strains producing either
capsular type 5 or 8 in different animal species and different countries. Poutrel et al has
shown that 73% of bovine, ovine and caprine S. aureus produced polysaccharide type 5
or 8 capsule34o. These isolates showed a distinct difference in distribution of these
capsular types among these animals. Among bovine isolates type 5 was predominant
(51.4%) while type 8 was found in less than 20% of isolates. Conversely, capsular type
8 was significantly more frequent in caprine and ovine strains, 68.5% and 75.8%,
respectively, with type 5 significantly less frequently detected. In the present study
92.2% of strains were positive for cap5 or cap8. Six strains were negative for both and
included isolates of ST22 from animals. Of the STs common to both isolate collections
only human isolates belonging to ST45/ST47 carried identical capsular polysaccharide
genes. Among strains from this study the cap5 gene was significantly overrepresented
among animal strains. While there was a difference in the overall distribution of the
cap8 gene between animal and human strains the difference was not statistically
significant. An investigation of capsule expression by bovine S. aureus performed by
Sordelli et aI, reported an equal but low frequency distribution of cap5 and cap8.
Surprisingly, 86.3% of isolates in that study were negative for both capsular types
compared to the 7.8% in this study407.Sordelli et aI, suggest that their strains, like those
of Poutral et aI, may carry an intact copy of the cap5 gene cluster that may have a
. . h 5E deri hem caosule nezati 252mutation m t e cap ren nng t p e g ve .
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3.4.6 Haemolysin typing
All isolates in this study harboured the genes for n, y and cS haemolysins. The
phenotypic detection of c, p, cS haemolysins and genotypic detection of y-haemolysin by
Peacock et aI, among S. aureus from human carriers and those with invasive disease,
has also shown a high frequency of c, y and cS haemolysins (range 69%_100%)332. In
contrast, Aarestrup et al has shown that the phenotypic expression of u-haemolysin in S.
aureus, from bovine and human sources, to be considerably lower". y-haemolysin has
been shown to be produced by virtually all S. aureus strains and is coexpressed along
with e-haemolysirr ". While p-haemolysin can be produced by a large number of S.
aureus strains, it is particularly prevalent among isolates of bovine origin107• This was
the case in this study where 78% of the animal isolates carrying the p-haemolysin gene
were of bovine origin. Only one isolate within the human isolate collection (ST30)
carried the p-haemolysin gene as did the ST30 from the animal isolate collection.
3.4.7 Coagulase typing
PCR amplification of the 5' variable region of the coa gene produced an amplicon of
the expected size in all 77 isolates. Subsequent endonuclease digestion of this amplicon
produced 18 restriction types. A study by Carter et al showed a similar number of
coagulase types at the 5' end of the gene among human and animal S. aureus isolates
from the UK, Italy, Russia and Malaysia'r'. In this study five RFLP patterns (A, C, E, G
and M) accounted for 65.8% of isolates. Similarly, discrete populations of S. aureus
were also identified in a study by Carter et aI, although a much higher proportion (93%)
of the MRSA isolates examined were assigned to one of only five major 5' coa types'".
Eleven of 14 STs, containing more than one isolate represented in this study, including
ST5, STI5, ST22, ST25 and ST30 produced unique restriction patterns. It has been
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suggested that coagulase evolution and the evolution of the clonal background, as
defined by the ST, are intimately related'". This intimate association is consistent with
the 5' coa data from this study. In contrast, the novel ST816 produced two different
restriction patterns that appear to be more closely associated to animal source than ST.
Amplification of the 3' (C-terminal) end of the coa gene produced eight different
amplicons. The number of repeating units ranged from three (261bp) to ten (828bp).
Numerous authors have shown variable numbers of repeating units among S. aureus
strains from humans, goats and cattleI69,213-215,218,370,398. Amplification of the 3' end of
the coa gene has been shown to be an unsuitable single method for the characterization
of S. aureus. Investigation of a number of recognized control strains has variations in
h b f d .. 213 214 Th .. h h bt e num er 0 tan em repeatmg umts ' . ese variations are t oug t to e caused
by either deletion or insertion of repeat units386• Also, RFLP of the amplified products
of the coa gene C-terminal has shown that unrelated strains could be linked to outbreak
clusters, thus limiting the effectiveness of this technique for typing unrelated strains386•
In this study animal and human isolates belonging to ST5, STI5, ST22, ST30 and
ST45/ST47 were placed into distinct restriction groupings .that produced variable
numbers of3' tandem repeats. Therefore, PCR amplification of the 3' coa gene, was not
a useful comparative technique.
There is a general consensus that S. aureus from animals and humans constitute
I . . .h h f h if . 401 401 497 Th . fseparate popu ations consistent WIt t e concept 0 ost speci ICIty , , . e aIm 0
this part of the study was to examine a range of virulence factor from S. aureus from
animals and humans, many of which were genotypically closely related, and to compare
these data to determine clonal similarities. The data show that isolates of a given clonal
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background share common genetic characteristics. Overrepresentation of the virulence
genes encoding ~-haemolysin, fnbA, sea, and caps and biofilm production between
animal and human S. aureus strains suggest that there may be a degree of host
adaptation. Isolates of STS, STlS, ST22, ST2S, ST30 and ST4S147 representing five of
the major human S. aureus clonal backgrounds, and detected in both animal and human
strains, shared virulence factors indicating an evolutionary relationship that would
suggest horizontal transfer of these clones between animals and humans.
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Chapter 4 Antimicrobial susceptibilities
4.1 Introduction
Increasing antimicrobial resistance has become a serious concern worldwide. Over the
past 35 years there has been an intense debate over the impact of the use of
antimicrobial agents in food animals and their effect on human health". To date there
has been no definitive answer to this question. Therefore, the agricultural use of
antibiotics remains controversial because of the possibility of drug resistant strains
being transferred to humans via contaminated food445• Large quantities of antibacterial
substances are used in the production of food and in companion animals261,342. These
include antibiotics for treatment, prophylaxis and until recently growth promotion.
Biocides are used to reduce or eliminate environmental contamination, preserve foods
and in the case of copper sulphate also as a mineral supplement in animals". Aarestrup
et at have reported that ten times more biocides are used in the production of food than
antibiotics'', Recently concerns have arisen regarding the potential emergence of cross-
resistance and co-resistance between widely used disinfectants and antibioticsi'". There
are few reports on the antimicrobial susceptibility of S. aureus isolates from animals in
the UK5. This present study was conducted to determine the frequency of antibiotic and
biocide resistance among S. aureus isolates from a range of animal species, to agents
commonly used in human clinical practice and in the production of food animals and to
compare the regional variations in antimicrobial resistance across the four geographic
locations.
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4.2 Materials and methods
4.2.1 Staphylococcal isolates
A total of 233 S. aureus were examined for antimicrobial resistance (Table 2.1 and
Figure 4.1)
Figure 4.1 Geographic sources of 233 animal S. aureus isolates.
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4.2.2 Disc diffusion testing
Disc diffusion susceptibility testing was carried out, using the antimicrobials listed in
Table 4.1, following the recommendations of The British Society for Antimicrobial
Chemotherapy (BSAC)2o. Four morphologically similar colonies were touched with a
sterile loop, and transferred into 2ml of sterile distilled water (Biomerieux, France). The
organism suspension was adjusted to McFarland 0.5 turbidity standard (1- 2 x 108
colony forming units (cfu/ml)) using sterile distilled water and a working solution
produced by performing a 1:10 dilution (1 x 107 cfu/ml). Isosensitest agar plates (ISA)
(Oxoid, UK) were inoculated, allowed to dry prior to the application of antibiotic discs
and incubated at 35-37°C in air for 18-20 hours. For oxacillin susceptibility testing ISA
supplemented with 2% NaCI was used and incubated at 30°C in air for 24 hours. After
incubation the zones of inhibition were measured and susceptibility interpretation made
based on BSAC criteria.
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Table 4.1 List of antimicrobial agents
Antimicrobial agent Disc code Concentration (Ilg) Suppliers
Amikacin AK 30
Chloramphenicol C 10
Ciprofloxacin Cip 1
Clindamycin Da 2
Erythromycin E 5
Fusidic acid Fa 10
Gentamicin Cn 10
Kanamycin K 30
Linezolid LZD 10
Mupirocin Mup 5 Oxoid, UK
Oxacillin Ox 1
Penicillin P 1 unit
QuinupristinlDalfopristin QD 15
Rifampicin Rd 2
Streptomycin S 10
Sulphamethoxazole RI 25
Teicoplanin Tec 30
Tobramycin Tob 5
Trimethoprim W 5
Tylosin Ty 30 Mast, UK
Vancomycin Va 5 Oxoid, UK
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4.2.3 Biocide Minimum Inhibitory Concentration (MIC) agar dilution assay
Isolates were tested for biocide MIC using the agar dilution method for measuring the
MIC of various biocides based on the NCCLS methodology (approved standard,
January 1997, M7-A4; vol 17, No2). Muller Hinton II cationic adjusted agar plates
(Becton Dickenson, UK), using 20ml of agar, were prepared following the
manufacturers instructions, and contained biocides in the ranges seen in Table 4.2. Each
MIC had growth control plate, containing no biocide, inoculated at the beginning and
end of each test batch. Growth control plates for triclosan MIC also included ethanol
control plates containing 640J.lI, 160J.lI,80J.lIand 10J.lIof 50% ethanol.
The biocide control isolates used were Staphylococcus aureus ATCC 29213,
NCTC12201, and NCTC 1132.
Table 4.2 List of microbicides
Biocide Supplier Solvent MIC range
H202 Sterile distilled water 0.001-0.064%
Triclosan 50% Ethanol 0.015-32J.lglml
Benzakonium chloride 0.5-256J.lglml
Cetylpiridinium chloride Sigma-Aldrich 0.5-256J.lglml
Formaldehyde Sterile distilled water 0.008-0.1%
Chlorhexadine 0.25-64J.lglml
Copper sulphate 2-12mM
Inocula were prepared as above (section 4.2.2)
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The working strength inocula were vortexed and 1 ml added to the appropriate well of
the multipoint inoculator replicator block (Denlay, UK). Each test plate was marked to
indicate the orientation of inoculation. Starting with a negative control, then followed
by the lowest biocide concentration and working up the range and ending with a final
negative control, each plate was inoculated with 1-2ll1 of test organism (cell
concentration 104 cfu/spot) using a Denlay multipoint inoculator (Denlay, UK). Each
plate was left at room temperature until each spot had dried then incubated at 37°C for
16-24 hours. The MIC was defined as the lowest concentration of antimicrobial agent
that completely inhibited growth.
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4.3 Results
4.3.1 Antibiotic susceptibilities of animal S. aureus isolates from Scotland and
Northern Ireland
A total of 233 S. aureus were examined for antibiotic susceptibility from livestock, wild
and companion animals. Thirty isolates (12.9%) were fully susceptible to the 22
antibiotics tested. Of those isolates resistant to one or more antibiotics, 84.2% were
resistant to one or two antibiotics and 15.8 % were resistant to more than three and were
considered as multiresistant (Figure 4.2)316.
Penicillin resistance was detected in 153/233 (65.2%) isolates and was the most
frequent type of resistance observed followed by tetracycline (31.8%),
sulphamethoxazole (20.2%), ciprofloxacin (19.7%) and streptomycin (10.7%) (Figure
4.3). Fifty one (21.9%) isolates exhibited resistance to antibiotics other than penicillin.
No resistance to fusidic acid, gentamicin, kanamycin, linezolid, mupirocin, oxacillin,
quinupristin/dalfopristin, teicoplanin or vancomycin was detected using the BSAC
testing criteria.
227
Figure 4.2 Frequency of antibiotic resistant S. aureus isolates from animals in Scotland
and Northern Ireland
39.5%
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The 233 S. aureus isolates were distributed across four different geographic locations:
Grampian (72), Highland (18), Northern Ireland (53) and Southwest Scotland (90).
There was considerable variation in the levels of antibiotic resistance between isolates.
In Highland region half of the isolates exhibited resistance to one or more antibiotics,
while in Southwest Scotland the figure was 95.6% (Figure 4.4).
Figure 4.4 Frequency of resistance to one or more antibiotics across the four geographic
locations.
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The frequency of antibiotic resistance of animal S. aureus isolates across the four
geographic locations is seen in Figures 4.5, 4.6, 4.7 and 4.8. Ciprofloxacin,
clindamycin, penicillin and tetracycline resistance were the only resistances detected in
all four locations. Resistance to Amikacin was only found in an isolate from a pheasant
from Highland region and chloramphenicol resistance only in a bovine isolate from
Grampian region. The highest occurrence of ciprofloxacin resistance was found in
chicken and a Phillips goose hawk isolate from Northern Ireland (45.3%) and in bovine
isolates from Southwest Scotland (18.9%). Resistance to clindamycin and the
macrolides, erythromycin and tylosin was most frequently detected in bovine isolates
from Grampian region (18%, 13.9% and 13.9% respectively) and least frequently
detected in bovine isolates from Southwest Scotland (Figure 4.8). Penicillin resistance
was found in all locations and showed remarkable variances between the four locations
from as low as 18.9% among chicken isolates from Northern Ireland to 91.1% among
bovine isolates from Southwest Scottish. Resistance to rifampicin was detected in only
a single equine isolate from Southwest Scotland (Figure 4.8). Streptomycin resistance
was not detected in the poultry isolates from Northern Ireland. The highest occurrence
of streptomycin resistance was in bovine isolates from Grampian region (25%). Over
half of the bovine isolates from Southwest Scotland (51.1%) were resistant to
sulphamethoxazole. Only one further isolate (bovine), from Grampian region, was
sulphamethoxazole resistant (Figure 4.5). Resistance to tobramycin was detected only in
Grampian region (1.4%). Trimethoprim resistance was found in only four bovine
isolates, two from Grampian and two Highland (Figure 4.5 and 4.6 ).
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4.3.2 Biocide susceptibility
The distribution of biocide MIC for the 233 S. aureus isolates are shown in Figures 4.9,
4.11,4.13,4.15,4.17,4.18 and 4.19. S. aureus isolates formed one large population of
susceptibilities to the biocide agents tested.
The MICs of benzalkonium chloride (BC) for animal S. aureus ranged from 0.5-8 ug/ml
(Figure 4.9). Fifty isolates (21.4%) were resistant to BC (MIC 2:4jlg/ml)39. Thirty nine
of the 50 isolates (78%), representing all locations, had an MIC of 4jlg/ml (Figure 4.10).
Isolates with an MIC of Sug/ml were not found in Highland region.
Figure 4.9 Susceptibility of animal S. aureus to benzalkonium chloride
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.O.5IJg/ml
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• SlJg/ml
5S.2%
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Figure 4.10 Regional variations in benzalkonium chloride MIC
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Resistant isolates were detected in only five animal sources, chicken, cow, horse, milk
and pig, representing seven different clones (Table 4.3). Isolates of bovine origin
accounted for 69.2% with an MIC of 4~g/ml and all of the isolates with an MIC of
Sug/ml.
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Table 4.3 Animal source, geographic location and clonal background of low level
benzalkonium chloride resistant S. aureus
Benzalkoniun
chloride MIC Animal source Geographic location Clone Number of isolates
(ug/ml)
Chicken Northern Ireland ST5 6
Cow Grampian ST9 2
4
Horse Southwest Scotland ST30 I
Grampian and
Milk Southwest Scotland ST9, ST97 23
Pig Highland ST5 I
Cow Northern lreland ST8l6 I
8 Grampian and
Milk Southwest Scotland ST7I 7
Low level chlorhexidine (CHX) resistance (MIC between 1.5 and 3).lg/ml)397 was
detected in 18 isolates (7.7%) (Figure 4.11). These isolates were represented by three
animal sources and four clones (Table 4.4). No low level CHX resistance was detected
in isolates from Highland region (Figure 4.12)
Figure 4.11 Susceptibility of animal S. aureus to chlorhexidine
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Table 4.4 Animal source, geographic location and clonal background of low level
chlorhexidine-resistant S. aureus
Animal source Geographic location Clone
Cow (n='!.2_ Northern Ireland ST816
Milk (n=16) Southwest Scotland ST71, ST97
Turkey (n=1) Southwest Scotland ST5
Figure 4.12 Regional variations in chlorhexidine MIC
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Sixteen (32%) of the 50 BC resistant isolates also showed low level resistance to CHX.
All of these isolates were of bovine origin and were represented by one of only three
clones (Table 4.5)
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Table 4.5 Animal source, geographic location and clonal background of low level
benzalkonium chloride and chlorhexidine-resistant S. aureus
Animal source Geographic location Associated SI
Cow (n=l) Northern Ireland 816
Milk (n=15)
Southwest Scotland 97,9and Grampian
The MIC range for cetylpiridinium chloride (CPC) for animal S. aureus isolates was
0.25-211g/ml (Figure 4.13). Only isolates from Northern Ireland and Southwest Scotland
had an MIC of 211g/ml (Figure 4.14). None of the 233 animal S.aureus isolates
expressed resistance to CPC (MIC = 2:411g/ml)416.
Figure 4.13 Susceptibility of animal S. aureus to cetylpiridinium chloride
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Figure 4.14 Regional variations in cetylpiridinium chloride MIC
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Triclosan MICs ranged between <0.007-0.03 ug/ml (Figure 4.15). A high proportion of
isolates from Highland region were from wild animals which may account for 72.2% of
these having an MIC of <0.007 ug/ml (Figure 4.16). None of the 233 S. aureus isolates
expressed resistance (MIC = ~l ~g/ml)417.
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Figure 4.15 Susceptibility of animal S. aureus to triclosan
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Figure 4.16 Regional variations in triclosan MIC
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All S. aureus isolates were susceptible to H202, formaldehyde and copper sulphate, with
MICs of 0.001-0.008% (Figure 4.17), 0.003-0.0125% (Figure 4.18), and 4-8 mM
respectively (Figure 4.19)4. Isolates from Northern Ireland were the most susceptible to
H202, with MICs of:::: 0.004% (Figure 4.20). The majority of formaldehyde susceptible
isolates from all geographic locations had an MIC of 0.006% (Figure 4.21).
Figure 4.17 Susceptibility of animal S. aureus isolates to hydrogen peroxide
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Figure 4.18 Susceptibility of S. aureus isolates from animal species to formaldehyde
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Figure 4.19 Susceptibility of S. aureus isolates from animal species to copper sulphate
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Figure 4.20 Regional variations in H202 susceptibility
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Figure 4.21 Regional variations in formaldehyde susceptibility
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4.4 Discussion
A large number of chemical microbicidal substances are used in the production of
livestock and in companion animal veterinary practice. This includes antimicrobial
agents to treat or control infectious diseases, disinfectants to reduce or eliminate
environmental contamination and food preservatives to inhibit bacterial growth.
4.4.1 Antibiotic resistance frequencies
In this study penicillin resistance was the most frequent resistance observed and was
detected in 65.2% of the isolates, predominantly from cattle where it is the drug of
choice in the treatment of mastitis. This finding agrees with data published by Vintov 'et
ai, from Ireland in 2003, where 71.4% of bovine S. aureus isolates exhibited penicillin
resistance458,4o,. In contrast, Wagge et al have reported that although the rate of mastitis
in cattle in Norway is high and penicillin is the antibiotic most commonly used in
treatment the frequency of penicillin resistance in S. aureus from cattle remains low at
10%462.This low level of penicillin resistance also contrast with data from the national
monitoring programme of Germany where the rate of resistance, in bovine S. aureus
isolates for 1997 was 52.2%, and bovine data from Brazil for 1992 where the rate of
resistance was 43.9%476.
In a study by Schwarz et al in 1998, on the rate of tetracycline resistance in S. aureus
isolated from cattle, horses, and rabbits, they reported a low level (9.3%) of tetracycline
resistance among these isolates and suggest that this could be correlated to the
preferential use of non-tetracycline antibiotics, such as the penicillins, to control disease
in these animals384. Data from this study contrasts with Schwarz et al where the rate of
246
resistance in wild (Pheasant and Phillips goose hawk), and domestic animal sources
(chicken, cow, milk, pig, and turkey) was almost four times higher (36.4%) and was in
close accordance with data from a study by Aarestrup et al 5 (2000) where 47% of S.
aureus isolated from chickens were tetracycline resistant, and GUIer et a/169 (2005)
where 27.9% of bovine S. aureus were tetracycline resistant.
Sulphamethoxazole in combination with trimethoprim accounted for 20% of the
veterinary antibiotic sales in the UK428• While the overall frequency of resistance to
sulphamethoxazole in this study was 23.2%, resistance to trimethoprim was found in
only three isolates, two bovine and one porcine. This level of sulphamethoxazole
resistance contrasts with data from Vintov et al who have shown a mean rate 'of
resistance of only 3.7% among bovine S. aureus isolates from across Denmark,
England, Finland, Germany, Iceland, Ireland, Norway, Sweden, Switzerland and the
USA 458. In contrast, Werckenthin et al have reported levels of resistance to
sulphonamides in Denmark and Germany of 52.6% and 50% respectively among bovine
S. aureus476•
The veterinary fluoroquinolone enrofloxacin is commonly used in the systemic
treatment of disease in a wide range of animal species!". This antibiotic is closely
related to fluoroquinolones, including ciprofloxacin, which is an active metabolite of
enrofloxacin, used in human clinical medicine'i". In this study ciprofloxacin resistance
was the fourth most common resistance, and was detected in 19.7% of the isolates. This
level of resistance was comparable to data published by Aarestrup et al, in 2000, where
the rate of resistance in S. aureus isolated from Danish poultry was 30%.5 These levels
of resistance contrast with German data published by Wallmann465, from 2002-2003,
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where no resistance to enrofloxacin was detected from S. aureus isolated from cases of
respiratory disease in pigs and cattle or dairy cows with acute mastitis and by GUIer et
al, in which only 1.8% of S. aureus isolated from Turkish cattle with acute mastitis,
from 1995-2004, exhibited resistance to enrofloxacin169•
The macrolides, tylosin and spiramycin, were commonly used as AGP in the production
of pigs and poultry until banned in the ED in 1999. Large quantities continue to be used
in domestic and companion animal therapy". Macrolide resistance data from eNS
isolates from poultry in Switzerland, S. hyicus from pigs, and S. aureus from poultry in
Denmark have all shown a much higher frequency of macrolide resistance than the
7.9%, in isolates from pheasant, pig, Phillips goose hawk and cow, detected in this
study5,144,471,476. S. aureus isolated from cattle in Germany have shown a rate of
resistance (11.4%) to macrolides more in line with the results in this study476.
A low level of resistance to the aminoglycoside, other than streptomycin, has previously
been reported by Frei et al in livestock animalsl44• In this study streptomycin resistance
was found in 12.3% of isolates, mostly from cattle, which is .consistent with resistance
data from S. aureus isolated from mastitic cattle in Brazil476, Switzerland, and England
with resistance rates of 12.1%, 11.8% and 9.2% respectively'i", and rabbit and ovine
data from Spain with a resistance rate of 16%158. In contrast, higher levels of
streptomycin resistance was found in Germany where 29.3% of bovine isolates from
mastitis were resistant476.
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Reports of methicillin resistance in S. aureus in animals have become more frequent in
recent years270,387.As early as 1975 Devrise reported the isolation of 68 MRSA from
mastitic milk samples from Belgian dairy herds103. More recently MRSA have been
isolated from surgical wound infections in horses'?", respiratory, urinary and wound
infections in dogs, cats, a rabbit and a seaI27o,318.These MRSA isolates have been
shown to closely resemble the predominant clone found in humans (EMRSA-15)
suggesting that the transmission of MRSA between humans and animals can and does
occur318. Reports by van Belkum et aI, Guardabassi et al and Wulf et al have recently
confirmed pig to human transmission of MRSA ST398, a lineage thought to have
originated in pigs443,461,492.This strain has now been detected in pig populations in
numerous European countries, Canada and Singapore and represents an important
human health risk461. However, all 233 of the S. aureus isolates tested from Scotland
and Northern Ireland were susceptible to oxacillin.
Virginiamycin, a veterinary streptogramin, was used in Europe as an AGP until banned
in 1999. Its use as an AGP in the production of chickens, turkey, pigs, and cattle
continues in the USA and this has been shown to select for virginiamycin resistant
strains of E. faecium which are cross-resistant to the human streptogramin
. . in/d le. .. (S 'd™)287427475 R f t t .qumupnsti a topristm ynercr ", eports 0 s rep ogramm non-
susceptibility in human isolates of S. aureus have been publishedi". There have been
no reports of quinupristinJdalfopristin resistance in animal S. aureus isolates, which is
consistent with data from this study.
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Linezolid, a recently introduced antibiotic for the treatment of multiresistant Gram
positive infection in humans, has never been licensed for use in animals. There have
been several reports oflinezolid resistance in clinical isolates ofVREI82,327. A review of
the literature has revealed a report of linezolid resistance in three MRSA. These isolates
were from patients receiving linezolid for dialysis-associated peritonitis, and exhibited a
G2576T mutation in DNA encoding the central region of domain V of 23S rRNA 435.
This mechanism of resistance has only been reported in rare laboratory linezolid
resistant mutants of S. aureus435• Aires et al have more recently shown that the presence
of chloramphenicollflorfenicol (efr) resistance gene encoding a 23S rRNA
methyltransferase confers cross resistance to linezolid24• Even though linezolid is not
licensed for use in animals florfenicol is frequently used in the treatment of livestock.
Therefore, the generation of efr mediated cross resistance to linezolid would have health
implications for humans. So far there have been no reports of S. aureus resistant to
linezolid in animals, which concurs with data from this study.
Glycopeptide resistance is a limited but growing global problem in S. aureus isolates
from humans67,187. No glycopeptide resistance was detected in this collection and there
have been no publications of glycopeptide resistance in S. aureus isolated from animals
even though avoparcin, a veterinary glycopeptide, was used as a growth promoter in pig
and poultry production for many years until the rise in GRE forced the EU to ban its
use.
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In this study 9.8% of isolates were resistant to clindamycin which was consistent with
the rate of 7.7% reported by Gentilini et al in bovine S. aureus from Argentina isolated
between 1996-1998152 and 7.1% reported by Rajala-Schultz et al in bovine CNS from
the USA isolated between 2001-2002345, but was higher than the published resistance
rates in S. aureus from cases of bovine mastitis in Denmark (2.3%), Switzerland (3.2%),
Brazil (4.5%), and France (4%) isolated between 1994-1999476• The frequency of
clindamycin resistance of bovine S. aureus from Germany, isolated in 1997, was more
than double (22.8%) the rate seen in this study476.
Resistance to mupirocin is divided into two groups: low level with MICs of >8 - ~256
mg/l and high level with MICs >256 mg/l. Low level resistance is due to alterations in
isoleucyl-adenylate-tRNA synthetase (IRS) that inhibit protein synthesis. High level
resistance is associated with an additional IRS that is encoded by the ileS2 gene
commonly reported on plasmids=". Both high and low level mupirocin resistance has
been reported in S. aureus isolated from humans although the frequency of resistance
remains 10~33. In a study by Walker et al it was shown that a reduction in the
prevalence of mupirocin resistance could be achieved with ~ore restrictive controls on
prescribing'?", A survey of mupirocin susceptibility of human clinical Gram positive
pathogens isolated in Korea failed to detect mupirocin-resistant staphylococci in 1999,
14 years after its introductiorr'". In a study by Yun et aI, in 2003, they report high level
mupirocin in five percent of human clinical S. aureus and no low level resistance
detected'?", Manian et al have reported the asymptomatic nasal carriage of a mupirocin-
resistant MRSA in a pet dog that was associated with recurrent infections and
colonisations among household contacts280• This finding was, however, considered
transmission from a human source. The observation that no mupirocin resistant isolates
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were detected in this study probably reflects the exclusive use of this drug in human
medicine.
The frequency of antibiotic resistance varied geographically with only 50% of S. aureus
from Highland region resistant to one or more antibiotics while the frequency was
highest in Southwest Scotland (95.6%). Werckentin et al have also reported that the
rates of resistance of animal staphylococci varied widely according to the animal
species, resistance properties and geographic source of the isolatest". Resistance to
only four of the 22 antibiotics tested: ciprofloxacin, clindamycin, penicillin and
tetracycline were detected in all locations. The highest frequency of resistance to
ciprofloxacin and tetracycline and lowest frequency of penicillin resistance was seen in
isolates from Northern Ireland. Over 90% of these isolates were from chickens. The
high frequency of resistance to tetracycline in poultry isolates in this study contrasts
with the lower levels reported in broiler poultry isolates of S. aureus by Aarestrup et al 5
and eNS by Frei et a/144 and cattle, horse, cat, and rabbit isolates of S. aureus by
Schwarz et a1384• A study by Wallmann et al has also shown a high prevalence of
ciprofloxacin and tetracycline resistance among S. aureus from poultry. They concluded
that apart from ciprofloxacin and tetracycline, antibiotic· resistance could still be
considered low among poultry S. aureus465• This was the case for S. aureus isolates
from Northern Ireland. However, approximately 20% of poultry isolates from Northern
Ireland were also resistant to penicillin. Tetracycline resistance was also high among
bovine isolates from Grampian region (40.3%) and porcine isolates from Highland
region (33.3%). Schwarz et al have also shown staphylococci from pigs to have a high
rate of tetracycline resistancel'". The frequency of resistance among bovine isolates in
. that study was only 1%. They concluded that the high level of tetracycline resistance in
porcine S. aureus could be related to the widespread use of tetracycline on pig farms
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and the low levels of tetracycline resistance in bovine S. aureus could be correlated to
the preferential use of non-tetracycline antibiotics such as the ~-lactams384. Certainly,
among the S. aureus isolates from bovine sources, mainly from Grampian region and
Southwest Scotland, the levels of penicillin were high. Similarly high levels of
penicillin resistance have been found among staphylococci from domestic animals in a
number of different countries ranging from 50% in the USA to 71.4% in Ireland4s8. In
the Scandinavian countries, where the use of penicillin in cattle and poultry is tightly
controlled the rates of resistance to penicillin were much lowers. In this part of the study
resistance levels for clindamycin were higher than for erythromycin, across the four
locations. As clindamycin, a lincosamide antibiotic, and erythromycin, a macrolide
antibiotic, have common targets in the bacterial ribosome; isolates that are resistant to
one class may be resistant to the other class, and to type B streptogramins (MLSB
phenotype). Luthje et al have reported clindamycin resistant erythromycin susceptible
staphylococci isolated from animals. These isolates carried copies of the lnu (A) gene
that encodes a lincosamide inactivating enzyme with no activity against macrolide
antibiotics278. It is possible that the higher frequency of clindamycin resistance among
the isolates in this study could be due by the presence of the lnu (A) gene. Resistance to
clindamycin varied from 1.1% in Southwest Scotland to 27.8% in Highland region.
High levels of clindamycin resistance in S. aureus from cattle have been reported from
Finland, Germany, Iceland, Ireland, Switzerland and the USA97. While giving no exact
figure on the percentage frequencies of resistance in these countries the reported MIC90
in each country was between 4-8 ~gI ml (resistance breakpoint >0.5 ~g/mI2o). In
contrast, no resistance to clindamycin and only 3% resistance to erythromycin was
reported by Gianneechini et al among staphylococci from dairy cattle in Uruguay'<'.
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It is interesting to note that an isolate from a Phillips goose hawk from Northern Ireland,
a wild bird which is unlikely to have received sustained antibiotic therapy, was multiply
antibiotic resistant exhibiting resistance to five antibiotics while the isolate from a saker
hawk was fully susceptible, Numerous sources of antibiotic contamination, antibiotic
resistant organisms and resistance genes have been reported and it is possible that this
multi-resistant isolate in the wild bird may have originated from one of these
environmental sources or through feeding on contaminated rodent pests from farms
(Figure 4.22)336,426,
Figure 4,22 Model of the distribution and transfer of antibiotics, antibiotic resistance
d b ia in th bi h 426genes, an actena I t e 10SP ere ,
Wildlife Environmental
(birds, rodents) (soil, water)
Abattoir
f
1-Sr\eSt
NewStock Fann Animals Humans rerrains
1 \
Animal feed
Pets Fruit & Vegetatjes
254
4.4.2 Biocide MICs
The most commonly used disinfectants for veterinary purposes are formaldehyde,
iodine, chloride compounds and copper sulphate. Copper sulphate is also used as a
mineral supplement in pigs, poultry and cattle". Resistance to quaternary ammonium
compounds (QAC) is well known and several resistance genes have been identified in
both Gram positive and Gram negative organisms. Recently Hasman and Aarestrup
have identified a transferable copper resistance gene in enterococci from animals and
humansl ".
Data on the susceptibility of S. aureus isolated from animals to antimicrobial
compounds used for disinfection is limited. This aim of this study was to determine the
frequency of biocide and copper sulphate resistance among S. aureus isolates isolated
from animals.
The results presented in this study indicate that there has been no development of
resistance to, copper sulphate (2:16 mM)4, cetylpiridinium chloride (2:4 Jlg/ml)4o,
hydrogen peroxide, formaldehyde, or triclosan (>0.1 Jlg/ml)417as all isolates formed one
large population in their susceptibilities to these compounds".
Resistance to cationic biocides in S. aureus is plasmid mediated and is due to the QAC
series of proteins. These resistance genes have been shown to be located on p-Iactamase
plasmids and are also known to integrate into the chromosome/". No clear-cut
definition exists for the classification of staphylococci as QAC-susceptible or QAC-
resistant isolates and the testing methodologies used are not standardised. In a study on
S. aureus carrying the smr gene; McDonnel and Russell classified isolates as BC
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resistant with an MIC >3 ug/ml. Leelaporn et al reported the MIC of BC resistant S.
aureus to be between 4 and 6 J..lg/mI255and in another study Littlejohn et al found the
MIC to be 6 J..lg/mf67• In contrast, Bjorland et al have reported the MIC of S. aureus
carrying the smr gene to be between 2.5 and 3 J..lg/mI4o. In this part of the study a
concentration of 4 ug/ml for BC was used for the detection of QAC-resistant S. aureus
isolates. Fifty (21.4%) isolates were resistant to BC. These isolates were from multiple
animal sources and a variety of clonal backgrounds. In a study by Aarestrup et al23%
of S. aureus isolated from livestock had an MIC to BC of ~4 ug/ml. In that study no
resistance cut-off point was given and all isolates were considered as susceptible", The
rate of resistance in this study is over twice that reported by Bjorland et al from dairy
cattle'". A study by Fraise, on the susceptibility of hospital strains ofEMRSA 16 to BC
reported MICs of 0.08 ug/ml, which is 6 times lower than the lowest MIC of S. aureus
isolates in this study. Benzalkonium chloride resistant S. aureus isolates occur
frequently in animals, especially dairy cattle, in the UK. This high rate of resistance
may be a reflection of the long term use ofQAC in the treatment of bovine mastitis.
The MIC values to chlorhexidine obtained in this study were in the range 0.25-4 ug/ml.
Low level resistance to CHX has been determined as having an MIC between 1.5 and 3
!J.g/mI416.Eighteen isolates (7.7%) exhibited low level CHX resistance (MIC 2 ug/ml).
Data published by Pitt et al339, on CHX susceptibility of human S. aureus, and
Aarestrup et at, on CHX susceptibility of animal S. aureus, have shown very similar
CHX MIC values to those obtained in this study. However, the MICs of isolates in this
study were spread over a wider range.
256
Sixteen of the 50 BC resistant isolates also exhibited low level resistance to CHX. A
similar frequency of co-resistance between BC and CHX has been reported by Sidhu et
al in an investigation into the genetic linkage between QAC resistance genes and p_
lactamase resistance among human clinical staphylococcal isolates'?".
Reduced susceptibility to CPC in MRSA has been reported by Irizarry et a1198. Over
90% of the MSSA isolates in that study were susceptible to CPC at concentrations of <
2f.lg/ml. A similar high frequency of low level CPC resistance has been reported in
human MRSA, compared with human MSSA, by Suller et afl6. All isolates in this
study were susceptible to CPC with MICs in the range 0.25 to 2f.lg/ml.
S aureus strains have emerged that exhibit low-level resistance to triclosan (MIC 1-4
f.lg/ml)79,369,44I. Cookson et al have reported low level triclosan resistance (MIC 2-4
ug/ml) in human MRSA strains. Bamber and Neal have also reported high level
triclosan resistance in human hospital S. aureus strains (MICs up to 32 ug/ml). All
isolates in this study had MICs to triclosan in the range <0.007-0.03f.lg/ml with over
70% susceptible at MICs of 0.007 ug/ml or less. These data concur with results
published by Suller et af16 who failed to detect triclosan resistance among human
clinical S aureus. They question the clinical significance of low-level triclosan
resistance detected by others in S aureus. Triclosan is known to be stable in the
environment and may be present on surfaces at low concentrations when used as a
disinfectant. There is concern that continuous exposure to sub-MIC concentrations of
triclosan may give rise to organisms with increased resistance to disinfectants and
antibiotics, although this concept remains to be demonstratedt'". Suller and Russell
attempted to select for biocide resistant S aureus isolates by repeated exposure of the
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isolates to increasing concentrations of biocide. They were able to demonstrate
increased MICs to CHX, CPC and triclosan. In the absence of biocide, however, the low
level resistance was not stably maintained'!". Work carried out by Fitzgerald et al also
failed to produce stably maintained biocide resistance in E. coli and S. aureus138•
Nicoletti et af were able to demonstrate high level stably maintained resistance to CHX
and QACs in Pseudomonas aeruginosa and Serratia marcescens'", Suller et al
concluded that there was no evidence to suggest that staphylococcal strains will show
increased resistance in the human clinical environment despite the potential for repeated
exposure to high concentrations ofbiocide416. In contrast, Bjorland et al have shown the
presence of QAC resistant S. aureus from dairy cattle that had persisted for over 20
months and were thought to be as a consequence of the continuous use of teat cream
containing QAC40• S. aureus isolates in this study were collected between 1999 and
2001 and were continuously subcultured on non-selective media over a period of four
years prior to biocide susceptibility testing. Therefore, low level resistance among these
isolates has remained stable in the absence of biocide exposure over an extended period.
Early studies into the bactericidal effectiveness of H202 against S. aureus strains have
been shown to be dependent upon a number of test parameters such as H202
concentration and temperature and the inherent characteristics of the test strain 460. The
bactericidal effect of hydrogen peroxide was shown to be less effective at an incubation
temperature of 37°C than at 54°C. The increased resistance to hydrogen peroxide is
thought to be related to the variability of catalase activity between S. aureus strains'".
Amin et al were able to show that S. aureus strains from cattle with high catalse activity
were more resistant to the effects of H202.18. These strains exhibited a two fold increase
in hydrogen peroxide MIC (0.025 to 0.05%) compared to those strain with low catalase
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activity'", All S. aureus isolates in this study exhibited MICs to H202 in the range 0.001
to 0.008% and were considerably lower than those published by Amin et al and Von
Ruden et atI7,460. The H202 MIC values obtained in this study are very similar to those
published by Aarestrup et al who considered their isolates to be very susceptible",
Rodgers et al have also shown peroxide based disinfectants to be effective against S.
aureus contamination of the surface of eggs supplied to hatcheries at the manufacturers
recommended concentration'?'.
Formaldehyde is a widely used disinfectant in the production of food animals. There
have been few studies examining the susceptibility of S. aureus strains to this agent.
Plasmid mediated transmissible formaldehyde resistance has been found in Serratia
marcescens and E. colt" 9,244.In these studies isolates were considered resistant at an
MIC value of'> 0.07%. The MIC range for isolates in this study was between 0.003 and
0.0125%. A similar range of formaldehyde MIC (0.003-0.006%) has been reported by
Aarestrup et at among S. aureus isolates from domestic animal species which they
considered susceptible based on the data published by Kaulfers et at and Kummerle et
aPI9,244.
Copper sulphate (CUS04) is commonly used as a footbath in milking yards to treat
lameness in dairy cattle and as a mineral supplement in pig and poultry production".
Acquired and transferable copper resistance has been most thoroughly examined in
Gram negative bacterial systems such as pco genes from E. coli 53and the cop genes
from Pseudomonas Spp77. Until recently few cases of copper resistance in Gram
positive bacteria have been reported and in most cases the resistance mechanism
remains unknown. Hasman et al have reported the first plasmid located, transferable,
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copper resistance gene in Gram positive bacteria named transferable £opper resistance
homologue to copB (tcrB). This plasmid was detected in an E. faecium isolated from a
pigI76. Few reports have been published on the susceptibility of S. aureus from animals
to copper. In this study all isolates formed one large population of susceptibility with
95% of isolates exhibiting an MIC of 8mM. The MIC values obtained in this study are
comparable to those previously observed by Aarestrup et at.
In conclusion, penicillin, tetracycline, sulphamethoxazole, ciprofloxacin and
streptomycin were the most frequently detected antibiotic resistances among S. aureus
isolates from animals. p-Iactam antibiotics, including penicillin, ampicillin, amoxicillin
and hetacillin, are the most widely used class of antimicrobial agents used in the
treatment of disease in cattle. The high frequency of penicillin resistance in this study
may be a reflection of the large proportion of isolates tested (67%) for antimicrobial
susceptibility being of bovine origin. No resistance was detected against fusidic acid,
gentamicin, kanamycin, linezolid, mupirocin, oxacillin, quinupristinldalfopristin,
teicoplanin or vancomycin. Resistance to all other antibiotics was low. The lack of
resistance to linezolid and mupirocin in S. aureus from animals is most likely due to
their exclusive use in human clinical medicine.
Regional variations in the frequency of antibiotic resistance in S. aureus from animals
have been shown previously and were also apparent in this study458. Penicillin and
tetracycline resistance was predominant in Grampian and Highland regions,
ciprofloxacin and tetracycline resistance in Northern Ireland and penicillin and
sulphamethoxazole resistance in Southwest Scotland. Variations in the distribution and
frequency of antibiotic resistance across different locations can be attributed to
differences in the regional prescribing policies of veterinary practitioners.
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Extensive use of disinfectants has led to the selection of staphylococcal isolates resistant
to such compounds in human hospital environments, as well as in food animal
production I79,255. In the present study S. aureus isolates from livestock, wild and
companion animals have either not or only to a limited degree developed low level
resistance to biocides. The failure of Suller et al to train S. aureus isolates with stably
maintained resistance to biocides casts doubt over the clinical significance of biocide
resistance. It has been shown that there can a linkage between biocide and antibiotic
. . hvl .. I d f h 397417D"c th c.resistance In stap y OCOCCI ISO ate rrom umans ' . ismrectants may ererore act
as selective pressures for the retention of plasmids that contain the genes for resistance
to numerous antimicrobial substances. Further work needs to be done investigate the
genetic basis of low level resistance to BC and CHX and determine whether there is any
genetic linkage between biocide and antibiotic resistance in the S. aureus isolated from
animals from the UK397•
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Chapter 5 Molecular mechanisms of tetracycline and erythromycin resistance and
horizontal resistance gene transfer studies
5.1 Introduction
Antimicrobial substances are vital drugs for prophylaxis and treatment of bacterial
infections in humans and animals+". Since the introduction of antimicrobials into
human medicine, staphylococci have shown a frequent and rapid development and
spread of antimicrobial resistance, particularly in nosocomial infections. Unfortunately,
this development has not been documented continuously in the veterinary field476. In
Europe, staphylococci isolated from animals are included in the national antibiotic
susceptibility monitoring programmes of eight countries (Austria, Belgium, Denmark,
France, Germany, the Netherlands, Portugal, and the UK). Schwarz and co-workers and
Aarestrup and co-workers have determined the presence and frequency of selected
antibiotic resistance genes among staphylococci isolated from animals from across
Europe and in particular Germany and Denmark respectively5,382,384.
Tetracyclines and macrolides have been used for therapy and prevention of
staphylococcal infections in humans, animals, and plants384.Studies on the genetic basis
of macrolide and tetracycline resistance in staphylococci of human origin have been
performed''!'. In addition, the distribution of tetracycline and macrolide resistance
determinants among Staphylococcus spp, including S. aureus, from several domestic
. I . h . I b d c. Id' 5263384454 Aaruma species as previous y een reporte rrom se ecte countries" , , . n
investigation of the current literature has no reports on the genetic basis of tetracycline
or macrolide resistance in S. aureus from livestock, wild, or companion animals from
the UK and only limited data from other countries including the USA46,269,310.
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The increase in antimicrobial resistance and the impact on human health is an emerging
problem worldwide. Since exposure to antimicrobial agents is the most important factor
in the development of antimicrobial resistance, animals and animal products, including
food, are thought to be significant sources of resistant bacteria for humans325• S. aureus
is becoming increasingly virulent and resistant to antibiotics due to the horizontal
transfer of mobile genetic elements (MGE)418,463. The transfer of antibiotic resistance
genes between a wide range of bacterial species, in human and laboratory rodent
intestine, between animal and human strains of enterococci, and other bacterial species
has been investigated27,89,96,394.
The aims of this study were to determine the presence and relative frequency of genes
encoding tetracycline, and macrolide resistance in S. aureus from livestock, wild, and
companion animals and humans from the UK and companion animals from the USA; to
investigate possible structural variation in the tetK genes from S. aureus isolates from
animals and humans; and to investigate the transferability of tetK resistance plasmids
from animal strains to the lab strain S. aureus 8325-4.
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5.2 Materials and methods
5.2.1 Bacterial strains
Four isolate collections were used; the first isolate collection comprised of 74
tetracycline resistant and 16 erythromycin resistant animal S. aureus isolates (Table
5.1). These resistant isolates were identified amongst the 233 animal S. aureus
collection (Table 2.1), the second isolate collection comprised of seven tetracycline and
12 additional erythromycin resistant animal MRSA isolates from the USA, supplied by
the Dept of Veterinary Medicine, University of Pennsylvania (Table 5.2), the third
isolate collection comprised of 53 tetracycline resistant human MSSA and MRSA
isolates (Table 5.3) and the fourth isolate collection comprised of 67 erythromycin
resistant human MRSA isolates (Table 5.4). Isolate collections three and four were
supplied by the Scottish MRSA reference laboratory.
Table 5.1 Tetracycline and erythromycin resistant animal S. aureus isolates from the
UK
Animal species Tetracyclineresistant isolates Erythromycinresistant isolates
Chicken 30
Cow 28 10
LivestockMilk 7
Pig 5 3
Turkey 2
Pheasant 1 2
Wild
Phillips goose hawk I 1
Total 74 16
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Table 5.2 Tetracycline and erythromycin resistant animal S. aureus isolates from the
USA
USA
Animal species Tetracycline Erythromycin
resistant resistant
Dog 7
Horse 6 4
Parrot I 1
Table 5.3 Tetracycline resistant human MSSA and MRSA isolates
Isolation year PFGEtype MSSA MRSA
EIS I
EI6 2 4
2001 104 5 3105 2 2
1051112 I
107 I
108 2
109 2
2002 I I I 1 1112 1
116 3
117 1
118 1
120 1
2003 121 1 1122 1
124 1 1
126 1 1
127 5
2004 136 1141 1
147 1
153 1
2005 154 1
155 1 1
Total 20 33
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Table 5.4 Erythromycin resistant human MRSA isolates
Isolation year PFGEtype Isolation year PFGE type
108 108-SI(LD)
1997 104 112y
10Sa 2002 126a112a ISa
10Sh 161
1998 III b 112
16-28 126
99b 139/142
lOSs 107/111
108-28 136
109a 126
1999 118b EIS
12a 1161124
15-30 116/124
16-108 127
99a 127
128 138
2000 EI7 EI6
108qr 2004 116/124105-50
108-42 EIS
lilt
112w EI6I I I
12Sa 105/1082001 126c
140a 1051108
141a
14Sa 139/142
149a
16-119 1321154
eNS3
5.2.2 tetK long PCR primer design
Primers were designed from Genebank sequence S67449, for the tetK gene of plasmid
pT 181, using Genefisher interactive primer design software- http://bibiserv .techfak.uni-
beilefeld.de/bibi/Tools Primer Design.html, and amplified an 1146bp internal fragment
of the 1380bp tetK gene.
5.2.3 Resistance gene PCR
The genes coding for ermA, ermB, ermC, tetK, tetL, tetM and tetO were amplified using
the PCR primers and amplification conditions outlined in Table 5.5. PCR was
performed on a Techne Genius thermal cycler. A positive and negative control was
included in each run.
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5.2.4 Gel electrophoresis
Electrophoresis was performed using six microlitres of peR product loaded in a 1.5%
Neuseive agarose (Cambrex, UK) gel in a 0.5% TBE solution (Gibco, UK) at 150V for
40 minutes.
Plasmid DNA electrophoresis was performed using thirty microlitres of plasmid extract
loaded in a 0.8% Neuseive agarose (Cambrex, UK) gel in a 0.5% TBE solution (Gibco,
UK) at 65V for 20 minutes followed by 23V for 16 hours. The size of each plasmid was
determined by comparison with a A DNA molecular weight ladder (0.12-23.lkb) (Roche
Applied Sciences, Germany).
Following electrophoresis gels were stained with lug/nil. ethidium bromide solution
(Sigma, UK) for 30 minutes visualised by uv transillumination (UVP, UK) and the
image stored digitally using Vision Works 32 software. The size of each peR product
was determined by comparison with the appropriate control strain and an appropriate
molecular weight ladder (Gibco, UK).
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5.2.5 Restriction endonuclease digestion of tetK long peR product
The 1146bp predicted PCR product was fed through restriction analysis software at
http://www.ualberta.cal-stothard/javascript/index. Results indicated that endonucleases
AluI, HincIU, KpnI and RsaI would give a selection of distinct restriction patterns (see
Table 5.6). Endonuclease digest reactions were performed following the method in
section 3.2.4.
Table 5.6 Restriction endonucleases
Restriction enzyme Supplier Enzyme concentration REact® buffer Cleavage site Cut positions
113,232,292
Alul Invitrogen, UK 500u 1 AG/CT and 664
Hincll Invitrogen, UK 300u 4 GTY/RAC 26 and 896 .
Kpnl Invitrogen, UK 2000u 4 GGTAC/C 418
Rsal Invitrogen, UK 1000u 1 GT/AC 182 and 416
5.2.6 Preparation of antimicrobial stock solution for broth microdilution minimum
inhibitory concentration (MIC)
Antimicrobial stock solution of 1280)lg/ml was prepared using the following formula
taking into consideration the assay potency of the antimicrobial.
Volume (ml) = Actual weight of antimicrobial powder (mg) x Antimicrobial potency (Ilg/ml)
Desired concentration (I 280J.lg/ml)
Antimicrobials were dissolved III an appropriate solvent and stored at _20DC until
required.
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5.2.7 Broth microdilution MIC
Broth microdilution MIC determination was performed following the recommendations
of the British society for antimicrobial chemotherapy). One hundred microlitres of
MUller Hinton II broth (Becton Dickinson, UK) was added to 12 wells of a 96 well
microtitre plate (Coming Incorporated, New York, USA). A 1:5 dilution of
antimicrobial stock solution was performed giving a working concentration of
256Jlg/ml. One hundred microlitres of antimicrobial working solution was added to the
first well followed by serial two-fold dilutions giving a concentration range of 128 -
0.06Jlg/ml. Test isolate suspension was prepared in sterile distilled water, adjusted to
McFarland 0.5 (1-2 x 108 cfu/ml) followed by a 1:10 dilution (1 x 107 cfu/ml). Five
microliters of isolate solution was added to each well (final cell concentration 5 x 105
cfu/ml) and incubated at 37°C for 16-24 hours. The MIC was recorded as the lowest
concentration of antimicrobial agent that completely inhibits growth.
5.2.8 Double disc diffusion test
All erythromycin resistant isolates were tested for inducible clindamycin resistance by
the double disc diffusion method as described by Feibelkom et all3o. Isolates were
inoculated on MUller-Hinton II agar following the method in section 4.2.2. The
induction test was performed by manually placing a 2Jlg clindamycin disc and a 15Jlg
erythromycin disc approximately 12mm apart. Each plate was incubated at 37°C in air
for 16-18 hours and zone diameters recorded. Blunting of the zone of inhibition around
the clindamycin disc indicates positive induction.
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5.2.9 Transfer of plasmid resistance
5.2.9.1 Mixed culture transfer (MeT)
In selecting strains for MCT isolates were tested for bacteriophage susceptibility,
against phages J, 85 and 95, following the method in section 2.2.3 (Table 5.7). Strains
that were lysed by phage were used in MCT experiments with a recipient that had been
lysogenised by the corresponding phage (Table 5.8). All phages and recipient strains
were supplied by Professor W.B. Grubb, Curtin University of Technology, Perth,
Western Australia.
Table 5.7 Bacteriophage used in MCT experiments indicating their titre and propagating
strain
Bacteriophage Titre (pfu/ml) Propagating strain
J 1.2xlO1o WBG248
85 3.lxlOl2 WBG286
95 1.4xlO1o WBG696
The selection plates for antibiotic resistance plasmid transfer were prepared using brain
heart infusion agar (BHIA) containing fusidic acid (Sug/ml) and rifampicin (25Ilglml)
and the antibiotic, for which resistance transfer is being selected, at the appropriate
concentration.
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Table 5.8 Phage free S. aureus NCTC 8325-4 recipient strains, chromosomally resistant
to rifampicin and fusidic acid, lysogenised by phage.
Recipient strain Lysogenised by phage
WBG879 85
WBG1876 J
WBG822 95
5.2.9.2 Resistance plasmid transfer byMeT
To 5 ml of BHIB (Oxoid, UK) containing 0.01 M CaCh 100~1 each of overnight BHIH
cultures of donor and recipient isolates were inoculated. Broth mixtures were incubated
for 24 hours at 37°C. Following incubation, cultures were centrifuged at 2,000rpm for 5
minutes and excess broth removed. The pellet was reconstituted following the addition
of 100~1 of BHIA. Each selection plate, containing fusidic acid (Sul/ml), rifampicin
(25~l/ml) and the antibiotic for which resistance transfer was being selected, was
inoculated with 50~1 of culture. Dilutions of 10-7, 10-8 and 10-9were prepared from the
remaining 50~1 of culture. One hundred microlitres of each dilution was inoculated
onto Isosensitest Agar (Iso) (Oxoid, Basingstoke, UK) for transfer frequency
estimation. All plates were incubated for 48 hours at 37°C before recording results.
Any growth on selection plates after 48 hours of incubation indicated that resistance
transfer had occurred. Transcipient organisms were cultured for purity on selection
plates prior to examining co-transfer of resistance by the agar disc diffusion method
(BSAC 2001).
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5.2.10 Conjugation
5.2.10.1 Polyethyleneglycol (PEG) method433
To a 20 ml glass universal 2 ml each of overnight BHIB culture of donor and recipient
strains were mixed and pelleted by centrifugation at 2,000rpm for five minutes and the
supernatant discarded. The cell pellet was reconstituted in 500111of BHIB containing
40% PEG (4000) (Sigma, UK) and incubated overnight at 37°C with shaking. Cells
were again pelleted by centrifugation (as above) and resuspended in lml ofBHIB. From
this mixture 100111was plated onto selection plates containing fusidic acid, rifampicin
(concentrations as above) and the resistance marker being transferred. The plates were
incubated for 48 hours at 37°C before examination for growth. Estimation of transfer
frequency was performed following the method in section 5.2.9.2. Any colonies found
on plates were subcultured onto selection plates for analysis of resistance gene transfer.
Donor and recipient isolates were inoculated seperately in 2 ml of BHIB and processed
as above. These cultures were incorporated as transfer negative controls.
5.2.10.2 Broth transfer
To a 20 ml glass universal a mixture of overnight BHIB cultures of donor and recipient
strains was prepared at a ratio of 1:3 (recipient:donor) and incubated for 6 hours at
37°C. Cells were pelleted by centrifugation at 3,000rpm for five minutes and
supernatant discarded. The cell pellet was reconstituted in IOOll1of BHIB. From this
mixture, 50111was plated onto selection plates containing fusidic acid, rifampicin
(concentrations as above) and the resistance marker being transferred. Estimation of
transfer frequency was performed following the method in section 5.2.9.2. Plates were
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incubated for 48 hours at 37°C before examination for growth. Any colonies found on
plates were subcultured onto selection plates for purity assessment.
5.2.11 Plasmid extraction
To a IOml glass universal of BHIB 3-5 colonies of each test isolate was inoculated and
incubated for 6-7 hours at 37°C. Cells were pelleted by centrifugation at 3,000rpm for
10 minutes and supernatant discarded. The cell pellet was resuspended by vortexing,
added to a I.5ml microtube and centrifuged at IO,OOOrpm for 10 minutes and
supernatant discarded. The cell pellet was reconstituted in 500lli of NET buffer and
centrifuge at IO,OOOrpmfor 10 minutes and supernatant discarded. The cell pellet was
reconstituted in 250111of buffer PI (Qiagen, UK), 8111of lysostaphin and 20111of
lysozyme, mixed by vortexing and incubated for 30 minutes at 37°C. The lysate was
cooled to 20-25°C and 250111of buffer P2 added. The suspension was gently inverted 4-
6 times and incubated at room temperature for 5 minutes. Following incubation 350111
of chilled buffer N3 was added and immediately inverted 4-6 times and incubated on ice
for 15 minutes. The suspension was centrifuged at 12,000rpm for 10 minutes, the
supernatant decanted into a fresh 1.5ml microtube and further centrifuged at 12,000rpm
for 10 minutes. The supernatant was applied to a Qiaprep spin column (Qiagen, UK)
and centrifuge at 12,000rpm for 1 minute and the flow through discarded. The spin
column was washed with 0.5ml of PB buffer, centrifuged at 12,000rpm for 1 minute
and the flow through discarded. A further centrifugation was performed at 12,000rpm
for 1 minute to remove any residual wash buffer. Plasmid DNA was eluted by applying
70111of EB buffer and incubating at room temperature for 1 minute followed by
centrifugation at 12,000rpm for 1 minute. Plasmid DNA was stored at 4°C until
required.
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5.2.12 Endonuclease digestion of plasmid DNA
Endonuclease digestion of plasmid DNA was performed following the method III
section 3.2.4
5.2.13 Loss of resistance/plasmids
To S ml of nutrient broth, S III of an overnight nutrient broth culture was added and
incubated overnight with shaking at 37°C and 43°C. For three days this procedure was
repeated. On day four, 1III of the culture was diluted in Sml of nutrient broth and plated
out for single colonies on Columbia blood agar. Individual colonies were selected and
screened for loss of resistance by disc diffusion susceptibility method. Plasmid
extraction was performed on all suseptible isolates (section S.2.11)
5.2.14 tetKprobe labeled with Digoxigenin-ll-dUTP
The tetK probe, labeled with non-radioactive digoxigenin-ll-dUTP (DIG), was
produced using primers tetKI and 2 and PCR cycling conditions in Table S.l, and the
PCR DIG probe synthesis kit (Roche Applied Science, Germany). Probe synthesis took
place in a mixture containing Sill lOx concentration PCR buffer with MgCI2, Sill PCR
DIG labeling mix, lul of primers tetKI and 2 (SOpmol), 4111of the amplification product
of tetK PCR made up to SOIlI with molecular grade water (Sigma, UK). The DIG
labeled PCR product was purified using the QIAquick® PCR purification kit.
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5.2.15 QIAquick® peR purification protocol
To purify PCR products SOO!!1of buffer PBI was added to 100!!1ofPCR product mixed
thoroughly, applied to a QIAquick spin column and centrifuged at 13,000rpm for 30
seconds. The flow-through was discarded and the spin column washed in 0.7S ml of
buffer PE and centrifuged at 13,000rpm for 30 seconds. The flow-through was again
discarded and the spin column centrifuged at 13,000rpm for a further 30 seconds. The
QIAquick spin column was placed in a clean l.Sml microcentrifuge tube. DNA was
eluted by the addition of SO!!1of buffer EB (l0 mM Tris-HCI, pH 8.S) to the centre of
the QIAquick membrane, incubated at room temperature for 1 minute, and then
centrifuged at 13,OOOrpmfor 1minute. Purified DNA was stored at -20QC.
5.2.16 Southern blot hybridisation
5.2.16.1 Buffers and reagents
Buffer 1
To 11 of distilled water 11.6lg of malic acid and 8.76g ofNaCI was added and adjusted
to pH7 using IN NaOH (Sigma, UK).
Buffer 2
To 100ml of buffer 1 Sg of blocking agent (Roche, Germany) was added, dissolved at
SO°Cthen autoclave sterilised at 121QCfor IS minutes.
Hybridisation buffer
To 100ml distilled water 2Sml of 20x sodium citrate-sodium chloride (SSC), 0.2ml 10%
sodium dodecyl sulphate (SDS) (Qbiogene, UK), 19 blocking reagent (Roche Applied
Science, Germany), and O.lg laurylsarcosine (Sigma, UK) was added, dissolved at SO°C
and stored at -20°C.
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Blocking reagent stock (10%)
Ten grams of blocking reagent (Roche Applied Science, Germany) was added to 100ml
of maleic acid. The blocking reagent was dissolved at 60°C for 16-18 hours and stored
at -20 QC.
O.SMNaOH-1.SM NaCI
To 11of distilled water 20g NaOH and 87.66g NaCI (Sigma, UK) was added and stored
at room temperature.
O.SMtris-HCI-3M NaCI pH8
To 11of distilled water 60.5g Trizma base and 87.66g NaCI was added, adjusted to pH8
with IN HCI (Sigma, UK) and autoclave sterilised at 121°C for 15 minutes.
20x SSC
To 11of distilled water 176g Sodium citrate and 351g NaCI was added, adjusted to pH7
with IN NaOH and autoclave sterilised at 121°C for 15 minutes.
2x SSC-O.I% SDS
To 11 of sterile distilled water 50ml of 20x SSC and 5ml 10% SDS (Qbiogene) was
added and stored at room temperature.
0.2x SSC-O.I% SDS
To 11 of sterile distilled water 5ml of 20x SSC and 5ml 10% SDS (Qbiogene) was
added and stored at room temperature.
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5.2.16.2 Vacuum blotting
Plasmid agarose gels were photographed, rinsed in distilled water and excess gel
trimmed. A piece of Hybond N+ nylon was cut slightly larger, 5mm all round, than the
gel and placed on the vacuum blotter platform. A window was cut in a vacugene mask,
smaller than the nylon, placed over the nylon and the gel added to completely cover the
mask window. A vacuum of 40 mm Hg was drawn and 50ml of 0.2 M HCI poured over
gel and left for 4 minutes. The gel was neutralized by the addition of 50ml of 0.5 M
NaOH-l.5 M NaCI (PH8) for 3 minutes followed by 50ml of 0.5 Tris-HCI-3 M NaCI
(pH8) for 4 minutes. The gel was then flooded with 50ml of 20x SSC for 2 hours to
allow the transfer of DNA from gel to Hybond N+ nylon. The bottom left hand comer
of the nylon was marked with a T for orientation and DNA fixed by baking at 80°C for
2 hours.
5.2.16.3 DNA-DNA hybridization
Prehybridisation
The Hybond N+ nylon membrane was placed, DNA face up, in a glass hybridization
tube (Hybaid™, UK) containing 5 ml of hybridization buffer. The tube was placed in a
hybridization oven and prehybridisation allowed to proceed at 42°C for 2 hours.
Hybridisation
The labeled DNA probe was denatured at 95°C for 10 minutes followed by 4°C for 10
minutes and diluted 1:lOin tissue grade water (Sigma, UK). AI: 100 dilution of probe
in hybridization buffer was added to the hybridization tube and hybridization allowed to
proceed at 60°C for 16-18 hours.
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Post-hybridisation washes
The hybridization solution was removed and stored at _20DC for reuse. The nylon
membrane was washed twice in O.2x SSC-O.I% SDS for 15 minutes at room
temperature, followed by a further two washes in O.2x SSC-O.l % SDS for 15 minutes at
65DC.
Chemiluminescence detection with CDP Star™
All incubations for the detection procedure were carried out at room temperature. After
post hybridization washes the membrane was added to a Petri dish, I ami of a 1% block
buffer, prepared in buffer 1, was applied and gently shaken for 30 minutes. The nylon
membrane was washed twice in buffer 1 for 15 minutes. Substrate dye (one tablet
containing 45 JlINBT and 33 JlI x-phosphate dissolved in 10ml tissue grade water) was
applied to the membrane and incubated in a dark room for reaction development. The
chemiluminescent reaction was stopped by washing in water; the membrane was dried
then photographed.
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5.3 Results
5.3.1. Detection of tetracycline resistance genes
One hundred and thirty four S. aureus isolates were examined for the presence of the
tetracycline resistance genes. These included all 81 tetracycline resistant animal isolates
and 53 tetracycline resistant human isolates, selected based on their year of isolation
and PFGE pattern. All isolates tested carried at least one of the tetracycline resistance
genes, tetK, tetL and tetM (Table 5.9 and Table 5.l0). The tetO gene was not detected
in any of the strains tested.
Table 5.9 Distribution of tet genes in S. aureus from animals
Animal species Geographic source (n) tet ene combinationK K+M L L+M M
Chicken NI (30)_ 30
Cow G (28) 10 10 4 2 2
Livestock Milk G (~SWS (I) 7
Pig Hm_ 5
Turkey SWS (2) 2
Companion Horse USA_@_ 6
Parrot USA (I) I
Pheasant H (I) 00 IWild
Phillips goose hawk NI_ill_ I
Total 81 54 10 5 2 10
G, Grampian, H, Highland; NI, Northern Ireland, SWS, Southwest Scotland, USA, United States of America
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Table 5.10 Distribution oftet genes in MRSA and MSSA in human
PFGE type MSSA(n 20) MRSA(n 33~
(n) lei gene combination lei gene cobination
K K+M L+M M K K+L+M K+M L+M M
EIS (I) I
EI6(6) 2 3 I
NARES (8) 4 I I I I
lOS (4) I I 2
105/112 (I) I
107 (2) I I
108 (2) I I
109 (2) I I
111(2) I I
112 (1) I
116 (3) 3
117 (I) I
118 (I) I
120 (I) I
121 (I) I
122 (I) I
124 (2) I I
126 (2) I I
127 (5) 5
136 (I I
141 (I I
147 (I I
153 (I I
154 (I I
ISS (2 I I
Total 17 I I I 21 I 3 I 7
tetK was carried by 79% (64/81) of the animal isolates and 81.1% (43/53) of the human
isolates and was the most frequent type of resistance gene observed (Figure 5.1). A
total 54/64 (84.4%) animal isolates and 38/43 (88.4%) human isolates carried tetK
alone. The remaining 10 (15.6%) animal isolates carried tetK in combination with tetM.
These isolates were all from cattle from Grampian region. Five of the human isolates
carried tetK in combination with tetM (4 isolates) and tetL + tetM (1 isolate). Twenty
two (27.2%) animal isolates and 15 human isolates carried the tetM gene: 10 animal and
eight human isolates carried it alone. Two animal and two human isolates carried tetM
in combination with tetL. tetL was detected in seven animal and three human isolates.
Only animal isolates carried tetL alone (Figure 5.2). The combination of tetK + tetL did
not appear in any of the isolates tested. Among the human isolates a higher frequency of
tetK was found among the MSSA (90%) while the frequency of tetM was greatest in
isolates of MRSA (36.4%) (Figure 5.3). These differences were not statistically
significant (Fisher's exact test P= 0.96 and P= 0.37 respectively).
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lkb
500bp
lOObp
1 2 73 4 5 6
Figure 5.2 Multiplex peR-amplified tet genes from representatives of S. aureus
exhibiting resistance to tetracycline. Lane 1, lOObp ladder; lanes, 2-7 correspond to
isolates in table 5.11
Table 5.11 Isolates represented in figure 5.2
Lane Isolate Number tet gene Animal source
pT181, pSTS-9, tetK, tet L, tetM
2 2567 and BM2509 and tet0 controls
3 O1.9740.M tetK Turkey
4 02.4259.W tetK and tetM Cow
5 O1.9763.L tetL Pheasant
6 02.4280.N tet Land tetM Cow
Phillips goose
7 O1.9796.B tetM hawk
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5.3.2 Tetracycline MIC
The tetracycline MICs of all resistant isolates were in the range 4-> 128 mg/l (Figure
5.4). A total of 98% of human isolates had an MIC of :'516mg/l compared with only
38.3% of animal isolates. For both isolate collections those carrying the tetK gene alone
had the widest MIC range (Table 5.12). Animal isolates carrying the tetK gene alone
had the lowest MICso (32 ug/ml) and the highest MIC9o. In contrast, the lowest MICso
(8 ug/ml) among the human isolates was found in those carrying tetM alone or in
combination with tetL.
Figure 5.4 Distribution of tetracycline MICs of all animal and human resistant strains
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5.3.3 lelK long peR RFLP
Thirty representative tetK positive isolates, 15 animal and 15 human, were selected
based on the animal source, and PFGE pattern. The tetK long PCR product for each
isolate was examined (Figure 5.5) by restriction endonuclease digest, using the AluI,
RsaI, HincHI and KpnI, and produced indistinguishable restriction patterns in line with
computer predictions (Figures 5.6,5.7,5.8 and 5.9). The presence of identical resistance
genes in S. aureus from different animal and human sources and from different clonal
background suggests that the transfer of tetK between animal and human S. aureus
isolates can and does occur.
2 J 4 5 6 7 8 9 10 J I 12
1146bp
Figure 5.5 Undigested products of tetK long PCR. Lanes 1 and
12, 123bp molecular weight marker; lanes 2-11, correspond to
isolates in table 5.13
Table 5.13 Isolates represented in figure 5.5
Lane Isolate No PF type Isolate source
2 01.9709.W A
3 02.4276.N T
4 02.4222.Q D Animal
S 01.9766.E T
6 01.9743.D A
7 02.S389.H 16
8 03.3797.B IS
9 03.IOS9.P I.OS HUl11an
10 03.4741.G 127
I 1 03.3736.T 111
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2 3 4 5 6 7 8 9 10 11 12
Figure 5.6 RsaI restriction fragment digest patterns of tetK long PCR products. Lanes 1
and 12, 100bp molecular weight marker; lane 2, Water control; lanes 3-11, correspond
to isolates in table 5.14
2 3 4 5 6 7 8 9 10 11 12
Figure 5.7 KpnI restriction fragment digest patterns of tetK long PCR products. Lanes 1
and 12, 100bp molecular weight marker; lane 2, Water control; lanes 3-11, correspond
to isolates in table 5.14
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2 3 4 5 6 7 8 9 10 11 12
lkb
500bp
100bp
Figure 5.8 HindI restriction fragment digest patterns of tetK long PCR products. Lanes
1 and 12, 100bp molecular weight marker; lane 2, Water control; lanes 3-11 correspond
to isolates in table 5.14
2 3 4 5 6 7 8 9 10 11 12
lkb
500bp
100bp
Figure 5.9 AluI restriction fragment digest patterns of tetK long PCR products. Lanes 1
and 12, 100bp molecular weight marker; lane 2, Water control; lanes 3-11, correspond
to isolates in table 5.14
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Table 5.14 Isolates represented in figures 5.6,5.7,5.8 and 5.9
Lane Isolate No PFGEtype Isolate source
3 02.4276.N T
4 02.4222.Q D
Animal
5 01.9766.E T
6 01.9743.D A
7 02.5389.H 16
8 03.3797.B 15
9 03.1059.P 105 Human
10 03.4741.G 127
11 03.3736.T 111
5.3.4 Detection of macrolide resistance genes
Ninety five S. aureus isolates were examined for the presence of the erythromycin
resistance genes ermA, ermB and ermC (Figure 5.10 and Figure 5.11). These included
all 28 erythromycin resistant animal isolates (Table 5.1 and Table 5.2) and 67
erythromycin resistant human isolates, selected based on their year of isolation and
PFGE pattern (Table 5.4). A total of 84.5% carried one of the three macrolide resistance
genes. The ermC gene was the most frequently detected resistance gene in the animal
(71.1%) and human (41.8%) isolate collections (Figure 5.12). Among the animal
isolates the ermC gene was found in all three animal groups (companion, livestock and
wild). A total of 7/28 (25%) of animal isolates and 20/67 (30%) of human isolates
carried ermA. Only two isolates, one animal and one human, carried ermB. Eighteen
isolates, all human, did not produce a peR product using the primers listed in Table 5.5
and were classified as non-typablej'".
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1 2 3 4 5 6 7
1kb
500bp
100bp
Figure 5.10 Multiplex PCR-amplified ermA and ermC genes from representatives of S.
aureus exhibiting resistance to erythromycin. Lane 1, 100bp molecular weight ladder;
lanes 2-7, correspond to isolates in table 5.15
Table 5.15 Isolates represented in figure 5.10
Lane No Isolate No erm gene Animal source
2387/00 and -
2 ermA and ermC Control strains
113ero-2222
3 01.9796.B ermA
Phillips goose
hawk
4 01.9760.1 ermC Pheasant
5 1408-1 ermA Dog
6 1866 ermA Dog
7 02.4265.C ermC Cow
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1 2 3
1kb
500bp
100bp
Figure 5.11 PeR-amplified ermB gene from representatives of S. aureus exhibiting
resistance to erythromycin. Lane 1, 100bp molecular weight ladder; lane 2, RN 11 ermB
control isolate; lane 3, animal strain number O1.9763.L.
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5.3.5 Distribution of erythromycin MICs
The erythromycin MICs of all resistant isolates were in the range 32->256 mg/l with
31.4% of human isolates in the range 32-256 mg/l (Figure 5.13). All animal isolates had
an MIC of>256 mg/I. Non-typable human isolates had the widest MIC range. However,
the MICso and MIC90 for all gene classes was >256 mg/I (Table 5.16)
Figure 5.13 Distribution of erythromycin MICs of all animal and human resistant
isolates
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Table 5.16 Distribution of erythromycin MIC and erm gene in MRSA from humans
Gene
Erythromycin MIC (mgll)
32 64 128 256 >256 MICso MIC90
ermA 1 1 5 13 >256 >256
ermB 1 >256 >256
ermC 1 5 22 >256 >256
NT 1 1 2 4 10 >256 >256
5.3.6 Induction of clindamycin resistance in erythromycin resistant S. aureus
strains
Disc diffusion testing produced three distinct resistance phenotypes (Figure 5.14 a, b
and c). All 28 animal and 48/67 (71.6%) human erythromycin resistant isolates
exhibited co-resistance to clindamycin (MLSB phenotype). A total of 78.6% of the
animal isolates, carrying ermA, ermB or ermC, were constitutively clindamycin resistant
and were also resistant to tylosin, a 16 member veterinary macrolide (Figure 5.15). The
remaining isolates were inducibly resistant to clindamycin, showing the characteristic
blunting of the zone of inhibition, and were susceptible to'tylosin (Figure 5.14 a). In
contrast to the animal isolate data, 47 human isolates carrying either ermA or ermC
exhibited the inducible MLSB phenotype. Only a single human isolate, carrying the
ermB gene, was constitutively resistant to clindamycin. All human non-typable isolates
exhibited the negative resistance phenotype (Figure 5.15).378
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a b
c
Figure 5.14 Examples of resistance phenotypes observed in double disc diffusion
testing. Top row (A) Inducible phenotype, (B) Constitutive phenotype. Bottom row, (C)
Negative phenotype.
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Figure 5.15 Characteristics of animal and human erythromycin resistant strains
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5.3.7 tetK resistance gene transfer studies
5.3.7.1 Conjugation
III Human
.Animal
18
Two methods of conjugation were used; the polyethylene glycol (PEG) and broth
transfer methods. Seventeen randomly selected tetracycline resistant animal isolates,
harbouring the tetK gene, were used as donors and WBG879, WBG1876 and WBG822
were recipient isolates. No resistance transfer was observed following either method of
conjugation.
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5.3.7.2 Mixed culture transfer (MeT)
Seventeen S. aureus isolates from a variety of animal species were tested for
susceptibility to phages J, 85 and 95 for use in MeT. Single isolates were susceptible to
phage J and phage 85 and five isolates were susceptible to phage 95 (Table 5.17).
Table 5.17 Phage susceptibilities of selected animal strains
Phage
Test isolate Isolate source PFGE subtype
J 85 95
01.9709.W Chicken A7 R R S
01.9714.A Chicken A9 R R R
01.9740.M Turkey AI4 R S S
01.9774.T Pig AI2 R R S
01.2795.Z Milk 025 R R S
02.4277.E Cow AI2 R R S
01.976S.P Pig TS R R R
02.4275.G Cow AI2 R R R
02.42IS.Q Milk 015 R R R
02.4222.Q Milk 02 R R R
02.4263.W Cow TS S R R.-
02.4257.Q COW T3 R R R
02.4260.Z Cow T4 R R R
02.4259.W Cow T7 R R R
02.42SS.R Cow T2 R R R
02.4276.N Cow T5 R R R
02.4256.Z Cow T4 R R R
Transfer of tetracycline resistance was detected only for isolate 01.9709.W and
WBG822. The transfer frequency was 1.4 x 10-4transcipientldonor.
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5.3.8 Verification of lelK gene transfer
The transcipient, donor and recipient isolates were tested for the presence of tetracycline
resistance by broth microdilution MIC, tetK PCR, RS-PCR and PFGE. The transcipient
had an MIC of 16 ug/ml, the donor MIC was 32 ug/ml, and the recipient was sensitive
with an MIC of <0.06 ug/ml. By PCR the tetK gene was present in the transcipient and
donor isolates and absent from the recipient strain (Figure 5.16). The transcipient and
recipient strains produced RS-PCR and PFGE banding patterns that were
indistinguishable and were dissimilar to those of the donor strain (Figures 5.17 and
5.18).
Ikb
500bp
IOObp
1 2 3 4 5
Figure 5.16 tetK PCR amplicons of donor, recipient and transcipient. Lane 1, 100bp
molecular weight ladder; lane 2, tetracycline susceptible recipient; lane 3, pT181
positive control; lane 4, donor strain (WBG822) and lane 5, transcipient
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2 3 4
Figure 5.17 RS-PCR patterns of donor, recipient and transcipient strains. Lane 1. S.
aureus NCTC8325 reference strain; lane 2, donor; Lane. 3, recipient and Lane 4,
transcipient
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674kb
324kb
208kb
175kb
135kb
80kb
~10kb
1 2 43
Figure 5.18 PFGE banding patterns of the donor, recipient and transcipient. Lane 1,
donor; lane 2, S. aureus NCTC 8325 reference strain; Lane 3, recipient and Lane 4,
transcipient
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By plasmid extraction the donor strain contained four and the transcipient strain
contained three plasmids indicating three plasmids were transferred during the MeT
experiment (Figure 5.19a). The lelK gene has been found on plasmids ranging from 4.2-
4.5kb. Therefore, the bright band, of approximately 4.4kb, indicated by the black arrow
in lanes one and two was thought to be a tetK plasmid. Southern hybridisation revealed
that both donor and transcipient contained four, and faint fifth, plasmids of
approximately 5.5kb, 4.4kb, 2.3kb, 2.2kb and 2.0kb that hybridized with the lelK probe.
These plasmid bands have been shown to represent; I, supercoiled plasmid DNA; I',
covalently closed relaxed circular DNA; II, nicked open circular DNA; III, linear
plasmid DNA and SS, single stranded plasmid DNA (Figure 5.19b).
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2 3 4 2 3 4
23.1kb
"
9.4kb
6.6kb
4.4kb
2.3kb
2.0kb
(a) (b)
Figure 5.19 (a) Plasmid profiles of the donor, recipient and transci pient. Lane 1, donor;
lane 2 transcipient; lane 3 recipient and lane 4 A-DNA molecular weight marker. The
bands marked with a black arrow indicate the predicted (elK plasmid. (b) Southern
hybridization of donor, recipient and transcipient. Lane 1, donor; lane 2 transcipient;
lane 3 recipient and lane 4 A-DNA molecular weight marker. I, supercoiled plasmid
DNA; I', covalently closed relaxed circular DNA; II, nicked open circular DNA; III,
linear plasmid DNA; SS, single stranded plasmid DNA.
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An examination of the restriction enzyme recognition sites of plasmid pT181 that
digestion of the tetK plasmid with HindIII and Xbal should produce two fragments, one
of 2.3kb and one 4.4kb, that should hybridise with the tetK probe (Figure 5.20)151.
OR!
HindIII 3797
XbaI3782
pT18I
4.4kb
HindIII 1445
Figure 5.20 Restriction map of the tetracycline resistance plasmid pTI81. ORI, origin of
DNA leading strand synthesis; tet, tetracycline resistance gene.
Hybridisation of the plasmid endonuclease digests produced bands of the predicted size
confirming the transfer of a 4.4kb tetK plasmid from 01.9709.W (a S. aureus isolated
from a chicken) and WBG822 (S. aureus 8325-4 strain lysogenised by phage 95)
(Figure 5.21).
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23.1kb
9.4kb
6.6kb
4.4kb
2.3kb
2.0kb
(a) (b)
Figure 5.21 (a) HindIII andXbaI endonuclease digestion of plasmid extracts. Lanes 1-3,
HindIII digest of WBG822 recipient, 01.9709.W donor and 01.9709.W-WBG822
transcipient; Lanes 4-6 XbaI digest of WBG822 recipient, 01.9709.W donor and
01.9709.W-WBG822 transcipient; Lane 7, A-DNA DIG-labelled molecular weight
marker. (b) Hybridisation of HindIII and XbaI endonuclease digests of tet); plasmid.
Lanes 1-3, HindIII digest of WBG822 recipient, 01.9709.W donor and 01.9709.W-
WBG822 transcipient; Lanes 4-6 XbaI digest of WBG822 recipient, 01.9709.W donor
and 01.9709.W-WBG822 transcipient; Lane 7, A-DNA DIG-labelled molecular weight
marker.
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5.3.9 Loss of resistance/plasmids
The transcipient (01.9709.W-WBG822) and donor (01.9709.W) strains were incubated
for four days at 37°C and 43°C in nutrient broth (Oxoid, UK), subcultured onto
Columbia blood agar for purity assessment then examined for resistance loss by disc
diffusion. Donor and transcipient isolates incubated at 37°C retained plasmid mediated
tetracycline resistance. No tetracycline resistance was detected in either isolate after
incubation at 43°C. Plasmid extraction and subsequent electrophoresis confirmed the
loss of all plasmids and of tetracycline resistance in isolates incubated at 43°C. The tetK
positive control strain pT181 was included as a control strain. Loss of tetracycline
resistance was also detected in this strain after four days incubation at 43°C while no
loss of resistance was detected in the culture incubated at 37°C.
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5.4 Discussion
5.4.1 Tetracycline resistance genes in S. aureus isolates
In the first part of this study the presence of the four specific tetracycline resistance
genes (tetK, tetL, tetM and tetO), thus far found in staphylococci, was determined
among animal and human S. aureus isolates. PCR characterization of the 134
tetracycline resistant strains examined showed they all carried one of the three
tetracycline resistance genes, tetK, tetL and tetM alone or in combination and an
absence of the tetO gene. Similar data on the prevalence of the tetracycline resistance
genes tetK, tetL or tetM and absence of tetO among S. aureus isolate, between 1987 and
1998 from livestock, including cattle, pigs, rabbits, mink, turkey and duck, companion
animals, including cat, dog, guinea pig and pigeon, and between 1997 and 1999 from
humans, have previously been published by Schwarz et al and Bismuth et aPS,3S4.
The tetK gene is considered to be indigenous to staphylococci, often located on small
plasmids, for example pTI8I, which can be mobilized or transduced between members
of the same or related staphylococcir'". Studies by Schmitz et ap74, Trzcinski et at34,
Bismuth et aps, Ardic et al23, Huys et all96 and Aarestrup et al5 on the presence of
tetracycline resistance genes among S. aureus and CNS from animals and humans have
all shown tetK to be the most prevalent tetracycline resistance determinant38,384. The
tetK gene was also the most frequently detected tet gene among strains in this study,
present in 79% of animal and 81.1% of human tetracycline resistant strains. Because of
the omnipresence of the tetK gene among S. aureus isolates from animals, data from
this part of the study indicate that tetK has established itself as an endemic tetracycline
resistance determinant among animal S. aureus as it has in human S. aureus.
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The tetL gene was originally found in various Bacillus spp but more recently it has been
described in five other Gram-positive genera, including staphylococci, Mycobacterium
spp, and Streptomyces spp, and in the Gram-negative anaerobes, Fusobacterium spp,
and Veillonella Spp295,473.Previous studies have shown a low prevalence of tetL in
isolates of S. aureus, predominantly from pigs and in MRSA, but not MSSA, from
humans374,383,384.Data from this study has also shown a low frequency of tetL (8.6%) in
animal isolates, mainly from cattle but not pigs, and human isolates. Schwarz et al have
also found the tetL gene to be present in 8% of tetracycline resistant staphylococci
isolated from a selection of domestic and companion animals. In that study <1% of S.
aureus carried tetL and it was the predominance of this gene among isolates of S. sciuri
that accounted for the increased frequency''". In this study, no tetL was detected in S.
aureus isolates from companion animals.
tetM was the second most frequently detected tetracycline resistance gene among
animal and human S. aureus in this study. Mostly located on conjugative transposons,
tetM genes have been shown to be easily transferred with these mobile elements'f",
Reports by Bismuth et aP8, Schmitz et aP74 and Ng et al31 ~..have also found tetM to be
the second most prevalent tet gene in human MSSA isolates and the most prevalent
gene in isolates of MRSA. While tetM can be found in combination with tetK, they all
report that tetK is never found alone in human MRSA. In contrast, Trzcinski et al have
shown tetK to be the sole source of tetracycline resistance in 32% of human MRSA
isolates from Poland434. Seven isolates of MRSA, from companion animals, were
examined in this study and all carried telM as the sole source of tetracycline resistance.
These animal isolates were previously characterized (data not included) as MRSA
USA 100, belonging to MLST ST5, a common human epidemic clone229.This suggests
308
a similar predilection of tetM for animal MRSA or it is also possible that this represents
MRSA transmission between humans and companion animals387• The transmission of
MRSA (EMRSA15) from humans to companion animals has previously been reported
by Manian and Guardabassi et aI168,280. A report by Voss et al, in 2005, found pig to
human transmission of MRSA multi-locus sequence type ST398 in The Netherlands'?'.
de Neeling et al and Khanna et al have documented a high prevalence of this MRSA
clone in slaughter pigs in The Netherlands and Canada95,229. It is believed that this S.
aureus lineage originated in pigs and has been the cause of serious human infections in
The Netherlands, Germany and AustriaI93,487. In contrast, a recent report by Jones et al
has shown that not only was tetK the most prevalent tet gene, among human MRSA and
MSSA isolates, but was the sole source of tetracycline resistance in 73.9% and 73.8%
of isolates respectively'{'. In this study there was a variation in the distribution of the tet
genes between human isolates of MRSA and MSSA where the frequency of tetM
among MRSA was double that detected in MSSA.
Among both isolate collections the combined presence of tetK + tetM and tetL + tetM
was seen at relatively low frequencies. In neither isolate collection was the combination
tet(K) + tet(L) seen. A single human MRSA isolate simultaneously carried tet(K), tet(L)
and tet(M). Bismuth et aI, in a study on gene heterogeneity for tetracycline resistance in
staphylococcal species from humans, have reported the presence of tetK + tetL in S.
aureus and tetK, tetL + tetM in S. epidermidis'", It has been reported by Schmitz et al
that the combination of tetK + tetM genes was approximately 10 times more prevalent
in tetracycline resistant MRSA than MSSA375. There was a difference in the distribution
of this gene combination in isolate s from this study. However, the overall number of
isolates carrying both tetK and tetM was low making a comparison difficult.
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Tetracycline resistance caused by the tetO gene was first detected in campylobacter,
enterococci and streptococcal species of human and animal origin and have a common
. h MI09110341501 f h . .ancestor WIt tet "'. Reports 0 t e tetO gene III staphylococci are rare. The
TetO determinant is not associated with conjugative elements which accounts for it
being less widely distributed that tetM 73. The tetO gene was not detected in either of the
S. aureus isolate collections in this study. Although, Schwarz et al have reported the
presence of tetO in the chromosomal DNA of S. intermedius and S. xylosus isolated
from domestic animals384•
The almost identical distribution of tet genes in animal and human S. aureus in this
study shows that similar tet genes encode tetracycline resistance among S. aureus from
these different reservoirs.
5.4.2 Analysis of tetK long peR RFLP products
RFLP, of tetK long PCR products, was performed to determine the genetic relatedness
of tetK genes from animal and human S. aureus isolates. Endonuclease digestion, with
four restriction enzymes, of the tetK long PCR products of 15 animal and human
tetracycline resistant isolates revealed these genes to be genetically homogeneous. No
previous reports on the structural similarities of the tetK genes isolated from animal or
human S. aureus could be founding a search of the online database of the United States
national library of medicine (http://www.pubmed.gov). Data published by Salyers et ai,
on the sequence analysis of the tetQ gene found in different Gram-negative anaerobes
has shown sequence similarities of 96-100%. Salyers et al concluded that this high
sequence similarity supported the hypothesis that the gene had been spread by
horizontal gene transfer and ruled out convergent evolution, the independent evolution
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of two versions of the same gene202• As the tetK gene is located on small highly mobile
plasmids it is likely that the presence of indistinguishable tetK genes in S. aureus
isolated from animals and humans may be due to horizontal gene transfer between these
two populations, although the direction of transfer remains unknown. It is also possible
that the tetK genes in both animal and human strains may have been introduced from
bacteria from different ecosystems. Therefore, both the source and direction of
transmission of tetK remains to be confirmed.
5.4.3 Tetracycline MICs
The tetracycline MIC for all isolates was determined by the broth microdilution method.
Results show a wider tetracycline MIC range for animal S. aureus strains (8-> 128mg/l)
compared to that of the human strains (4-32mg/l) and of those published by Aarestrup et
at,IO in S. hyicus from pigs (4-64mg/l) and S. aureus from poultry (4-64mg/l) from
Denmark and Vancraeynest et al in S. aureus from rabbits (16-64mg/l) from five
European countriest'". The higher MICs in isolates from this study, compared to those
of animal isolates from Denmark, are likely a reflection of the higher levels of
tetracycline consumption in UK agriculture3,428. Over 98% of human isolates had an
MIC of :::;16mg/l while 85% of animal isolates had an MIC of ::::32mg/l, The low MIC
levels seen among human isolates in this study contrasts with data from Bismuth et al,
Trzcinski et al and Sekiguchi et al who have all reported tetracycline MICs ranges of
between 16-512mg/1 among human S. aureus isolates from France, Poland, Turkey,
Bulgaria, Latvia, Slovenia, Hungary, Russia and Japan38,388,434. Over the past decade, as
the frequency of tetracycline resistance has increased, there has been a reduction in the
use of tetracyclines in the treatment of human S. aureus infections which may account
c. h . th . 351lor t e lower MICs compared to those seen In 0 er countnes .
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In a review, of tetracycline resistance determinants in 1996, Roberts reported that an
interesting property of ribosomal protection proteins is that they do not normally confer
high level tetracycline resistance, as compared to the efflux genes3S3.Recent reports
have shown tetracycline MICs for human S. aureus isolates carrying lelK or lelM alone
to be comparable. Among the human isolates those carrying lelK or lelM alone had
identical MICso and MIC90 results. Conversely and consistent with Roberts, animal
isolates in this study carrying the lelK gene alone had a fourfold higher MIC than
isolates carrying the lelM gene alone3s3. A low number of isolates, in both animal and
human S. aureus populations, carried the lelM gene making a comparison between the
two populations unfeasible. A study by Bismuth el al reported that the gene
combination lelK + lelM had an additive effect on the tetracycline MIC compared to
lelK or zerM alone". In neither population in this study did the presence of multiple tet
genes result in an appreciable increase in the tetracycline MICso or MIC9o.
5.4.4 tetK resistance gene transfer
5.4.4.1 Conjugative transfer
From plasmid profiling, it was observed that the lelK positive strain carried a plasmid
with the estimated size of 4.2-4.4 kb which indicated the presence of a pTl81-like
plasmid227. The lelK-containing plasmid pT181 (GenBank accession number J01764) is
regarded as the prototype of a family of small naturally occurring transmissible
plasmids that are known to occur not only in clinical S. aureus but also in tetracycline
resistant staphylococci from the environment, wild rodents and insectovarsl77•
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The ability of S. aureus strains isolated from animals to transfer plasmid mediated
tetracycline resistance was studied in conjugation and mixed culture transfer
experiments. Seventeen isolates from domestic animal species representing the major
PF groups were selected. Of the seventeen isolates selected for transfer by PEG and
broth mating no resistance gene transfer was detected. Resistance gene transfer among
staphylococci by conjugation has previously been reported438,44o. Plasmid mediated
resistance was successfully transferred between laboratory strains of S. aureus and S.
epidermidis by McDonnell et al and Forbes et al by filter mating at transfer frequencies
of 10-6_10-8 141,288. The transfer of mupirocin and chloramphenicol resistance was
undertaken by Udo et al between laboratory isolates of coagulase negative
staphylococci (eNS) and S. aureust", They reported no plasmid mediated resistance
transfer between eNS and S. aureus and suggest that this may be due to the presence of
a restriction-modification barriel40• The role of restriction-modification systems is to
prevent the uptake of potentially harmful or lethal DNA, such as bacteriophages, or
prevent the acquisition of superfluous genes that may compromise fitness due to
increased metabolic demandl'". Waldron and Lindsay have shown substantial variations
in the genes encoding Saul (saul hsdS genes), a lineage ..specific type I restriction-
modification system that blocks horizontal gene transfer in and between S. aureus
isolates of different lineages. They also revealed that these differences corresponded to
the major S. aureus lineages and suggest that horizontal gene transfer within lineages
occurs at a higher frequency than between Iineages'f". The isolates used in this study
belonged to the major MLST groups found among the animal collection. These
included ST5, ST9 and ee97. The recipient strain used in this study was, S. aureus
8325-4, a human strain belonging to ST8. Therefore, conjugative transfer of tetracycline
resistance between these strains may have been inhibited by the presence of lineage
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specific restriction-modification systems. A previous study by Shoemaker et al has
shown that conjugative tetracycline resistance gene transfer exhibited regulated transfer
requiring the donor to be initially pre-treated with low levels of tetracycline. After
induction the rate of transfer increased by 1000-10,000 fold394. Antibiotic pre-treatment
of bacteria induces an SOS response that has been shown to promote the transfer of
conjugative resistance elements. In contrast to the data from Shoemaker et aP9\ Beaber
et aP2 have shown that the SOS response could not be induced by antibiotics to which
the donor strain is resistant. None of the 17 donor isolates used in this study was
initially pre-treated with tetracycline. Therefore, it is possible that conjugative transfer
of the tetK gene may have occurred but at such a low frequency that it could not be
detected under these experimental conditions. A study by Udo et al was also
unsuccessful in transferring plasmid mediated tetracycline resistance between S. aureus
strains by conjugation=".
5.4.4.2 Mixed culture transfer
Early experiments on the transfer of resistance plasmids in mixed broth cultures
indicated that successful transfer was dependent on calcium ions and investigators
attributed this method of transfer to be phage mediated conjugation=". Isolates used in
mixed culture transfer were selected on the basis of phage susceptibility to phages J, 85
and 95. Four isolates exhibited susceptibility to phages 85 or 95 and were mated with
the corresponding lysogenised S. aureus isolates. A single donor S. aureus isolate
(01.9709.W) from a chicken, belonging to ST5, transfered tetK mediated resistance to
the recipient isolate WBG822 (S. aureus 8325-4 lysogenised with phage 95) at a
transfer frequency of 1.4 X 10-4. Udo and Grubb have also shown phage mediated
tetracycline resistance transfer between a human clinical S. aureus strain and a
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laboratory mutant strain, although at a much lower transfer frequency than seen in this
study439. Initially resistance transfer was established by broth microdilution MIC and
tetK PCR of the transcipient strain together with donor and recipient. To confirm that
plasmid transfer had occurred between O1.9709.W and WBG822, the donor, recipient
and transcipient strains were analysed by RS-PCR, PFGE, plasmid isolation, plasmid
restriction digest and subsequent Southern hybridisation. The transcipient was shown by
RS-PCR and PFGE to have banding patterns identical to WBG822. Three plasmids of
approximately 15 kb, 9 kb and 4.4 kb were transferred between donor and recipient.
DNA-DNA hybridisation analysis revealed five bands demonstrating homology to the
tetK probe in the plasmid extracts of donor and transcipient but not the recipient strain.
Experiments on the in vitro replication of the tetK plasmid, pT181 by Khan et al, have
shown that this plasmid could be present intracellularly in five different structural
forms227• Southern blot analysis of plasmid pT181 revealed five bands hybridising with
a tetK probe and was subsequently shown to correspond to; super coiled plasmid DNA;
covalently closed relaxed circular DNA; nicked open circular DNA; linear plasmid
DNA; and single stranded DNA. These bands were consistent to those seen in the initial
hybridisation experiment. Restriction analysis, using' HindIII and XbaI, and
hybridisation analysis of the plasmid extracts of donor and recipient isolates confirmed
the horizontal transfer of a 4.4 kb, pTI81-like, plasmid.
Incubation of the donor and transcipient isolates for four days at 37°C and 43°C
resulted in the stable maintainence of the 4.4 kb plasmid and in the expression of
tetracycline resistance at 37°C and the loss plasmid mediated tetracycline resistance at
43°C.
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These data verify that the horizontal transfer of a tetracycline resistance plasmid
between strains 01.9709.W, isolated from a chicken, and WBG822 had occurred. The
frequency of plasmid transfer in this study was also higher than previously reported by
McDonnell et at and Forbes et atI41,288.
5.4.5 Macrolide resistance genes in S. aureus isolates
In S. aureus a number of genes confer resistance to macrolides predominantly by target
site modification. The genes responsible for this target site modification have been
designated ermA, ermB, and ermC and are present in 94-98% of resistant isolates478•
Additionally, and at very low frequencies, resistance can also be caused by inactivation,
encoded by ereA and ereB, and active efflux, encoded by msrA and msrB 263,354,384,474.
All of the 28 animal and 56177 (73.1%) human isolates carried one of the erm genes.
The ermC gene was the most prevalent macrolide resistance gene, in both animal
(71.4%) and human isolates (41.8%), followed by ermA. Data on the prevalence of
macrolide resistance genes in staphylococci from different animal species and from
humans have been published46,263,269,277,310,312,478. Analysis' of erythromycin resistance
determinants in S. aureus of poultry and human origin from the USA has shown ermA
to be predominant (100% in poultry and 88% in humans) followed by ermC (50%) in
poultry and ermB (72%) in human isolates310• Nicola et at has also shown that the ermA
gene was the predominant macrolide resistance gene of human S. aureus isolates
originating from the USA between 1958 and 1969312• Both authors conclude that ermC
has only recently become prevalent in the S. aureus population 140. Also study by Westh
et at has shown that while in human S. aureus in Denmark from the late 1950's ermA
was solely responsible for erythromycin resistance by 1988 ermC had replaced ermA as
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the dominant gene478. They also reported that the ermA and ermC genes were
responsible for over 98% of erythromycin resistance in human blood culture isolates
with the ermB gene infrequently found. These data contrast with those of Nawaz et al
who have found the ermA gene to be the predominant erythromycin resistance gene
carried in 72% of human clinical S. aureus collected in 1999 while ermC was carried in
only 4% of these isolates'". Data published by Liithje and Schwarz has shown that
ermB was the predominant resistance gene among erythromycin resistant S. aureus
isolated from domestic and companion animals collected in Germany between 2003 and
2005277• In contrast, in both isolate collections in this study the ermB gene was detected
at a frequency of between 1.5-3.6%. In agreement with data from this study,
investigations into the molecular mechanisms of macrolide resistance conducted by
Weisblum and Schmitz et al, among S. aureus isolated from humans, and Jensen et al
and Nawaz et ai, among S. aureus isolated from domestic animals, have all shown a
very low frequency of ermB gene detection202,310,375,474.
It is interesting to note that while ermA has been shown to be the predominant
resistance gene found in MRSA of human origin, followed by ermC, both ermA and
ermC were found at an identical frequency among the human isolates of MRSA in this
studY3,140,263. This data contrasts with that of Spiliopoulou et al who found that ermC
was most prevalent amongst human MRSA in Greece collected between 1999 and
2001, which they attribute to the spread of two major MRSA clones 409. It is likely that
the equal distribution of ermA and ermC genes among the human MRSA in this study is
as reflection of the large number of different clonal backgrounds examined. The ermA
gene was the most prevalent erm gene detected in companion animals, previously
characterized as USAlOO ST5, from the USA. It has been proposed that MRSA isolated
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from companion animals originate from humans''". The MRSA USAlOO clone is a
common human MRSA and it is therefore likely that these isolates were of human
origin. Kennedy et at have also shown ermA to be the most prevalent macrolide
resistance gene found in human community acquired MRSA in the USA which they
attribute to the recent emergence and expansion of the USA300 MRSA clone223.While
in this study all S. aureus isolated from animals carried one of the erm genes, over one
quarter of human S. aureus isolates were non-typable using primers for the ermA, ermB
and ermC genes. Jensen et at have also reported the absence of erm genes among S.
aureus from human clinical sources and staphylococci from cattle although at a much
lower frequency''". As PCR for the msrA, msrB, ereA, and ereB genes was not
performed in that study or this study it could not be ruled out that these genes may be
present in the non-typable resistant isolates.
5.4.6 Erythromycin MIC of human and animal S. aureus isolates
The human S. aureus isolates exhibited a wide erythromycin MIC range with erm gene
non-typable strains exhibiting the widest MIC range (32->256mg/I). Regardless of the
class of erm gene present all animal strains exhibited an MICso and MIC90 of~256 mg/l.
This high level macrolide resistance has been reported previously by Liithje et at in
CNS from cattle and S. aureus from human sources276,277.While the MIC range of the
CNS from cattle was between 4-2:128 mg/l over 70% of these isolates had an MIC of
~128 mg/l. Those isolates with high MIC values carried either ermB or ermC expressed
both inducibly and constitutivelr76,277. The human isolates also carried mainly erm
genes, expressed in most cases constitutively, which conferred erythromycin MIC
values of 2:64 mglI277.Spiliopoulou et at have also shown erm gene containing MSSA
and MRSA isolated from humans exhibiting MICs to erythromycin in the range 8-
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>1024 mg/I. In the same study they also noted that some ermC containing MSSA could
be susceptible to erythromycin by disc diffusion using the NCCLS criteria and had
MICs, of between 1-3 mg/l, well below the published breakpoint'f". As not all strains in
this study were examined for the presence of ermC it is possible that some strains
exhibiting susceptibility to erythromycin, by disc diffusion, may carry copies of ermC.
5.4.7 Induction of clindamycin resistance in erythromycin resistant isolates
The results of this study have shown three distinct MLSB resistance phenotypes;
inducible, constitutive and negative. Among the animal isolates all livestock and wild
animals, regardless of erm gene, expressed constitutive resistance. While among the
companion animals there was an equal distribution of constitutive and inducible
resistance. This high level of constitutive resistance in staphylococci from livestock
and companion animals has been reported previously by Luthje and Schwarz and their
results are in agreement with data from this studl76• Resistance to 14, 15 and 16
membered lactone ring structures in macrolides is a characteristic of constitutive erm
gene expression resulting in high macrolide MICs. The use of tylosin, a 16 member
veterinary macrolide, therapeutically in animals may explain the high frequency of
constitutive MLSB resistance seen among the animal strains. No 16 member macrolides
are licensed for use in humans/'". Therefore, it is likely that this accounts for the lack of
constitutive macrolide resistance in the human isolates in this study. A study by Steward
et al have also shown that the majority of human S. aureus carrying either ermA or
ermC expressed inducible MLSB resistance while those carrying ermB resistance was
constitutivel!'. These results are in concordance with data from this study where all
human isolates carrying either ermA or ermC expressed an inducible MLSB phenotype
and those carrying ermB expressed a constitutive resistance phenotype. Steward et al
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also reported the presence of erythromycin resistance and clindamycin susceptibility, an
MLSB negative phenotype, in 10% of the isolates tested. These isolates were shown to
carry the msrA gene which encodes active drug efflux411• All erm gene non-typable
isolates in this study also had the negative ML8B phenotype. peR for the detection of
the msrA gene was not performed. The lack of an erm gene together with a negative
ML8B phenotype suggests the presence of an active efflux mechanism in these isolates.
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Chapter 6 Overall conclusions and future work
6.1 Conclusion
The hypothesis of this study is that antibiotic use in animals has influenced antibiotic
resistance in human S. aureus strains. In order to investigate this hypothesis the
similarity of clones, the frequency of antibiotic resistance, the resistance genes
responsible for tetracycline and macrolide resistance and the possibility of resistance
gene transfer between animal and human S. aureus was examined.
The first step in determining the similarities between animal and human S. aureus
involved an evaluation of phenotypic and genotyping methods to ensure that all isolates
could be typed and that these methods had a suitable level of discrimination.
Antibiogram and phage typing have been used to characterize S. aureus isolated from
animals for 50 years. All isolates were typable by antibiogram and a discriminatory
value of 88.2% was obtained. The poor discriminatory power of this method is
attributed to the fact that two strains with no epidemiological link can have the same
antibiogram while two isolates of the same clone can acquire and lose plasmid mediated
antibiotic resistance and exhibit different phenotypes. Seventy six percent of animal
isolates were typable by bacteriophage typing and a discriminatory value of 83.5% was
obtained. Similar high levels of nontypability have been shown previously with bovine
and human S. aureus isolates459• Due to the low discriminatory values of both methods
and in the case of phage typing poor typeability these methods were unsuitable for
characterizing S. aureus isolated from animals.
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The PCR based typing method, RS-PCR, resolved 27 distinct banding patterns with a
discriminatory value of 86.2%. Although all isolates could be typed by this method the
low level of discrimination makes it unsuitable for characterizing animal S. aureus
isolates.
PFGE, MLST and spa typing had a typeability value of 100% and were shown to be
highly discriminatory with values of 93.1%, 91.4% and 95.4% respectively. A high
level of concordance was demonstrated between these three typing methods. While spa
typing does not have the resolving power of PFGE subtyping, it has several advantages
in terms of speed, ease of use, ease of interpretation and standardization. Although spa
typing proved to be superior in discriminatory power, PFGE is suitable tool for typing
S. aureus isolated from animals in short term outbreak situations, providing results
comparable to those obtained by MLST. Of the three DNA based techniques used
MLST produced the lowest discriminatory value. This method sequences conserved
core genes that encode essential proteins and is better suited for long term
epidemiological and evolutionary studies. Tenover et al, has reported that no single
typing method appears to be clearly superior in all cases. The current ability of spa
typing to distinguish both molecularly and epidemiologically linked strains rapidly and
easily makes it particularly well suited for typing S. aureus isolated from animals'r'.
Based on MLST analysis animal S. aureus isolates belonged to 18 different clonal
backgrounds. Four predominant clones, CC5, CC9, CC97 and CC814, accounted for
84% of the isolates. The CC5 clone was represented by isolates from chicken, cattle,
partridge, pig and turkey from Grampian, Highland, Northern Ireland and Southwest
Scotland. The CC814 clone was represented by avian isolates from Highland and
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Northern Ireland. The CC9 clone was represented by isolates from cattle and pig from
Grampian and Highland regions. The CC97 clone, with the exception of a single
chicken isolate from Northern Ireland, was represented by isolates from cattle. Two
bovine predominant clones, CC9 and CC97, have been isolated from cases of hospital
infection but are not a significant source of human infection. However, CC5, is known
to be the third most prevalent S. aureus clone in the UK24o, one of the five major
hospital acquired S. aureus clones world wide and is the most prevalent clone in the
USA and Japan.
Five further S. aureus clones in this study (CC15, CC20, CC22, CC30 and CC45) found
in the animal isolate collection have also been isolated from humans. In addition to the
CC5 above this finding is particularly noteworthy in light of the clinical importance of
CC22 (EMRSA-15), CC30 (EMRSA-16) and CC45 (Berlin clone) as the three most
common causes of nosocomial bacteraemia in the UK. The relatedness of the six clones
found in both animal and human isolate collections was further supported by the
analysis of 20 different virulence determinants.
Thirteen percent of animal isolates were susceptible to the 22 antibiotics tested and
73.4% resistant to two or fewer. The highest frequency of resistance was to penicillin
(65.2%) followed by tetracycline (31.8), sulphamethioxazole (20.2%), ciprofloxacin
(19.7%) and streptomycin (10.7%). Isolates of CC5 exhibited resistance to
ciprofloxacin, clindamycin, erythromycin, penicillin, streptomycin, tobramycin and
tylosin, CC 15 to penicillin and tetracycline, CC22 to penicillin and rifampicin and
CC30 to penicillin. Isolates belonging to CC45 were fully susceptible. No resistance to
fusidic acid, gentamicin, kanamycin, linezolid, mupirocin, oxacillin,
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quinupristinldalfopristin, teicoplanin or vancomycin was detected. Therefore, S. aureus
isolates of animal origin exhibit resistance to antibiotics commonly used in the
treatment of human infection.
Currently there are no internationally recognised breakpoints for biocide susceptibility
testing. This study has found that S. aureus isolated from animals in the UK have either
not or to only a limited degree developed low level resistance to biocides commonly
used for disinfection. The determination of low level resistance to benzalkonium
chloride and chlorhexidine in this study was based on previously published MIC data by
Suller and Russell and Cookson et aF8,417. At present the clinical significance of low
level biocide resistance in S. aureus is not clear.
Examining the genes underlying tetracycline resistance in both animal and human
isolate collections showed an identical distribution of tet genes and in both cases tetK
was predominant. This gene was carried by animal isolates belonging to CC5 and
CC15. Furthermore RFLP of tetK amplicons, from animal and human isolates,
produced indistinguishable restriction patterns. The obser-vation of identical resistance
genes in different clonal backgrounds and from different geographical locations
suggests that horizontal transfer of the tetK gene, rather than convergent evolution, has
occurredP.
Examining the genes underlying macrolide resistance in both animal and human isolates
collections ermC followed by ermA were predominant. This has previously been
reported by Westh et al and Nicola et aPI2,478.Two bovine isolates belonging to CC5
carried the ermC gene and an isolate from a Phillips goose hawk, also CC5, carried the
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ermA gene. This data shows that wild and livestock animals can carry S. aureus clones,
commonly found in humans in the UK, that harbour the predominant macrolide
resistance genes.
High frequency transfer of a 4.4kb lelK plasmid from a chicken S. aureus, CC5 clone,
to a laboratory S. aureus strain (8325-4) was observed. Moreover, this transfer of
plasmid mediated tetracycline was shown to be stably maintained.
In conclusion spa typing has been shown to be the most flexible and suitable method for
typing S. aureus isolates from animals. S. aureus clones that cause serious infection in
humans can be isolated from wild, livestock and companion animals. These clones
exhibit resistance to antibiotics used to treat human infection, harbour the same
tetracycline and macrolide resistance genes and are able to horizontally transfer the lelK
gene. These data are therefore supportive of the hypothesis that animals represent an
important reservoir of antibiotic resistant S. aureus with the ability for strain and
antibiotic resistance gene transfer between animals and humans
6.2 Future work
Two observations from this study merit further investigation. Firstly, human S. aureus
isolates have been shown to carry copies of the ermC gene but could be susceptible to
erythromycin by disc diffusion testing and have MICs below the published
breakpoint'?". It would therefore be interesting to determine if this phenomenon could
be found in S. aureus from animals, what mechanism is preventing the expression of
this gene and if the MIC could be increased by exposure to macrolides.
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Secondly, the eft (chloramphenicollflorfenicol resistance) gene encodes a 23S rRNA
methyltransferase that confers resistance to linezolid, an antibiotic used exclusively in
humans. Two bovine isolates were resistant to chloramphenicol. It would be interesting
to examine these animal isolates for the presence of the eft gene and if present what
affect this has on the linezolid MIC.
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